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ABSTRCf
The overall emphasis in this thesis is the study of the
regulation of virus infections by natural killer (NK) cells. In initial
analyses, vaccinia virus (VV)-infected cells were found to be more
sensitive to NK cell-mediated lysis during a discrete period of time
post-infection. This enhanced susceptibility to lysis correlated with
enhanced triggering (but not binding) of the effector cells and a
concomitant decrease in target cell H- class I antigen expression.
Furthermore VV -infected cells became resistant lysis
allospecific cytotoxic T lymphocytes (CTL) at a time when they were
very sensitive to killing by NK cells or VV -specific CTL. This
suggested that alterations in class I MHC antigens may affect target
cell sensitivity to lysis by NK cells.
The hypothesis that viral peptide charging of H- class I
molecules can modulate target cell sensitivity to NK cell-mediated
lysis was tested by treating target cells with synthetic viral peptides
corresponding to the natural or minimal immunodominant epitopes
defined for virus-specific CTL, and then target cell susceptibility to
NK cell-mediated lysis was assessed. None of the 12 synthetic viral
peptides used were able to significantly alter target cell lysis by NK
cells under any of the conditions tested.
In order to determine if H- class I molecules were required in
the regulation of a virus infection by NK cells in vivo intact or NK-
depleted (treated with anti-asialo GMI antiserum) 2-microglobulin-
deficient ( 2m (-/-)) mice, which possess a defect in H- class I
antigen expressIOn, were infected with the prototypic NK-sensitive
virus, murine cytomegalovirus (MCMV). In anti-asialo GMl- treated
~2m (-/-) mice, as well as in ~2m+ (H- class I normal) control mice
also treated with anti-asialo GMl, a significant enhancement in
splenic MCMV titers as compared to NK-intact animals, was ob$erved.
When thymocyte expression of H- class I molecules (H-2Db) in
normal mice was analyzed it was found that following MCMV
infection, H-2Db expression was significantly greater than the low
level of expression found in uninfected thymocytes. In marked
contrast thymocytes from ~ 2 m (-/-) mice did not display any
detectable 2Db before or after infection. These in vivo results
demonstrate that NK cells can regulate a virus infection, at least in
the case of MCMV independent of H-2 class I molecule expressIOn.
Thymocytes from uninfected normal mice were found to be
very sensitive to NK cell-mediated lysis, whereas those from MCMV-
infected animals were completely resistant, presumably due to the
protective effects of MCMV -induced interferon (IFN). However
thymocytes from MCMV -infected ~2m (-/-) mice were only slightly
protected from lysis by NK cells, consistent with the inverse
correlation between MHC class I antigen expression and sensitivity to
NK cell-mediated lysis. These results provide in vivo evidence
suggesting a requirement for MHC class I molecules in IFN -mediated
protection from lysis by NK cells.
In addition to the analysis of H- class I molecules on target
cells, the identity of a molecule present on the surface of all NK cells
Vll
and other cytotoxic effector cells, which is recognized by 
monoclonal antibody (mAb) generated in this laboratory designated
CZ- , and can also modulate NK cell triggering, was also of interest.
This laboratory has previously reported that this antigen
upregulated on cytotoxic (and other) lymphocytes following a virus
infection in vivo, or upon activation in vitro. Using competitive FACS
analysis and fibroblasts transfected with various isoforms of CD45, it
was found that mAb CZ- l recognizes a sialic acid-dependent epitope
associated with a subpopulation of CD45RB molecules.
VllI
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CHAR I
INODUCI0N
A. Overview of Natural Killer (NK) Cells
Discovery and initial characterization of natural killer cells.
the early 1970s, a few groups studying the immune response to
tumors began report the ability leukocytes from
nonimmunized animals (Herberman et aI., 1973; Nunn et aI., 1973;
Greenberg and Playfair, 1974) and humans (Takasugi et aI., 1973) 
lyse various target cells. In these initial, reports, it was not entirely
clear which effector cell(s) was mediating this cytolytic activity For
example, one study (Herberman et aI., 1973) was only able 
conclude that the effector cells were "not a-bearing lymphocytes
and therefore not T cells. Another report suggested that the effector
cell(s) mediating spontaneous cytotoxic reactivity against P815
mastocytoma targets was of "neither phagocytic or T-cell origin
(Greenberg and Playfair, 1974). These initial studies stimulated an
interest to determine if, indeed, a novel naturally cytotoxic effector
cell capable of killing tumor cells existed. In investigations of cell-
mediated immune responses to tumor cells particular those
tumors induced by murine leukemia viruses, it was found that
leukocytes from unimmunized mice could " specifically" lyse leukemia
cells induced by Moloney leukemia virus and those induced by other
means which resulted in the expression of endogenous retroviral
antigens (Kiessling et aI., 1975a; Herberman et aI., 1975a). These two
groups were also able to demonstrate that the effector cell
responsible for this lytic activity was a nonadherent (Le., non-
macrophage/monocyte), non- , non- lymphoid cell (Kiessling et at,
1975b; Herberman et aI., 1975b). The results of these studies
suggested that a new type of cytotoxic lymphoid cell existed and was
given the name
, "
natural killer" (NK) cell, by Kiessling and his
colleagues (Kiessling et aI., 1975a b). Following this initial
characterization of NK cells, these and other groups went on 
further show that NK cells are bone marrow-derived (Haller and
Wigzell 1977; Welsh 1978), large granular lymphocytes (LGL;
Timonen et aI., 1979), which express receptors for the Fc portion of
IgG (CDI6; Herberman et aI., 1977a), in addition to a low density of
what was previously thought to be primarily a cell-specific antigen
in mice , Thy 1 (Herberman et aI. , 1978). It was also found that NK
cells could be further distinguished on the basis of the expression of
asialo GMI (Kasai et aI., 1980) and NK1.1 (Glimcher et at, 1977) in
mice, or CD56 (Lanier et aI. , 1989a) in humans. These last 3 markers
in addition to CD 16, are used to identify and enrich for highly
purified populations of NK cells.
uction and au mentation of NK cell activi . A number of
studies found that certain pathogenic such as Bacilleagents,
Calmette-Guerin (BCG), which is a strain of My cob act e r i u m
tuberculosis (Wolfe et at, 1976), parasites such as Toxoplasma
(Hauser et aI. , 1982) or Trypanosoma (Hatcher and Kuhn, 1982), or
viruses (Welsh and Zinkernagel 1977; Herberman et aI., 1977b;
MacFarland et aI., 1977; Wong et aI., 1977) could induce NK cell
activity. Furthermore, synthetic compounds, such as tilorone, poly
I:C or pyran copolymer, could also enhance NK cell activity (Gidlund
et at, 1978; Djeu et at, 1979). This was due, at least in part, to the
ability of these agents to stimulate the production of a./~ type
interferons (IFNa./~), which are potent inducers of NK cells (Gidlund
et aI., 1978; Welsh, 1978; Djeu et aI., 1979) and, like IFNy, can
stimulate NK cell blastogenesis in vivo (Biron et aI. 1984).
Additionally, it was found that a lymphokine important for T cell
growth interleukin 2 (IL-2), could augment the cytotoxic activity of
NK cells (Henney et at, 1981), be used as a growth factor in the 
vitro propagation of NK cells (Herberman, 1982), and induce the
proliferation of NK cells in vivo (Biron et at, 1990). Furthermore
this growth factor has been used in clinical trials in which so-called
lymphokine-activated killer (LAK) cells (Grimm et at, 1982) have
been propagated in vitro with IL-2 and then adoptively transferred
into tumor-bearing patients, as an attempt at tumor immunotherapy
(Herberman et aI. 1987). Therefore, many natural and synthetic
substances have the capacity to significantly enhance the cytotoxic
ability of NK cells and these, in some cases, have found their way into
the clinic.
Ste s involved in the c tol tic rocess b NK cells. As is the
case for cytotoxic T lymphocytes (CTL), the killing of a target by NK
cells can be separated into at least 4 distinct steps as outlined below
(Figure 1):
1. Recognition and binding: The recognition of and binding to a
target by an NK cell is (Mg2+)-dependent, but (Ca2+)- independent
(Hiserodt et aI., 1982; Quan et at, 1982). This occurs via ill-defined
receptors, but a number of adhesion molecules have been suggested
to play a role in the interactions between an NK cell and its target.
Many of these molecules have also been implicated in target cell
recognition by T lymphocytes. For example, leukocyte functional
antigen- l (LF A-I) on the effector cells can use either intercellular
adhesion molecule (ICAM)- 1 or ICAM- as ligands on the targets
(Springer, 1990). The interaction of NK (or T) cell CD2 with its ligand
LFA- (CD58) appears to be very important in signalling of the
effector cells (Ritz et at, 1988; Bierer et at, 1989). It has recently
been found that a marker predominantly found on human NK cells,
CD56 (also known as Leu- 19 or NKH- l), is actually neural cell
adhesion molecule (N -CAM; Lanier et aI., 1989a). Although mAb to
CD56 have not been shown to inhibit either cytotoxicity or the
binding of NK cells to their targets by themselves (Nitta et aI., 1989;
Lanier et aI., 1991a), these mAb can synergize with mAb to LFA-
and/or LFA-3 to block both reactions (Nitta et aI., 1989). number
of other adhesion molecules, not necessarily restricted to NK cells,
have been suggested to play a role in NK cell-mediated lysis (Kare et
at, 1991), but the importance of these molecules in the killing of
targets by NK cells remains to be established.
Figure
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Steps II the killing of targets by natural killer (NK) cells
NK cells can also bind to and specifically kill target cells that
have been sensitized with a specific antiserum or antibody by a
phenomenon known an ti bod y -depe nden t cell-mediated
cytotoxicity (ADCC; van Boxel et aI., 1972). In this case, the Fc
portion of the IgG antibodies bound to the target cell interacts with
the FcY receptor molecule (CDI6) present on the NK cells (Herberman
et at, 1977a). The events subsequent to this step in the killing of a
target cell by NK cells is the same as conventional NK cell-mediated
lysis described below.
2. Tri erin of th effector ells: Phosphoinositide turnover is
an important component of calcium-dependent cell signalling.
Initially, phospholipase cleaves phosphatidylinositol-
bisphosphate, which generates inositol 1,4,5 -trisphosphate (IP3) and
diacylglycerol (DAG). IP3 stimulates the release of intracellular
calcium ((Ca2+h) from internal stores, ultimately followed by a (Ca2+)
influx from the external environment, whereas DAG activates protein
kinase C (PKC), which phosphorylates other proteins required in
signal transduction (Nishizuka, 1988; Berridge and Irvine, 1989).
This pathway is also important during signalling/triggering events in
NK cells. The significance of the role of (Ca2+) in NK cell-mediated
lysis is apparent by the inhibition of target cell lysis by EDT A (Welsh
1978; Hiserodt et aI., 1982) or EGTA (Hiserodt et at, 1982; Quan et aI.,
1982). Upon the interaction of an NK cell with a, susceptible target,
inositol phosphates (most importantly, IP3) are rapidly (within 1
min) generated. This has been shown with rat (Gerrard et aI., 1987;
Seaman et aI., 1987; Atkinson et aI., 1989) and human (Chow et aI.,
1988; Steele and Brahmi, 1988; Windebank et aI., 1988; StAhls and
Caren, 1989; Chow and Jondal, 1990) NK cells. This response is not
observed with NK-resistant targets and is inhibited by compounds
which prevent phosphoinositide breakdown (Chow and Jondal, 1990).
An essential role for PKC in NK cell-mediated lysis has also been
demonstrated (Graves et aI., 1986; Ito et at, 1988; Chow et at, 1988;
Leibson et at, 1990; Hager et at, 1990; Chow and Jondal, 1990), with
PKC inhibitors able to block the lysis of the targets in a dose-
dependent manner (Ito et at, 1988; Chow and Jondal, 1990; Hager 
at, 1990). Following this signalling event, there is a reorientation of
the microtubule organizing center and cytoskeleton of the NK cell
toward the direction of the target cell (Carpen et at, 1983; Kupfer 
, 1983). This allows granules in the effector cell cytoplasm, which
contain cytotoxic moieties, to be positioned at the interface between
the effector and target cell.
3. Release of c totoxic fac ors from the ranules: Early studies
of the mechanism of NK cell-mediated cytotoxicity suggested that
lysis of the target cell required a secretory event in the effector cell
as compounds such as monensin or others capable of preventing
classical secretory mechanisms could inhibit the lytic event (Ortaldo
et at, 1980; Caren et at, 1981). It appeared by electron microscopic
analysis that cytotoxic effector cells contained secretory granules,
which were surmised to contain factors capable of mediating the
lysis of the target cell. Purified granules from CTL or NK/LGL tumor
lines were found to be able to induce the lysis of numerous target
cells, much like the effector cells themselves, supporting this
hypothesis (Henkart et at, 1984; Podack, and Konigsberg, 1984). The
electron microscopic studies and biochemical characterization of
these granules demonstrated the presence of perforin (Henkart et aI.,
1984; Podack and Konigsberg, 1984; Young et aI., 1986a), which is
homologous to complement , (C' ) component C9 (Tschopp et at, 1986;
Young et aI., 1986b; Zalman et aI., 1986), a family of serine esterases
(Masson and Tschopp, 1987), in addition to a polyadenylate-binding
protein, TIA-l (Tian et aI., 1991), among other factors, which can or
may play a role in NK cell-mediated lysis following their release.
4. Death of the target cell As mentioned above, one
component of the granules is the C9 homologue , perforin. In the
presence of (Ca2 +), polyperforin polymerizes and forms in the
membrane of the target cells a channel which, under electron
microscopy, resembles that induced by poly C9 itself (Henkart et at
1984; Podack and Konigsberg, 1984; Young et at, 1986a). These
polyperforin channels appear to induce the depolarization of the
resting membrane potential, the influx of water, and the leakage of
cytoplasmic contents (Young et at, 1986a). Following this is 
induction of target cell DNA fragmentation into nuc1eosome-sized
fragments and a "blebbing" of the target cell nuclear and plasma
membranes--a process commonly referred to as " apoptosis
programmed cell death (Cohen et at, 1992).
Inverse orre ation etw en tar et cell MHC class I anti
ression and sensitivit to NK cell-mediated l sis. In addition to
tumor cells, a number of other cells are susceptible to lysis by 
cells, particularly after activation with IFN or IL- For example,
nontransformed cells, such as thymocytes (Herberman et aI., 1977b;
Nunn et aI., 1977; Hansson et aI., 1979), peritoneal cells (Welsh et aI.,
1979; Kiessling and Welsh, 1980) or bone marrow cells (Nunn et aI.,
1977), are also sensitive to NK cell-mediated lysis. Furthermore,
some virus-infected cells
, '
which will be discussed in more detail
below, also appear to be more susceptible than uninfected cells to
lysis by NK cells. As it became apparent that NK cells could kill a
variety of target cells, it also became clear that the lysis of the
targets was major histocompatibility complex (MHC)- independent
(Welsh, 1978). , In fact, an inverse correlation between target cell
MHC class I antigen expression and sensitivity to NK cell-mediated
lysis was found with most . targets;' this was especially the case
(though not exclusively) for targets of hematopoietic origin. The
expression of low or no MHC class I molecules appeared to confer
sensitivity to NK cell-mediated lysis to the target (Ljunggren and
Kare, 1990). Karre developed what 'became known as the "missing
self" hypothesis. The hypothesis simply states that target cells which
do not express sufficiently high levels of self MHC class I will be
killed by NK cells. Although the inverse correlation between MHC
class I expression and sensitivity to NK cell-mediated lysis is not
absolute, there have been a number of different observations by
Kiirre and his colleagues, as well as by others, which support this
hypothesis.
The prototypic murine NK target cell is a Moloney leukemia
virus-induced leukemia cell line, Y AC- (Kiessling et aI., 1975a).
These cells express relatively low levels of H- class I antigens on
their surface, but upon in vivo passage as an ascites tumor in
syngeneic strain A mice, these cells become much more resistant to
NK cell-mediated lysis and express higher levels of H- class I
antigens (Piontek et aI., 1985). Furthermore, treatment of Y AC-
cells with IFN, which upregulates MHC class I antigens (Lindahl et aI.
1976), confers resistance of these targets to lysis by NK cells (Welsh
et aI., 1981; Piontek et aI., 1985). In contrast, treatment of target
cells with protein synthesis inhibitors, such as cycloheximide, which
have the capacity to block MHC class I synthesis (Reichner et at,
1988), renders such targets more sensitive to lysis by NK cells
(Kunkel and Welsh, 1981). Obviously, exposure of target cells to
reagents which addition altering MHC class molecules
described above, may also have other global effects which could
modulate target cell sensitivity cell-mediated lysis
independent of the MHC. Experiments in both human and mouse
systems attempted to directly assess the role of MHC class I
molecules in the susceptibility of targets to lysis by NK cells. One
group used Daudi cells, a human EBV -transformed. B cell line which
possesses a defect in the ~2-microglobulin (~2m) gene and are HLA-
and transfected them with a normal copy of the human ~2m gene.
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This rescued HLA expression and increased the resistance of these
transfectants to killing ' by NK cells' (Quillet et aI. 1988).
Subsequently, C 1 R cells, a human lymphoblastoid line which
expresses no HLA-A or HLA- and is very sensitive to lysis by 
cells, were transfected with individual HLA-A or - genes (Storkus et
aI., 1989a, b). With one exception (HLA-A2), the transfectants
became much more resistant to NK cell-mediated lysis. Exon
shuffling experiments mapped the resistance to the a 1/ a 2 domains
of the transgene-expressed HLA molecules (Storkus et aI., 1989b).
In the mouse Y AC.:1 cells transfected with the Kb gene are
more resistant to NK cell-mediated lysis (Carlow et aI., 1990), and
~2m-deficient Y AC- l (Ljunggren et aI., 1990) or EL- (Glas et aI.,
1992) cells, which are very sensitive to NK cell-mediated lysis in 
vi t ro and in vivo models, respectively, become more resistant
following transfection with a normal ~2m gene. Furthermore, Con A
blasts from ~2m-deficient (~2m (-/-)) mice, which express very low
(almost undetectable) levels of free H- class I heavy chain (Koller et
aI., 1990; Zijlstra et aI., 1990), are very sensitive to lysis by NK cells
from normal mice, whereas Con blasts from their heterozygous
littermates are resistant (Hoglund et aI., 1991a; Liao et aI., 1991).
Very strong evidence for, a role of H-2 class I antigens in the NK cell-
mediated rejection of hematopoietic tumor cells in vivo was elegantly
demonstrated by Karre and his colleagues (Hoglund et aI., 1991b). In
this study, H-2b tumor cells inoculated into H-2b mice were not
rejected. However , these tumor cells were rejected by NK cells when
inoculated into transgenic H-2b mice which also expressed H-2Dd (D8
mice). As one would predict, H-2b tumor cells transfected with the
Dd gene were able to grow well in D8 mice. However, H-2b tumor
cells transfected with Dq were not rejected in normal H-2b mice, but
were in D8 mice. These results s ggested that the tumor cell H-
class I molecules were delivering a negative signal to (or preventing
the triggering of) the recipient s- NK cells, and thus the tumors were
able to grow. The relevance of this to, the recognition of targets by
NK cells will be discussed in more detail below. Therefore, a
significant body of evidence supports an important role for MHC class
I molecules in the sensitivity of target cells to NK cell-mediated lysis.
Reco nition of tar et cells b NK cells: utative rece tor
molecules. Because of the inverse correlation between target cell
MHC class I antigen expression and susceptibility to NK cell-mediated
lysis described above, two models to explain a possible role for class
I molecules in NK cell-mediated lysis were developed (Figure 2).
the first, the "target interference" model, access to an NK triggering
molecule on the surface of the target cell by an NK receptor is
obscured or blocked by MHC class I molecules (Figure 2a). With
more class I antigens expressed, the more interference (and less
triggering of the NK cell) occurs. The end result is a "resistant" target
cell. In the second model, the "effector inhibition" model, NK cells
have a receptor on their surface which directly interacts with MHC
class I molecules (Figure 2b). Upon this interaction, a negative signal
(a)
(b)
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Figure 2. Two models for the role of MHC class I molecules in the
sensitivity of target cells to NK cell-mediated lysis. a) " target
interference" model; b) "effector inhibition" model. From Ljunggren
and Karre, 1990.
is delivered to the NK cell, rendering it unable to kill the target.
Again, the level of class I on the target would confer either
sensitivity or resistance to NK cell-mediated lysis. Recent evidence
in both the mouse and human favor the second model.
mentioned the experiment by Karre and his colleagues
(Hoglund et aI." 1991 b), which presented in vivo evidence of a
negative signal being delivered to the NK cells. But this is only
consistent with this hypothesis. Recently, it has been shown that
when H-2b NK cells (NK1.1+ LAK) are separated on the basis of Ly-
(found on approximately 20% of NK1.1+ NK cells) (Yokoyama et aI.,
1990), these NK cells cannot kill targets which express H-2Dd
(Karlhofer et aI., 1992) or H-2Dk (W. Yokoyama and W. Seaman
personal communication). In contrast, Ly-49- NK cells could kill all
of the H-2d and H-2k targets which were resistant to lysis by Ly-49+
NK cells. Furthermore, mAb against either Ly-49 or Dd were able to
overcome this block in the ability of Ly-49+ NK cells to kill the 
2Dd-expressing targets (Karlhofer et aI., 1992). This suggested that
the interaction of Ly-49 and H-2Dd resulted in the delivery of a
negative signal to the Ly-49+ NK cells. Comparable evidence for a
similar phenomenon in a human system involves the HLA-Cw3
molecule. Human cells or mouse P815 transfectants expressing HLA-
Cw3 were resistant to a specific NK cell clone (Ciccone et aI., 1992).
Anti-HLA-Cw3 antibodies could prevent this block in target cell lysis.
As yet, no molecule on the human NK cell clone has been shown to
directly interact with HLA-Cw3.
The mAb 3. 3, originally described as an antibody specific for
rat NK cells, identifies a 60-kDa disulfide-linked homodimer nearly
exclusively expressed on NK cells (Chambers et at, 1989). The gene
encoding the antigen recognized by 3. 3 has been cloned, revealing
the 3. antigen to be type II integral membrane protein (C-
terminus is on the outside of the cell; Giorda et at, 1990). The
moiety recognized by the 3. 3 mAb has been designated NKR-Pl (NK
receptor protein - 1). The 3.2.3 mAb can mediate redirected lysis (Le.,
NK cells can lyse target cells which have the 3. 3 mAb bound to
their surface via the Fc receptor) (Chambers et at, 1989), stimulate
phosphoinositide turnover, and increase (Ca2+Ji in rat NK cells (Ryan
et at, 1991)--all characteristics one would predict for a putative NK
cell receptor molecule. Subsequently, this gene was cloned in the
mouse and found to be one of a family of at least 3 different genes
(Giorda and Trucco, 1991; Yokoyama et at, 1991). In fact, one of
these 3 NKR-Pl genes has been identified as encoding the mouse NK
marker, NK1.1 (Ryan et aI., 1992).
described above Ly- used separatecan
subpopulations of NK1.1+ NK cells (Yokoyama et aI., 1990). This
molecule has also been cloned (Yokoyama et aI. , 1989) and NKR-
NK1.1 , and Ly-49 share many common features: 1) along with the
Cmv- gene (murine cytomegalovirus resistance gene not yet
cloned) locus (Scalzo et at, 1992), these genes map. to a distal portion
of mouse chromosome 6 in a region now referred to as the "
Complex" (Yokoyama et at, 1991); 2) the proteins are all type 
integral membrane proteins; 3) they share extensive homology with
calcium-dependent lectin-binding proteins such as the
asialoglycoprotein receptor and the low affinity IgE FCE receptor
(Yokoyama et at, 1989; Giorda et at, 1990; Giorda and Trucco, 1991;
Yokoyama et at, 1991). Interestingly, a family of human genes
NKG2, which are restricted to NK cells (Houchins et at, 1991), has also
been described. Like the murine genes, they also encode type II
integral membrane proteins with putative lectin-binding domains
and map to the human homologue of mouse chromosome 6 (Hofer et
1992). However, they only share very limited amino acid
homology with Ly-49 or NKR-Pl (Houchins et at, 1991). Two
different mAb EB6 and GL183, which have been used to delineate
subpopulations of human cell clones, immunoprecipitate
molecules with a similar molecular weight as the NKR-Pl proteins,
although they do not appear to be disulfide-linked (Moretta et aI.
1990).
Another molecule in the mouse which may serve as an NK cell
receptor is identified by the mAb 5E6. NK cells expressmg the 5E6
antigen in an ' irradiated (C3H x B6)Fl mouse are able to reject bone
marrow grafts from an H-2d (BALB/c) donor (Sentman et at, 1989),
by a phenomenon known as "hybrid resistance" and the target
structure(s) or regulatory molecule for the target structure involved
has been mapped between the S and D regions of the mouse H-
complex (Yu et at, 1992). This might suggest that hybrid resistance
is an MHC class I-independent phenomenon. Recently, the gene
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encoding the 5E6 antigen has been cloned. It is also a class II
integral membrane protein, but interestingly, does not map to mouse
chromosome 6 (V. Kumar, personal communication).
Another NK cell receptor molecule candidate has been
identified usmg an anti-idiotype antiserum against a human LGL
structure, and F(ab')z fragments of this antiserum can block the lysis
of K562 target cells by human NK cells (Frey et aI., 1991). Human
and mouse cDN A corresponding to this structure have been isolated
and shown to be related to the cyclophilins (Anderson et aI., 1993).
Therefore, NK cells may use a variety of putative receptor molecules
in the killing of targets, whether it be by standard cell-to-cell
interaction or by ADCC as mentioned earlier.
nal transduction molecules resent on NK cells. A number of
signa nsducti molecules, which may or may not play a role in
NK cell function, are expressed on the surface of NK cells (some are
on other cells as well). Because these molecules are involved in
signal transduction and, as I mentioned above, the triggering of an
NK cell is an important step in the killing process, I briefly
summarize the most important molecules and their involvement (if
any) in NK cell activity.
1. Th 1 : A phosphatidylinositol-linked glycoprotein most
notably used as a marker for mouse lymphocytes, as mentioned
above, a low density of Thy 1 is also present on NK cells (Herberman
et at, 1978). Some evidence has indicated that Thy 1 can act as a
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signal transduction molecule in cells and in Thy I-transfectants
(Kroczek et aI., 1986), but its role in the function of NK cells is
unknown. ligand for Thy 1 has yet to be described.
2. CD2 : Also known as the sheep erythrocyte receptor, CD2 is a
member of the immunoglobulin superfamily of adhesion receptors,
as is its ligand , LFA-3 (CD58; Springer, 1990). CD2 appears to play an
important role in various human T cell (Bierer et aI., 1989) and 
cell (Ritz et aI., 1988) responses, but seems to be less important in
mouse NK cell activity (Nakamura et aI.
, '
1990).
3. CD8: Predominantly a cell marker for MHC class 
restricted T cells CD8 is also present on some human (Ortaldo et aI.,
1981) and all rat (Chambers et aI., 1989) NK cells. All mouse NK cells
are CD8- role for CD8 in T cell signalling is inferred from its
association with the s rc family tyrosine kinase, p561 (Janeway,
1992). At present CD8 has not been implicated in the function of NK
cells.
4. CD 1 6 : Also known as the FcyRIII receptor CD 16 is the NK
receptor involved in ADCC, as mentioned above. CD 16 has been
shown to be associated with the chain ' of CD3, which has been
demonstrated to play a major role in T cell signalling via the T cell
receptor (Anderson et aI., 1989, 1990; Lanier et aI., 1989b), as well
as the y-subunit of the high affinity Fc receptor for IgE (FceRI; Lanier
et aI., 1991 b; Vivier et aI., 1991a). The CD3 chain association with
CD16 has been demonstrated to be responsible for the induction of
the effector phase of ADCC (Vivier et aI., 1991b).
5. CD45: protein tyrosine ' phosphatase CD45 is present on
all leukocytes (Trowbridge, 1991). The alternative splicing of at least
3 exons (A, B, and C in the mouse) allows for the expression of
multiple isoforms of CD45 on the surface of leukocytes and, of
particular interest here,. lymphocytes (Johnson et aI., 1989;
Although not specifically an NK cell markerTrowbridge, 1991).
some anti -CD45 antibodies can inhibit NK cell-mediated lysis
(Seaman et aI., 1981; Newman et aI., 1983), in addition to T
lymphocyte responses to anti-CD3 and/or IL- (Gilliland et aI., 1990).
6. CZ- anti en: novel rat mAb generated in this laboratory
against purified mouse LGL, mAb CZ-l stains B cells CD8+ T cells and
NK cells, in addition to activated (but not resting) CD4+ T cells
(Vargas-Cortes et aI., 1992). mAb CZ- also marks the earliest
progenitor of B , T and NK cells (Vargas-Cortes et at , 1991). The
staining pattern of mAb CZ- is unlike any mAb we have seen, but
has some similarities (though not identity) with certain anti-CD45
mAb (e. , inhibition of IL- induced responses, Vargas-Cortes et at,
1991), suggesting some role in signal transduction. Therefore, the
identification of the moiety recognized by this novel mAb is of
interest and is the basis for Chapter VII.
Overview of the Immune Response to Virus Infections
Induction of NK cell activit viruses. Early during the
course of a virus infection is the induction of IFNa/~ production.
mentioned above, IFN and IFN inducers can activate NK cells by
augmenting their lytic capacity (Gidlund ,et aI., 1978; Welsh et aI.
1978; Djeu et aI., 1979). The appearance of NK. cell activity in the
spleens of virus-infected mice closely parallels the kinetics of IFNa/~
production (Welsh, 1978), and IFN pretreatment of NK cells in vitro
(Trinchieri and Santoli, 1978; Djeu 'et aI., 1979) or the administration
of IFNs in vivo (Gidlund et aI., 1978; Welsh, 1978; Djeu et aI., 1979;
Biron et aI., 1984) can aqgment NK cell-mediated target cell lysis.
This activation of NK cells begins to wane due, at least in part, to the
decline in virus-induced IFN production, as well as the synthesis and
release of transforming growth factor-~ 1 (Su et aI. , 1991).
Induction of virus-s ecific c totoxic T tes and
reco nition of viral anti ens b CTL. As the NK cell response
decreases over time, the generation of virus-specific CTL occurs and
peaks approximately 7 - 9 days post-infection with lymphocytic
choriomenigitis virus (LCMV; Welsh, 1978). Concomitant with the
induction of virus-specific CTL, virus-induced allospecific CTL
activity, although at a level below that observed . for virus-specific
CTL, can be detected in both mice (Yang and Welsh, 1986) and
humans (Tomkinson et aI., 1989).
Viral proteins are degraded into small fragments in the
cytoplasm of infected cells (Townsend and Bodmer 1989) by
processes which may include the participation of the recently
described proteosome components, some of which map to regions in
the MHC class II gene loci (Brown et at, 1991; Glynne et aI., 1991).
These peptide-sized fragments are then believed to be transported
into the endoplasmic reticulum by a heterodimeric complex encoded
by the genes , TAP- l and TAP-2 (Deverson et at, 1990; Monaco et aI.,
1990; Spies et aI., 1990; Trowsdale et at, 1990). The importance of
the T AP- l and T AP-2 gene products in peptide transport is evident
in mutant cells, defective for either the TAP- l (721.134 cells; Spies
and DeMars, 1991) or TAP-2 genes (RMA-S cells; Attaya et at, 1992).
In the endoplasmic reticulum or other pre-Golgi compartment
peptides form a heterotrimeric complex with the MHC class I heavy
chain and ~ -microglobulin (Yewdell and Bennink 1992). The
association of peptide and MHC class I molecules was identified using
different approaches: 1) the exogenous addition of small synthetic
peptide fragments (..15 amino acid residues) to appropriately MHC-
matched targets resulted in a sensitization of the targets for lysis by
MHC class I-restricted, virus-specific polyclonal CTL or CTL clones
(Maryanski et aI., 1986, 1988; Townsend et aI., 1986; Braciale et aI.
1987; Gotch et at , 1987; Pala et aI., 1988); 2) the crystal structure of
the human MHC class I molecule, HLA- , showed an electron dense
material in the cleft of the HLA-A2 molecule which appeared to be
peptide in an extended conformation (Bjorkman et aI., 1987); 3)
material extracted from virus-infected cells associated with MHC
class I molecules were HPLC-purified, sequenced, and shown to 
peptides of 8 or 9 amino acids in length (Rotzschke et ' aI., 1990; Van
Bleek and Nathenson These peptides corresponded 1990). '
previously-defined minimal immunodominant epitopes for virus-
specific pep tides lengths.CTL us i n g synthetic vanous
Furthermore, it could be shown that preparations of the larger (-15-
mer) defined epitopes,
In fact,
the CTLsynthesized peptides which
contained the ' natural peptide sequences as "contaminants
these "contaminants" could sensitize the appropriate targets for lysis
by specific CTL much more efficiently than the larger peptides
(Rotzschke et aI., 1990). More recent studies analyzing peptides
derived from uninfected cells in both mice (Falk et aI., 1991) and
humans CFaik et aI., 1991; Jardetzky et aI., 1991) have also found
peptides of 8 or 9 amino acids complexed with the MHC class I
antigens. In infected cells, as well as uninfected cells, following the
charging of an MHC class I molecule with an 8 or 9 amino acid
peptide either in the endoplasmic reticulum or other pre-medial
Golgi compartment (del Val et aI. , 1992), the heterotrimeric complex
traverses through the protein secretory pathway, and is expressed
on the surface for recognition by virus-specific CTL in an MHC-
restricted manner (Figure 3; Townsend and Bodmer, 1989; Yewdell
and Bennink, 1992).
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Figure 3. Processing and presentation ' of peptide antigens on MHC
class I or class II molecules. In this thesis, the emphasis is on the
processing of endogenous viral peptide antigen on MHC class I
molecules (left half of cartoon) for presentation to virus-specific CTL
and NK cells. Proteins are degraqed into peptide-sized (.c 15 amino
acid residues) and transported into a pre-Golgi (probably
endoplasmic reticulum) compartment by specific transporter
molecule(s), where the peptides charge the MHC class I molecules
traverse through the Golgi complex and subsequently expressed on
the surface of the cell. From Braciale, T. J. , and V. L. Braciale. 1991.
Immunology Today 12:124-129. 
Sensitivity of Virus-Infected Cells to
NK Cell-Mediated Lysis
Earl studies. The first reports analyzing the susceptibility of
virus-infected targets to NK cell-mediated lysis suggested that
following a virus infection human target cells were more sensitive to
lysis by human NK cells in overnight cytotoxicity assays (Trinchieri
and Santoli, 1978). number of different viruses were used, and
most gave the same result. This experimental design did not allow
one to distinguish between NK cell activation and the innate
susceptibility of the target to lysis by NK cells, as significant levels of
IFN ex were produced in those long, overnight assays (Santoli et aI.,
1978a, b). This IFN now known to be made predominantly by Ia
dendritic-like cells (Bandyopadyay et aI., 1986; Fitzgerald-Bocarsly et
aI., 1988), activates NK cells to higher levels of cytotoxicity, and
enables the NK cells to lyse the virus-infected target cells in the
vicinity. Experiments designed to byp ss an overt NK cell activation
phenomenon have used short-term (e.g., 3-S h) cytotoxicity assays
(Welsh and Hallenbeck, 1980), highly activated NK cells (Welsh
1978; Welsh and Hallenbeck, 1980; Borysiewicz et aI., 1985), and/or
nonactivated NK cells incubated with antibodies to IFNa/~ or with
metabolic inhibitors which block IFN synthesis or action (Casali and
Oldstone, 1982; Fitzgerald
Bandyopadhyay et at, 1986).
et at, 1982; Bishop et aI., 1983;
Experiments designed in that manner
have shown that cells infected with any of several viruses, such as
herpes simplex virus type 1 (HSV- l; Welsh and Hallenbeck, 1980;
Munoz et aI., 1983), murine cytomegalovirus (MCMV; Bukowski and
Welsh 1985), Sendai virus (Welsh and Hallenbeck 1980) and
vaccinia virus (VV; Welsh et aI., 1989), can often be rendered more
sist than uninfected targets to NK cell-mediated lysis.
Role of increased NK cell indin vir infected tar s or
nhanced tri erin of the effector cells. Work with some viruses
such as vesicular stomatitis virus (VSV), has correlated enhanced
binding to enhanced killing (Moller et. aI. 1985), but in other
systems, such as Sendai virus, enhanced binding can occur without
enhanced lysis (Welsh and Hallenbeck, 1980). Given that NK cells
can bind to most target cells in the absence of virus infection, it
would that post-binding might greaterseem event
significance in enhancing the lysis of virus-infected targets. Cold
target competition assays have often shown that virus-infected cells
compete better than uninfected cells against NK cell-mediated lysis
of target cells (Minato et aI., 1979; Blazar et aI., 1980; Welsh and
Hallenbeck, 1980); this has often been interpreted as an indicator of
enhanced binding of NK cells to the virus-infected targets, but it also
could be interpreted to mean enhanced, triggering of the NK cells and
secretion of their cytotoxic moieties. Of note is that IFN can protect
target cells from NK cell-mediated lysis by inhibiting triggering
without inhibiting binding, and' IFN-treated target cells fail to
compete in cold target competition assays (Trinchieri and Santoli
1978; Welsh and Hallenbeck, 1980; Trinchieri et aI., 1981; Welsh et
at, 1981).
Role of vira! glycoproteins in enhancing target cell lysis by NK
cells. Another aspect of a virus infection which might play a role in
the sensitivity of virus-infected targets to NK cell-mediated lysis is
the expression of viral glycoproteins. Soon after infection of cells
with a number of viruses, serologically detectable viral glycoproteins
are present on the surface. Glycoproteins purified from influenza
(Arora et at, 1984), LCMV and measles (Casali et aI., 1981), mumps
(Hiirfast et at, 1980), and Sendai (Alsheikhly: et aI., 1983) viruses
increase target cell lysis by NK cells. The NK cell-mediated killing of
HSV- infected fibroblasts has been reported to be inhibited by Fab
fragments obtained from the serum of HSV - seropositive donors or
by mAb specific for the HSV - 1 glycoproteins gB and gC (Bishop et at,
1984). In contrast, antisera or mAb specific for VSV glycoproteins
do not alter , the killing of VSV -infected targets by NK cells, and the
cell surface expression of VSV glycoproteills (G) in VSV G- transfected
COS cells does not render them more sensitive to lysis by NK cells
(Moller et aI. , 1985). However, targets infected with temperature-
sensitive VSV glycoprotein mutants and grown at the nonpermlsslve
temperature are not killed very well, whereas those grown at the
permissive temperature are very susceptible to NK cell-mediated
lysis (Moller et aI., 1985). It is unclear at what step of the killing
process these glycoproteins might act, but the , augmented killing
observed in most . of these systems appears to be IFN -independent,
regardless of whether soluble viral glycoproteins were directly
added to effector cells and then ' washed out (Cas 1i et aI., 1981), or if
virus-infected targets were used (Bishop et aI., 1983; Moller et aI.,
1985). Although the expression of viral glycoproteins may 
associated with an increase in ' binding, of effectors to targets (Welsh
and Hallenbeck, 1980; Moller et aI., 1985) this does not always result
In an Increase in target cell lysis. Therefore, a role for viral
glycoproteins in conferring enhanced susceptibility of target cells to
NK cell-mediated lysis may depend upon the virus.
Role of MH ass I antigens in the sensitivity of virus-infected
target cells to NK cell-mediated lysis. As mentioned above, there is
an Inverse correlation between target cell MHC class I antigen
expression and susceptibility to lysis by NK cells. One would predict,
therefore, that those viruses which decrease the levels of MHC class I
molecules in a particular target cell would make that cell more
sensitive to NK cell-mediated lysis. A number of different groups of
Vlfuses do reduce MHC class I expression (Maudsley and Pound,
Of these, the most highly cytopathic viruses will inhibit host1991).
cell protein synthesis, with a resultant decrease in MHC class I
expression. Other viruses reduce MHC class I antigens without
adversely affecting other cellular protein For example, the EIA
product of adenovirus 12 inhibits MHC class I, gene expression at the
level of transcription (Friedman and Ricciardi, 1988), whereas the
19-kDa product (E19) of the E3 gene of several adenovirus serotypes
specifically binds to the heavy chain of the class I molecule and
retains it in the endoplasmic reticulum (Burgert et aI., 1987; Tanaka
and Tevethia, 1988; Cox et aI., 1990, 1991). Some viruses, such as
human 'immunodeficiency virus- l (HIV- l; Scheppler et aI. , 1989),
inhibit MHC class I expression by unknown mechanisms. Other than
the work to be presented in this thesis, in only one report (Dawson et
aI., 1989), in which adenovirus-infected cells were tested, has virus-
induced alterations in MHC class I antigen expressi n been correlated
with sensitivity to lysis by NK cells, although, other studies in the
adenovirus system have not seen such a correlation (Routes, 1992,
1993 ).
I had mentioned above that a number of HLA class I molecules
transfected into the HLA- /HLA- B- CIR cells could confer NK-
resistance to such transfectants, with the exception of HLA- , and
that this property mapped to the a,1/a,2 domains (Storkus et aI.,
1989a, b). These same investigators then showed that a single
substitution of the His-74 residue to an Asp in the HLA-A2 molecule
was sufficient to allow this molecule to confer NK-resistance upon
transfection into CIR cells (Storkus et aI., 1991). Interestingly, His-
74 is near the peptide-binding groove in HLA-A2 and interferes with
access to a side pocket in the groove (Bjorkman et aI., 1987). This
suggested that the peptides residing the groove may
important factor whether not particular target cell NK-
sensitive NK-resistant. Therefore, alterations the peptides
presented would be predicted to modulate sensitivity to NK cell-
mediated lysis.
thesis.
This question will be addressed in detail in 
OBJECf OF THIS
The overall objective of this thesis has been to study the
regulation of a virus infection by NK cells. The major focus was on
cell surface molecules present on the target or effector cells which
could modulate the triggering of NK cells, and could therefore play
role in in vitro and in vivo events mediated by NK cells.
The molecules to be addressed here which are present on the
target cells and can negatively influence signal transduction in 
cells, are H- class I molecules, whereas the molecule on the surface
of NK cells which also appears to have an effect on NK cell triggering
is identified by the mAb CZ-
asked:
The following specific questions were
Is there is an enhanced sensitivity of virus-
infected target cells to NK cell-mediated lysis during a
discrete period of time post-infectio
2. If so, at what stage of the lytic process does this occur
and, how does this affect signal transduction in NK cells?
Under conditions of a virus infection of target cells
which alter sensitivity to NK cell-mediated lysis, is there
a change in the susceptibility of these targets to lysis by
allospecific or virus-specific ' CTL?
Does viral peptide charging of H-2 class I molecules
modulate target cell sensitivity to NK cell-mediated lysis
(and therefore NK cell triggering) in vitro?
Are H-2 class I molecules important in the regulation
of a virus infection by NK cells in vivo?
Are H- class I molecules required in IFN-mediated
protection from NK cell activity in vitro and/or in vivo?
What is the identity of the signal transduction
molecule on NK (and other cytotoxic effector) cells
recognized by the mAb CZ-
3 1
CHAPTR II
MATERIAS AN METHODS
A. Animals
Male A/J (H-
), 
BALB/cByJ (H-2d), C3HIHeSnJ (H-2k), C57BL/6
(H-2b) and C3H.OH (H-2Kd
, -
Dk) mice were purchased from The
Jackson Laboratory, Bar Harbor, ME and were used at 6 - 8 weeks of
age. Mice harboring the severe combined immunodeficiency (SCID)
mutation (CB. , H-2d background) were derived from breeders
originally provided by Dr. Donald Mosier, Medical Biology Institute
La Jolla, CA) and were bred and maintained under germfree
conditions in facilities at the University of Massachusetts Medical
Center (UMMC). The SCID mice were used at 4 - 6 weeks of age.
Breeder pairs of mice homozygous for a targeted mutation disrupting
the gene for ~2 -microglobulin (~2m (-
/- )), 
originally derived by Drs.
B. Koller and O. Smithies (Koller et at, 1990), University of North
Carolina, Chapel Hill NC, were kindly supplied by Dr. D. Roopenian
(The Jackson Laboratory). These mice were housed under specific
pathogen-free conditions and were used at 6 - 12 weeks of age.
B. Cell Lines
Y AC- cells are a Moloney virus-induced leukemia from A/Sn
mice; P52 is a T cell lymphoma from H-2b mice; P815 cells are a
mastocytoma from DBA/2 (H-2d) mice; R1.1 cells are a thymoma
derived from C58/J (H-2k) mice; RIE cells are derived from R1.1 cells
and are defective in ~2m gene expression (Allen et aI., 1986); DIR
(Waneck et aI., 1987) and RIE + Db (Allen t at, 1986) are R1.1 and
RIE cells transfected with the H-2Db gene, respectively; R1.1 , RIE
DIR and RIE + Db were provided by' Dr. G. Waneck , Massachusetts
General Hospital; 18.81 cells (H-2d) are a pre-B cell line provided by
Dr. J. Stavnezer UMMC. YAC- , P52, P815, R1.1 and RIE were
propagated in RPMI 1640 medium (Sigma Chemical Co. , St. Louis, MO)
supplemented with 10% heat-inactivated fetal bovine serum (FBS),
2mM L-glutamine and antibiotics (complete medium). DIR and RIE +
Db were grown in cOl1plete medium further supplemented with 500
jlg/ml of G418 (Gibco/BRL, Gaithersburg, MD). 18.81 cells were
propagated in complete medium with 10 mM HEPES buffer, 5 x 10-
M 2-mercaptoethanol, 0. jl M sodium pyruvate and 0.1 mM
nonessential amino acids as further supplements (MLC-medium).
L929 cells, a fibroblast line from C3H (H-2k) mice, the low H-2 class
I-expressing L929 variants, 5a- 15:9 and 4a- l:3, in addition to L929
cells persistently-infected with LCMV (L(LCMV)), were grown II
Eagle s minimum essential medium (MEM, Gibco) with the same
supplements as for complete medium. DAP- cells, an Ltk- L cell
derivative and DAP- cells transfected with the genes for H-2Db (L-
Db) and H-2Ld (L-Ld) (Lee et at, 1988) were propagated in Dulbecco
MEM, with complete medium supplements, and were obtained from
Dr. T. Hansen Washington University, St. Louis MO. Mouse embryo
fibroblasts (MEF) from C57BL/6 mice were maintained in Eagle
MEM as above. 'P2 parental and 'P2 transfectant cell lines expressing
the CD45 alternatively spliced exons A, B and C (T200/ABC), exons B
and C (T200/BC), exon C (T200/C), or none of the alternatively
spliced exons (T200/0), were obtained from Dr. I. Trowbridge, Salk
Institute, San Diego, CA. These cells were grown in Dulbecco s MEM
with 8% FBS, L-glutamine and antibiotics.
C. Viruses
The Armstrong strain of LCMV was prepared in BHK cells
(Welsh, 1978). The WR strain of vaccinia virus (VV) was propagated
in L929 cells (Bukowski et aI., 1983). recombinant VV expressing
a truncated form of the HIV -1 (IIIB) envelope gene (VV -abt 74 - 79)
was provided by Dr. J. Sullivan, UMMC. Mouse hepatitis virus (MHV)
strain A-S9 was plaque-purified in L929 cells and grown to a titer 
7 x 106 plaque-forming units (PFU)/ml. The Smith strain of MCMV
was obtained from the salivary glands of CS7BL/6 or BALB/c mice, 3
weeks following Lp. infection. The Indiana strain of VSV was
cultured in L929 cells. Mice received Lp. injections of all viruses
with the exception of VSV, which
retroorbital sinus (Lo.
was administered via the
Antibodies and Reagents
The 16- 1N and IS- SS hybridomas secrete monoclonal
allotypic anti- 2Kk and anti- 2Dk antibodies, respectively. The
28- 11-SS and 28- 14-8S hybrid om as produce anti- 2Db
alloantibodies that recognize conformational-dependent or -inde-
pendent determinants, respectively (Townsend et aI., 1989). The rat
anti-mouse H- class I mAb (clone Ml/42. HLK) is panreactive
for all mouse H- class I molecules (except H-2Db). These five
hybridomas were obtained from the American Type Culture
Collection, Rockville MD. CZ- l is a rat IgM (K), generated in this
laboratory by immunizing BB/W rats with Percoll-enriched activated
mouse large granular lymphocytes (Vargas-Cortes et aI., 1992). Hid
produces a monoclonal rat antibody which recognizes a determinant
on murine B cells and neutrophils (Bruce et aI., 1981). Monoclonal
anti-Lyt 2 antibody' was provided sulfate-cutan ammOnium
supernatant by Dr. E. Martz, Univ. of Massachusetts/Amherst.
following anti-CD45 restricted, exon-specific mAb were used:
The
the
exon A-specific 14.8 (Kincade et aI., 1981) and the ex on C-specific
DNL 1.9 (Dessner and Loken, 1981) mAb were provided by Dr. David
Parker, UMMC; the B exon-specific CD45R- l (clone 16A; Bottomly 
aI., 1989), unlabelled, biotinylated, or conjugated to RED613
(Gibco/BRL); and the pan-CD45-reactive clone Ml/9. HL. (Springer
et aI., 1978), unlabelled, biotinylated, or directly conjugated with
fluorescein isothiocyanate (FITC; Gibco/BRL). Most monoclonal
antibodies used in FACS analyses were used as crude supernatants as
described below, with the exception of CZ-l and the anti-CD45 mAb
(other than those that were purchased), which were ammonium
sulfate-concentrated and the phycoerythrin (PE)-supernatants
labelled anti-CD4 and FITC-Iabelled anti-CD8 mAb, which were
purchased from Gibco/BRL and used neat. PE- or FITC-Iabelled goat
anti-rat IgM antiserum (Il-chain-specific) was obtained from
Southern Biptechnology Associates (Birmingham, AL). FITC-
conjugated goat anti-rat IgG (y-chain-specific) antiserum was also
purchased from Southern Biotechnology Associates. , Phycoerythrin-
conjugated streptavidin (SA-PE) was obtained from Becton Dickinson
(Mountain View, CA). Rabbit antiserum against asialo GMI was
purchased from Wako (Dallas, TX). Purified mouse natural IFN~
(800,000 Units) was obtained from Lee Biomolecular (San Diego, CA).
Recombinant human IL-2 was obtained from Cellular Products , Inc.
(Buffalo, NY). Cycloheximide sialic acid, and N-acetylneuramin-
lactose were all purchased from Sigma.
Interferon-~ (IFN~) and Cycloheximide Treatment of Targets
Y AC- , R1.1 , RIE, DIR and RIE + Db cells were treated with
1000 U/ml of IFN for 18-24 hr at 37
with 25 Il g/ml of cycloheximide for
L929 cells were incubated
18-20 hr as previously
described (Kunkel and' Welsh, 1981). The treated cells were washed
twice in the appropriate medium before being added to the assays as
described below.
F. Effector Cell Generation
Activated NK cells. Mice were infected Lp. with 5 x 1() PFU of
LCMV. Alternatively, poly I:C (100 Ilg/mouse, Lp.) was administered
to the mice. Two (poly I:C) or 3 days (LCMV) later, spleens were
harvested, processed and introduced into the cytotoxicity assays at
various effector to target cell (E:T) ratios.
. J
Activated eritoneal exu ate PEC NK cells. C57BL/6 mice
were infected Lp. with 7 x 105 PFU of MHV. ' On day 3 post- infecti
the mice were sacrificed and the PEC were obtained. Macrophages
were removed by adherence on FBS-coated petri dishes.
The
nonadherent cells were removed, washed twice in 
complete medium,
and treated with J11d followed by rabbit complement (C' ; Pel-Freeze
, "
Biologicals, Brown Deer, WI). Dead cells were removed by density
gradient centrifugation on Lympholyte- (Cedarlane Laboratories,
Hornby, Ontario, Canada). The cell number was then adjusted as
required and used in (45Ca2+) influx assays as described below.
Virus-s ecific CTL. Mice received Lp. injections of 1 - 10 x 106
PFU of VV , 5 x 106 PFU of VV-abt 74-79, 5 x 1() PFU of LCMV, or
an Lo. infection with 1 x 106 PFU of VSV. On days 0 and 4 post-
infection, the , mice also received Lp. injections of 10 1.11 (BALB/c and
C57BL/6) or 20 III (C3HlHeSnJ) anti-asialo GM1 antiserum. Six to 9
days later, single cell suspensions of spleen cells were prepared and
used as effectors in 51 Cr release assays as described below.
enerated-1 ecific CTL ure 4 . A/J (H-2Kk
, -
Dd),
C3H/HeSnJ (H-2k), or C3H.OH (H-2Kd
, -
Dk) mice were irradiated with
750 R of y-irradiation (137Cs source, Gammacell 40, Atomic Energy of
Canada Ltd., Ottawa, Canada). One hour later, the mice received 5 
10 x 107 spleen cells from either BALB/c (H-2d) or C57BL/6 (H-2b)
mice by Lo. injection. Five days after transfer, spleen cells from the
recipient mice were prepared and used in the cytotoxicity assays.
Figure 4.
(CT).
IN VIVO GENERATION OF
ALLOSPECIFIC CTL
750 
1, 
00",
C3HtHeSnJ (H-
NJ (H-2KkOd
C3H,OH (H-2KdOk
inject 5 - 10 x 10 BALB/c (H- ) or
C57BU6 (H- ) spleen cells, Lo.
lSd",
isolate recipient splenocytes
Cr release assay
In vivo generation of allospecific cytotoxic T lymphocytes
J.y lOkine-activatedji er LAK cells. Spleens from CB .
SCID or normal C57BL/6 mice were aseptically removed, and single
cell suspensions were, prepared
concentration of 3 106 cells/ml.
and adjusted to a final cell
Recombinant human IL-2 was
added for a final concentration of 1000 U/ml. After 5 days at 37
the cells were washed twice in complete medium and were used 
effectors at varous E:T ratios in the 51 Cr release assays.
G. Target-Binding Cell Assay
Spleens from C3HIHeSnJ mice were harvested 3 days after
LCMV infection, and ' a single cell suspension was prepared by
homogenizing the spleens between the frosted ends of two
microscope slides. The spleen cell suspension was then passed over a
nylon wool column and mixed with uninfected or VV - infected L929
cells at an E:T ratio of 5: 1. The cells were then pelleted (300 x g) for
5 min and placed at 4 for 30 min. The pellets were gently
resuspended and effector/target cell conjugates were, enumerated by
microscopic examination in a hemacytometer.
H. 5 Cr Release Assay
Standard 4 - 6 h 51 Cr release assays were performed 
previously described (Yang and Welsh, 1986). Briefly, 1 x 106 target
cells were incubated with 100 JlCi of Na251Cr.o4 (Amersham
Arlington Heights, IL) for 60-90 min at 37 The targets were
washed three times in complete medium, and 1 x 104 or 4 x 104
(thymocytes only) cells (in 100 l) were added to the appropriated
wells of flat or bottom 96' well tissue culture plates (Costar
Cambridge, MA). An equal volume of effector cells was then added
per well at various E:T ratios.
Modifications of this assay for different types of experiments
are described as follows:
VV - infected 29 cells were preseeded into 6-welltargets.
tissue culture plates (5 x 105), 60-mm tissue culture dishes (1 x 106)
or 25-cm tissue culture flasks (1 x 106 - 2 x 106 ; Costar). After
allowing for adherence h), the cells were infected with VV-WR at
a multiplicity of infection (MOl) of 10 for various intervals at 37
The MOl was based on the initial cell input. The cells were dispersed
with trypsin, washed twice with complete medium and labelled with
51 Cr and used as targets as described above. In some experiments,
uninfected L929 cells were prelabelled with 5 , plated at 1 x 1()
cells/well in flat bottom 96-well plates, and infected with 
(MOI=10) for various time periods before effector cells were added
for the 5 Cr release assays.
tide- treated Two different methods of treatingtar ets.
target cells with peptides were used: a) 1 x 106 target cells were
treated with or, without 200 - 250 of the indicated synthetic
peptides and ' 100 Ci of 5 Cr in 1.0 ml complete medium, incubated
overnight (16 - 18 h) at 37 C, and washed 3 times in complete
medium before being added to the assay; b) target cells were
prelabelled with 1 00 Ci of 5 1 Cr for 1 h as described above and
plated (1 x 104 cells/well in 50 ,.d) in 96 well round or flat bottom
plates (Costar); peptides were added for a final concentration of 
Jlg/ml, and the plates were preincubated for 30 min at before
the addition of effector cells at various E:T ratios.
Peptides
The peptides used were the following (see also Table 1): Kb-
restricted HSV - 1 gB497 -S07 (TSSIEF ARLQF), Db-restricted influenza
NP36S-379 (IASNENMETMESSTL), Dd-restricted HIV- IIIB gp16031S-
329 (RIQRGPGRAFVTIGK), Kk-restricted influenza NPSO-
(SDYEGRLIQNSLI), Kd-restricted influenza HA147- 161
(TYQRTRALVRTGMDP) and Kk-restricted rabies NS191- 206
(EKDDLSVEAEIAHQI) peptides were purchased from Chiron
Mimotopes (Clayton, Victoria, Australia). Db-restricted LCMV NP397-
407 (QPQNGQFIHFY), Db-restrcted LCMV GP278-286 (VENPGGYCL), Ld-
restricted LCMV NP119- 127 (PQASGVYMG), Ld-restricted MCMV
IEp89168- 176 (YPHFMPTN), and Kb-restrcted VSV NS3-S9 (GYVYQGL),
in addition to the Db-restricted influenza and Kk-restricted rabies
peptides were synthesized by Dr. Robert Carraway, UMMC. These
peptides were purified to 95% homogeneity by reverse-phase HPLC
and peptides were further analyzed by amino acid analysis. The Kd-
restricted influenza HAs1S-S26 (ILAIYSTV ASSL) peptide was kindly
provided by Dr. F. Ennis, UMMC. Peptides were dissolved in DMSO or
water (as required) at a stock concentration of 1 10S Jlg/ml before
dilution in complete medium for the assays.
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J. Generation of Con A Blasts
Spleen cells were obtained from the indicated mouse strains
and single cell suspensions were aseptically prepared. One x 107
spleen cells/ml were treated with 2 J.g/ml of concanavalin (Con A;
Sigma) for 48 h at 37 The viable cells were obtained at the
interface after density gradient centrifugation on a Lympholyte-
gradient. The cells were then washed twice in complete medium,
and 1 x 106 cells were labelled with 100 IJCi of Na2
51Cr04 for 1 h at
as described above before use as targets in a 4- to 6-h 51 C r
release assay.
K. NK Cell Depletion In Vivo
NK cells were depleted in vivo by Lp. injection of 10 - 20 IJg of
anti-asialo GM1 antiserum that was administered at the same time 
the virus infections (Habu et aI., 1981; Kawase et aI., 1982).
L. FACS Analyses
Standan: sin e co irect immuno uorescent stainin
techni ue. For VV -infected L929 cells, the cells were seeded into
25-cm tissue culture flasks and after overnight adherence at 37
infected with VV WR for various time intervals at an MOl of 10.
the end of the infection period, the virus was UV -inactivated by
exposure for 15 min to shortwave UV light (254 nm). For L929 (VV-
infected and uninfected), 18.81 and the '12 transfectant cells, 200 J.1
the appropriate hybridoma supernatant (or J.1 of the
commercially prepared anti-CD45 mAb) ,were added to 1 x 106 cells.
After a 30 min incubation on ice, the cells were washed and labelled
with FITC-conjugated goat anti-mouse Igs (IgA + IgG + IgM, H and L
chains; Cappel Laboratories, Westchester, PA). The cells were then
incubated for 30 - 45 min on ice. After washing, the cells were fixed
in 4% paraformaldehyde for 10 min on ice, washed, and kept at 4
until FACS analysis by a FACScan IV (Becton Dickinson). For
thymocyte expression 2Db thymi were obtained from
uninfected or MCMV -infected (3 days post-infection) C57BL/6 or
~2m (-/-) mice and homogenized into single cell suspensions. The
thymocytes were then stained with the conformational-dependent
(28- 11-5S) or conformational-independent (28- 14-8S) anti- 2Db
monoclonal antibodies (Townsend et aI. 1989) from hybridoma
supernatants as performed above.
Two color direct immunofluorescence with moc tes. For
detection of thymocyte CD4 and CD8, thymi from individual
uninfected or MCMV -infected (3 days post-infection) mice were
harvested and single cell suspensions were prepared. The cells were
then stained with 5 f.1 of both PE-Iabelled anti-CD4 and FITC-
conjugated anti-CD8 per 1 x 106 thymocytes on ice for 30 min
washed, and fixed as above.
(Becton Dickinson).
Two color analysis was by FACStar
Com etitive FACS anal sis. The pre- cell line, 18. , was
treated with mAb CZ-l or Hid, in addition to the various anti-CD45
mAb. The cells were then stained with a PE-Iabelled goat anti-rat
IgM (Il-chain-specific) antiserum, and a FITC-conjugated goat anti-rat
IgG (y-chain-specific) antiserum. For competitive FACS analysis of
the '12 transfectants, CZ- l and either biotinylated anti-CD45RB or
anti-CD45 framework antibodies were added together, washed and
then labelled with a FITC-Iabelled goat anti-rat , IgM (Il-chain-
specific) and SA-PEe
Dickinson).
Two color analysis was by FACScan (Becton
M. Triggering Assay
measurement of (4SCa2+) uptake into cocultures of NK and
target cells was performed by a modification of that previously
described for human NK cells (Jondal et at, 1986; Gronberg et aI.
1988). Additionally, this assay was adapted for use in microtiter
plates. For the microassay, 5 IlCi of 45CaCl2 (ICN Biomedicals, Irvine
CA) in assay medium containing 10 mM HEPES buffer (Sigma) was
added' to each well of a 96-well V -bottomed microtiter plate (Costar).
Splenic effector cells from SCID mice 3 days post-LCMV infection
(Welsh et at, 1991) were enriched for NK cells by treatments with
J11d and C', followed by Lympholyte- centrifugation. The effector
cell concentration was adjusted to 2 x 106 cells/ml and 1 x 10S cells
were added per well. L929 cells, obtained at various intervals post-
VV infection (MOl = 10), were added to the appropriate wells at an
E:T ratio of 1: 1. The plates were centrifuged gently (50 x g) for 1 min
and incubated for 30 min at This time point was chosen 
order to maximize the time for NK cell triggering prior to lysis of the
target cell. The reaction was stopped by adding ice-cold 5 mM NiClz
(Sigma) in assay medium. The plates were then centrifuged at 500 x
g for 10 min at 4 C. After 2 more washes in assay medium
containing NiClz, the cells were lysed with 200 l of distiled H20, and
the supernatant was' added to 2 ml of scintillation fluid (Ecolite; ICN)
and counted in a liquid scintillation counter (LKB Instruments;
Rockville, MD). The net influx of (4SCa2+) was then determined.
N. Plaque Assay
Spleens from MCMV -infected were harvested 3 daysmice
post-infection, placed in 1 ml of complete medium on ice and
homogenized in a mortar and pestle device. Supernatants were
clarified by centrifugation (2000 x g, 15 min at 4 C). Ten-fold serial
dilutions of 100 JlI were added to the appropriate wells of 6-well
tissue culture plates (Costar), which we're pre seeded days
embryopreviously with approximately 1 x 10S C57BL/6 mouse
fibroblasts (early passage) per well and contained 1 ml complete
MEM. After a 90 min absorption at 37 C, the plates were overlayed
with 4.0 ml of a 1:1 (v/v) mixture of 2X medium 199 (Gibco/BRL)
and supplements and 1 % agarose (SeaKem ME FMC Corp., Rockland,
ME). After 5 days at 37 C in a humidified atmosphere, the overlay
was removed, and the plates were stained with crystal violet.
virus titers are indicated as plaque forming units (PFU)/spleen.
The
Statistical Analysis
For the determination of p values, Student s t-test was used.
, ,
CHAPTER III
STUDIES ON TARGET CELL SUSCEPTILITY TO
NK CELL-MEDIATED LYSIS FOLLOWIG VV INCTION
Window of Vulnerability" of Vaccinia Virus (VV)-Infected
L929 Cells to NK Cell-Mediated Lysis
As mentioned in Chapter I, early studies found that various
viruses could modulate target cell susceptibility to lysis by NK cells.
It should be noted that in the majority of those studies, the target
cells were infected from 1 to 3 days, depending on the virus. It is
certainly possible that as the course of certain virus infections
progressed, targets might have become more sensitive to lysis by 
cells during a discrete period of time post-infection and, due to the
assay conditions, this "window of vulnerability" was missed.
address this question, experiments were designed in order to avoid
overt IFN-induced effects upon the effector cells, which allowed me
to ' be confident that any alterations in target cell susceptibility to
lysis by various cytotoxic effector cells were, in fact, due to the virus
infection of the target itself.
number of different VIruses were tested. However VV was
used predominantly for several reasons: a) previous evidence in the
laboratory suggested that VV was an NK-sensitive virus in vivo
(Bukowski et aI., 1983, 1987); b) of the other cytopathic viruses
which can infect mouse fibroblasts, the kinetics of the cytopathic
i :
effect of this virus were slower than with others (e. , HSV- , VSV);
c) VV -specific CTL are easy to generate and examine in this system.
In order to determine if VV -infected cells were more suscep-
tible to killing by NK cells, time course studies were performed.
Activated NK cells from C3H/HeSnJ mice, 3 days following LCMV
infection, were added in short 4- assays to L929 cells that had been
infected with VV (MOI=IO) at various time intervals. Figure 5 shows
the results of 4 different experiments. NK cell-mediated killing of
VV -infected L929 cells increased as the infection progressed,
reaching a peak by 24 - 28 h post- infection , after which time it
began to decline. At later stages of infection, however, the target
cells became more resistant to lysis by NK cells, consistent with
results previously reported (Welsh and Hallenbeck, 1980; Welsh 
aI. , 1989). Lysis of target cells by endogenous, nonactivated spleen
cells averaged 5% or less at all time intervals examined (data not
shown). These results suggest that VV -infected targets are not
susceptible to lysis by non-activated NK cells, but do have a discrete
window of vulnerability" to lysis by activated NK cells. This window
of vulnerability to lysis was observed whether (experiments 2 - 4) or
not (experiment 1) the target cells were exposed to trypsin before
the cytotoxicity assay.
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Figure 5. "Window of vulnerability" of VV -infected L929 cells to
lysis by activated NK cells. L929 cells were infected with VV (MOl =
10 PFU/cell) for various intervals and served as targets of LCMV-
induced, activated spleen cells from C3HIHeSnJ mice in a 4-h 51 C r
release assay. Four individual experiments are presented. E:T ratio =
150:1. Experiment 1 (0 ) was performed using 51 Cr prelabelled
targets, whereas experiments 2 - 4 used target cells which were
infected with VV before 5 Cr labelling. The E:T ratio in experiment 1
was based on the target cell number at the time, of labelling with
51 Cr, which was approximately 48 h before the cytotoxicity assay;
therefore, due to cell division in the microwells, the actual E:T ratio
may be oeI50:1.
B. Effect of VV Infection on Effector/Target Cell Conjugates
In order to determine if the "window, of vulnerability
" to 
cell-mediated lysis was due to an increase in the number 
effector/target cell conjugates, L929 cells at various time intervals
after VV infection were mixed at an E:T ratio of 5:1 with 
LCMV-
induced, activated C3H/HeSnJ spleen cells that had been 
depleted of
most B cells, macrophages, and granulocytes by passage over nylon
wool. As shown in Table 2, whereas 43% of the uninfected L929 cells
bound lymphocytes, as the VV infection progressed, that number
steadily declined from 19% at 24 h post-infecti to 11 
by 48 
These results suggest that the observed "window of vulnerability
" to
NK cells was not due to increased binding of effectors to the 
target
cells, but, given the enhanced levels of lysis, the efficiency of a 
bound
effector cell to lyse a target must be markedly enhanced.
This low
level of binding at later stages of infection could have contributed to
the observed resistance of targets to lysis by NK cells.
C. Optimization and Analysis of NK Cell Triggering
A critical post-binding step in the process leading to the 
lysis of
a target cell by NK cells is the triggering of the effector cells (Welsh
1986). In order to measure triggering, I adapted an ' assay which
measures the uptake of (45Ca
2+) into human NK cells (Jondal et at,
1986; Gronberg et aI., 1988) for the study of murine NK cells. The
5 1
TABLE 2
Binding of NK Cells to VV -Infected L929 Cellsa
Hours Post- VV Infection Bound Tar ets
aNylon wool-passed spleen cells from C3HIHeSnJ mice were obtained
3 days post-LCMV infection and used at an E:T ratio of 5:1.
bL929 cells were infected with VV at an MOl of 10.
CEffector/target ' cell conjugates were enumerated after 30 min - 2 h
at 4
" '.' ..\;
NK-sensitive Y AC- l ' lymphoma and L929 cells, which are less NK-
sensitive, were initially compared. As shown in Table 3, expo 1
(45Ca2+) influx into PEC NK cells derived from MHV-infected C57BL/6
mice was considerably greater when Y AC- rather than L929,
targets were used. I also utilized activated spleen cells from LCMV-
infected SCID mice as effectors in this type of assay using Y AC-
targets. SCID mice have no functional T or cells (Bosma et aI.
1983), yet have normal NK cell function (Dorshkind et at, 1985;
Welsh et aI., 1991). The spleens, therefore, have a high frequency of
NK cells. In order to optimize conditions for SCID mouse NK cells
different E:T ratios were used. As is indicated (Table 3 , expo 2), the
maximum (45Ca2+) influx occurred at an E:T ratio of 1:1 , which would
enable the majority of the NK cells to find a target and be triggered.
Y AC- and L929 target cells were treated with IFN 
cycloheximide and tested in the triggering assays. Treatment of cells
with IFN has previously been shown to upregulate the expression of
MHC class I molecules (Lindahl et at, 1976; Bukowski and Welsh
1986a) and decrease their sensitivity to lysis by NK cells by
inhibiting the triggering process (Trinchieri and Santoli, 1978; Moore
et aI., 1980; Welsh and Hallenbeck, 1980; Welsh et at, 1981; Piontek
et at, 1985; Gronberg et aI., 1988). IFN~- treated Y AC- cells induced
less of a (45Ca2+) influx into PEC NK cells from MHV -infected mice
than did untreated Y AC- cells (Table 3, expo 3). Cycloheximide
treatment of L929 cells increases their susceptibility to NK cell-
mediated cytolysis (Kunkel and Welsh 1981), and decreases the
expression of H- class I molecules (Reichner et aI., 1988).
contrast to that observed with the IFN~-treated Y AC- cells, cyclo-
heximide-treated L929 cells induced a greater (45Ca2+) influx into PEC
NK cells (Table 3, expo 4). These results demonstrate reliability in the
triggering and correlations between triggering, enhancedassay
cytotoxicity, and reduced H- class I antigen expression.
D. Triggering of NK Cells during the "Window of Vulnerability
To determine whether the increased susceptibility of VV-
infected target cells to NK cell-mediated cytolysis during the
window of vulnerability" was due to an enhanced triggering of the
effector cells, (45Ca2+) uptake was measured in cocultures of LCMV-
induced, activated SCID mouse splenic NK cells and L929 cells at 0,
24 and 48 h post- VV infection. As shown in the 2 experiments
presented in Figure 6, the net (45Ca2+) influx into activated SCID NK
cells cocultured with uninfected L929 cells was low, peaked at 24 h
post- VV infection, and by 48 h was at or below that seen with umn-
fected These data indicate that the windowtargets.
vulnerability" of VV -infected targets to lysis by NK cells is correlated
with an enhanced triggering of the effector cells and is the first such
observation in a virus infection model in the absence of increased
binding.
TABLE 3 '
Analysis of NK Cell Triggering by (45Ca2+) Uptake
--------------------------------------------------------------------------------------
Exp. Cell Population b
Total (45Ca
(cpm)
Net (45Ca ) Influx
(cpm)
- - -   - - -   - - -   - - -   - - -   - - - -- - -   - - -   - - -   - - -   - - - -   - - -   - - -  - -   - - -   - - -   - - -  - --
PEC- 13,905
Y AC- 314
L929 546
PEC-NK + YAC- 74,634 59,415
PEC-NK + L929 27,507 12,056
SCID NK (8 x 105 cells) 457
Y AC- l (8 x 104 cells) 349
(8 x 105 cells) 951
NK + YAC- l (E:T=lO:l) 914 108(E:T=l:l) 10,797 389
PEC- 203
Y AC- 868
YAC-l + IFN~ 387
PEC-NK + Y AC- 68,632 56,561
PEC-NK + Y AC- l/lFN~ 45,869 34,279
PEC- 12,452
L929 ' 790
L929 cycloheximide 567
PEC-NK + L929 18,901 659
PEC-NK + L9291cyclo. 26,093 10,074
                 - - - - - - . .                - - - - - - -  - - - - - - - - - - - - - - - - - - - --
aStandard (45Ca ) influx assay with 5 x 106 effectors and 5 x 105 targets unless
indicated otherwise.
bEffector cells were either PEC from MHV- infected C57BL/6 mice or were
splenocytes from SCID (CB. 17 background) mice. E:T ratios are at 10:1 except
where indicated.
CBackground (in cpm) was subtracted.
dYAC- l cells were treated with 1000 D/ml of murine IFN~ for 20 h at 37
10000
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it -2500
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Figure 6. "Window of vulnerability" of VV -infected L929 cells
correlates with enhanced triggering of NK cells. L929 cells at 0, 24
and 48 h post- VV infection were cocultured with activated SCID
mouse NK cells in a micro- (45Ca2+) influx assay. The net (45Ca2+)
influx in two different experiments is presented.
CHAPTR IV
STUDIES ON VV -INUCED AL TERA TIONS OF TARGET CELL H-2 CLASS
I MOLECULES AN SUSCEPTBILITY TO CTL-MEDIATED LYSIS
A. H-2 Class I Surface Antigen Expression on
Target Cells Following VV Infection
Because inverse correlations between the expression of target
cell class I MHC antigens and sensitivity to or triggering of NK cells
have been noted in several systems (Ljunggren and Karre, 1990), cell
surface H-2Kk and -Dk class I molecules on L929 cells at various
intervals post- VV infection (MOI= 10) were monitored serologically
by FACS. As shown in Figure 7, H-2Kk and H-2Dk expression of VV-
infected L929 cells appeared to decrease (2-fold and 5-fold,
respectively) at 24 post- VV infection. Later in VV infection, an
increase in cell background with the FITC-Iabelled second antibody
made the interpretation difficult (data not shown). These res ults
suggest that alterations in the expression of H- class I antigen
expression might play role in the enhanced sensitivity of VV-
infected L929 cells to NK cell-mediated lysis.
B. "Window of Vulnerability" to NK Cell-Mediated Lysis is
Concomitant with a Decrease in Susceptibility to Killing
by In Vivo-Generated Allospecific CTL
Because I found that H- class I expression was decreased
following VV infection of L929 cells, the lysis of VV -infected cells by
, \,
$ i
class I-restricted allospecific CTL was examined. Figure 8 com-
pares the sensitivity of L929 cells (H-2k) at various time points after
VV infection to killing by VV-specific CTL and by in vivo- generated
allospecific (anti- 2k) CTL in 3 different experiments. It is evident
that as the VV 'infection progressed , susceptibility to lysis by VV-
specific CTL increased, reached a peak at 24 h and subsequently
declined. In contrast, sensitivity to killing of uninfected L929 cells
by in vivo-generated allospecific CTL was high, but continually
decreased throughout the VV infection of the target cells. These data
indicate that when VV - infected cells were more susceptible to killing
by NK cells (Fig. 5) and VV-specific, CTL during a discrete window of
time post-infection, they had become resistant to lysis by allospecific
CI.
C. ' Affinity of In Vivo- Generated Allospecific CTL
One argument that might explain the results described above
would be that the allospecific CTL were of low affinity compared to
the high affinity VV -specific CTL, obtained 6 or 7 days post-infection.
In order to determine if the in vivo-generated allospecific CTL were
of high affinity, several serial dilutions of anti-Lyt 2 (CD8) antibody
were included in a 5- cytotoxicity assay. As shown in Figure 9, the
highest antibody concentrations used inhibited only about 50% of the
lysis mediated by allospecific CTL, indicating that at least half of the
FITC Control
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10910 fluorescence IOQ10 fluorescence IOQ10 Iluorescence
Figure 7. Cell surface expression of H-2Kk and H-2Dk on L929 cells
following VV infection. L929 cells (uninfected or 24 h post- VV
infection) were labelled with Kk - or Dk -specific monoclonal
alloantibodies followed by FITC-conjugated goat anti-mouse Ig
antiserum, and expression of Kk and Dk were analyzed by FACS.
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Figure 8. Sensitivity of VV-infected L929 cells to killing by VV-
specific CTL and anti- 2k allospecific CTL. L929 cells were used as
targets in 4-h 51 Cr release assays at various intervals after VV
infection for VV -specific (--- ) or in vivo-generated allospecific 
(- 
CTL. Three individual experiments are presented (corresponding
closed and open symbols). E:T ratios = 100:1 for VV-specific, SO:1 for
all 0 specific CTL.
tf 20
NoAb 1 :8100 1 :2700 1 :900
Dilution
1 :300
Anti- Lyt
Figure 9. Anti-Lyt 2 antibody-mediated inhibition of allospecific
(anti- 2k) and VV-specific CTL. Various dilutions of anti-Lyt 2
mAb were added to wells containing L929 cells (uninfected for
allospecific CTL or 24 h post- VV infection for VV -specific CTL).
Percent 5lCr release was determined in a 5-h' 5 Cr release assay. E:T
ratios: allospecific CTL, 50:1; VV-specific CTL ' 100:1. Symbols:
allospecific CTL (D); day +6 VV -specific CTL 
(.. 
); day + 7 VV -specific
CT (8).
, ,
allospecific killing was mediated by CTL of sufficiently high affinity
to not require CD8-mediated adhesion for cytotoxic function.
D. Killing of L929 Cells by Anti-Kk and Anti-Dk Allospecific CTL
The previous experiments showed that not only were the VV-
infected target cells resistant to killing by anti- 2k allospecific CTL
but also illustrated differences in the down-regulation of H-2Kk and
H - 2 D k expression following VV infection of L929 cells. As CTL
responses against L929 cells (H-2k) are restricted by H-2Kk or H-2Dk
antigens (Blanden et aI., 1975), it was possible that the loss in
susceptibility of VV - infected target cells to lysis by allospecific CTL
was more pronounced in those specific for Kk or Dk To investigate
this possibility, anti-Kk and -Dk allospecific CTL were generated in
A/I (Kk Dd) and C3H.OH (Kd Dk) mice, respectively. As Figure lOa
illustrates, anti- 2Kk allospecific CTL, derived from BALB/c (H-2d)
spleen cells and generated in irradiated A/J recipient mice
efficiently lysed uninfected L929 cells. At 24 h post- VV infection
target cell susceptibility to these effector cells was markedly
decreased and completely abolished by 48 They were, however
sensitive to VV -specific CTL. As was observed for KLspecific CTL
anti-Dk allospecific CTL killed uninfected L929 cells and VV infection
of the target cells abrogated their susceptibility to killing by these
effectors (Figure lOb). Other targets with different allotypes were
used to that the killing when present was due to anensure
allospecific CTL phenomenon and not to other cytotoxic cells (not
shown). These results indicate that the sensitivity to killing by both
anti-Kk and -Dk allospecific CTL is decreased in L929 cells following
VV infection. To be sure that the VV -specific CTL were recognizing
the L929 (H-2k) ' targets appropriately, these effector cells were also
generated in A/J (Kk Dd) and C3H.OH (Kd Dk) mice and compared 
those obtained from C3H/HeSnJ (Kk Dk) mice. As shown in Figure 11
and reported elsewhere (Zinkernagel and Doherty, 1979; Mtillbacher
et aI., 1989), the bulk of the anti- VV response was Kk-restricted.
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Figure 10. Sensitivity of VV -infected L929 cells to lysis by anti-
2Kk (a) or - 2Dk (b) allospecific CTL. In a, allospecific CTL
generated in A/J mice (H-2KkD d , solid bar) were compared to VV-
specific CTL obtained from C3H/HeSnJ mice (H-2KkDk , shaded bar).
E:T ratios were 50:1 for allospecific CTL, 100: 1 for VV -specific CTL.
In b, allospecific CTL were generated in C3H.OH mice (H-2KdDk, solid
bar). The other effectors are as in a. L929 cells were used as 
targets
in a 5-h 51 Cr release assay at various intervals post- VV infection
(MOl = 10). E:T ratio was 50:1 for all effectors in b.
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Figure 11. Demonstration that the bulk of VV -CTL activity against
VV- infected L929 cells is KLrestricted. C3H/HeSnJ (H-2Kk , Dk; black
bars), A/J (H-2Kk , Dd ; striped bars), and C3H.OH (H-2Kd , Dk ; grey
bars) mice were infected Lp. with 2 x 106 PFU of VV. Six days later
spleens were harvested and used as effectors against uninfected
L929 cells or those infected with VV for 24 or 43 hours in a 5 -h 51 C 
release assay. MC57G cells (H-2b) served as a negative control. E:T
ratio = 100:1.
E. Sensitivity of L929 H-2 Class I Variant
Cell Lines to Lysis by' Allospecific CTL
I showed above that there was both a reduction in H- class I
antigen expression, on L929 cells following VV infection, in addition
to enhanced resistance to killing by allospecific CTL. In order to
determine if this reduction in the levels of H- class I molecules after
VV infection was sufficient to abrogate target cell susceptibility to
allospecific CTL-mediated lysis, L929 variant cells which expressed
lower levels of H- class I antigens were used. As shown in Figure
, 4a- l:3 cells expressed lower levels of H- class I antigens (2-
fold) as compared to normal L929 cells. However, in contrast to that
found in VV -infected targets, the L929 variant cells were still killed
by allospecific CTL at high levels. Whereas 74% lysis (19.9 lytic units
(LU)/106 cells) of normal L929 cells was observed using allospecific
CTL at a 50:1 E:T ratio, 48% lysis (7.9 LU/I06 cells) was obtained
when the L929 variant cells were used as target cells (one LU
represents the number of effector cells required to lyse 25% of the
target cells). Similar results were found with another variant line
5a- 15:9 (62% lysis, 10. LU/I06 cells). Because cycloheximide
inhibits protein synthesis and the reexpression of H- class I
molecules on the cell surface (Reichner et aI., 1988), L929 cells were
treated with 25 1. g/ml of cycloheximide for 18 - 20 h (Kunkel and
Welsh 1981) and used as targets. As shown in Figure 13,
cycloheximide treatment of L929 cells resulted in a 13-fold decrease
...
In H- class I antigen expressIOn, but these targets also remained
relatively sensitive to lysis by allospecific CTL (32% lysis (3.2 LU/I06
cells) as compared to 57% lysis (9. 1 LU/I06 cells) with untreated
L929, 50: 1 E:T ratio). Although the reduction in H-2 class I molecules
on L929 cells ' after cycloheximide treatment was substantially
greater than that found after VV infection ' these cells still served as
adequate targets for allospecific CTL. Therefore, the decrease in H-
class I antigen expression does not by itself explain the VV -induced
abrogation of susceptibility to allospecific CTL-mediated lysis.
Susceptibility of L929 Cells Persistently-Infected with LCMV
(L(LCMV) Cells) to Killing by VV -Specific, LCMV -Specific, or
Allospecific CTL after VV Infection
The above data suggested that the modulation in the sensitivity
of VV -infected target cells to lysis by NK cells or allospecific CTL may
have been due to alterations in endogenous peptide presentatio
class I molecules. To test this hypothesis, L(LCMV) cells were
infected with VV at an MOl of 10 for various lengths of time and
then used as targets in a 51 Cr release assay. VV - or LCMV -specific
CTL were obtained from spleen cells derived from C3H/HeSnJ mice, 7
- 8 days after an Lp. infection with VV (1 x 107 PFU) or LCMV (5 x
104 PFU), respectively. In vivo-generated allospecific (anti- 2k)
CTL were obtained from irradiated C3H/HeSnJ, mice 5 days after
receiving either BALB/c (H-2d) or C57BL/6 (H-2b) donor spleen cells.
As shown in Figure 14, VV-specific CTLwere unable to lyse L(LCMV)
cells before infection with VV. However, after VV infection
, the
sensitivity of L(LCMV) cells to killing by VV -specific CTL increased
and peaked at 12 -24 Whereas L(LCMV) cells were killed 
LCMV -specific CTL or by allospecific CTL before VV infection,
infection of these targets ' with VV resulted in a rapid loss in
susceptibility to lysis by either of these effector cells.
These results,
in addition to those described above, are consistent with the
hypothesis that alterations in endogenous peptide presentati
VV -infected targets may have affected target sensitivity to 
lysis by
allospecific (or' LCMV -specific) CTL, and possibly even by NK 
cells.
As will be shown in the following chapter, however, my evidence
does not support a role for peptide 
modification in enhancing the
susceptibility of targets to lysis by 
NK cells.
CLASS I ANTIGEN EXPRESSION
Normal L929
LUl106 cells= 19.
% Lysis = 74
4a- 1 :3
LUl106 cells = 7.
% Lysis = 48
5a- 15:9
LU/106 cells = 10.
% Lysis = 62
log 10 fluorescence
Figure 12. L929 variants expressing reduced levels of H- class I
antigens comparable to VV -infected L929 cells are susceptible to
lysis by allospecific CTL. The L929 variants, 4a- l:3 and Sa-1S:9,
were stained with a rat anti-mouse H- class I antibody, followed 
a FITC-Iabelled mouse anti-rat antibody. Analysis was by FACS. The
cells were also used as target for in vivo-generated allospecific CTL
derived from CS7BL/6 donors (C3H/HeSnJ recipients). E:T ratio =
SO: 1 , 6- assay. Cytotoxicity results are indicated as % lysis and lytic
units (LU)/106 cells.
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Figure 13. Cell surface expression of H- class I molecules on
cycloheximide- treated (25 g/ml, 19 h) L929 cells. The cells were
labelled with a monoclonal rat anti-mouse H- class I antibody,
followed by a FITC-conjugated mouse anti-rat antibody. Analysis
was performed by FACS. In parallel, samples of untreated or
cycloheximide-treated L929 cells were labelled with 51 Cr and used as
target in a 6-h 51 Cr release assay with allospecific CTL (generated in
C3HIHeSnJ mice with C57BL/6 donors) as effectors at a 50:1 E:T ratio.
The results of the cytotoxicity assays are indicated in the text.
.. 20
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Figure 14. Susceptibility of VV-infected L(LCMV) cells to killing by
CTL. L929 cells, persistently-infected with LCMV were infected with
the WR strain of VV at an MOl of 10. At various times after
infection, the cells were used as targets in a 4-h 51 Cr release assay.
The following effector cells were employed at an E:T ratio of 100:1:
VV-specific CTL (0 
), 
LCMV-specific CTL (A), allospecific CTL
generated in irradiated C3H/HeSnJ mice (H-2k) with BALB/c (H-2d)
donors 
(.); 
allospecific CTL using C57BL/6 (H-2b) donors (0).
CHAR 
STUDIES ON TH ROLE OF VIRAL PEPTDE CHARGING OF H-2 CLASS I
MOLECUES IN TH SUSCEBILITY OF TARGET CELLS TO LYSIS BY
NK 
Overnight Treatment of Target Cells with Synthetic Viral Peptides
does not Alter Sensitivity to NK Cell-Mediated Lysis
Because the results in the previous chapter were consistent
with viral peptide charging of H- class I molecules modulating
target cell susceptibility to NK cell-mediated lysis, and because of
work showing that modifications in the MHC peptide-binding groove
alters target cell susceptibility to lysis (Storkus et aI., 1991), I
decided to test this hypothesis directly. Initially, I used an in vitro
approach in which I added synthetic peptides, corresponding to the
natural or minimal immunodominant epitopes as defined for 
virus-
specific CTL (Old stone, 1991). Table 1 shows the peptides that were
used. In the experiments shown in Table 4 target cells were
pretreated overnight with 200 - 250 of the indicated peptides,
washed and used in 4 - 6 h 51 Cr release assays. Influenza has been
shown to be an NK-sensitive virus ' in mice and hamsters (Stein-
Streilein and Guffee, 1986; Guffee et aI., 1989). In the representative
experiments shown in Table 4, no significant difference in 
the
sensitivity of targets pulsed overnight with 3 different influenza
peptides, which are presented on different H- class I molecules, to
NK cell-mediated lysis, compared to targets treated with no peptide.
Furthermore, neither the Ld-restricted IEpp89 immunodominant
.
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peptide from the prototypic NK-sensitive VlfUS, MCMV, nor the
minimal immunodominant peptide from VSV N (Kb-restricted), were
able to modulate susceptibility of the indicated targets to lysis by 
cells. In order to demonstrate that these peptides were indeed
charging the appropriate H- class I molecules, primary VlfUS-
specific CTL were generated by infecting mice of the appropriate
haplotype with the appropriate virus and harvesting spleen cells 6 
days post- infection for use as effectors in the assays.
Virus-
specific CTL were not generated against all of the viral peptides
because some primary CTL are difficult, if not impossible, to induce
in vivo for testing in vitro. However, I was able to use either
primary virus-specific CTL or peptide-specific CTL clones for 
most of
the peptides. For example, as shown in Table SA, 18.81 (H-2d) pre-
cells prepulsed with the Kd-restricted influenza HA5l5- 526 
peptide
and then washed, were killed quite well by the CTL clone, B7-
B7,
which is specific for this peptide. Additionally, primary CTL 
induced
by VSV were able to efficiently kill PS2 (H-2b) cells, but only after
the targets were pretreated with the appropriate peptide (Table SA).
Peptides corresponding to defined immunodominant epitopes
from HSV-l gB (Kb-restricted) and LCMV NP (Db- and Ld-restricted)
were also tested. LCMV has been defined as an NK-resistant virus in
mice (Bukowski et aI. , 1983). Although some evidence suggests that
HSV- is NK-sensitive in humans (Santoli et at, 1978a, b; Fitzgerald
et at, 1982; Bishop et at, 1983, 1984) and mice 
(Lopez et at, 1980;
Habu et aI., 1984), our laboratory has reported that NK cells are not
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required to regulate this infection in CS7BL/6 mice 
(Bukowski and
Welsh, 1986b). The HSV-l and LCMV peptides did not significantly
alter the sensitivity of the target cells to NK cell-mediated lysis
(Table 4). As shown in Table SA, LCMV-specific CTL from either H-
2b (CS7BL/6) or H-2d (BALB/c) mice were able to kill targets
prepulsed overnight with the appropriate Db- or Ld-restricted 
LCMV
peptides, respectively.
One other peptide derived from sequences from a virus with
unknown NK-sensitivity (rabies NS, Kk-restricted) and one from the
HIV- (IIIB) gp160 (Dd-restricted), were 'also evaluated. These
peptides were also unable to affect the susceptibility of the targets to
NK cell-mediated lysis (Table 4). To demonstrate that the HIV-
(IIIB) Dd-restricted peptide was indeed charging the appropriate H-
class I molecules, gpl60-specific CTL were induced by infecting
BALB/c (H-2d) mice with the recombinant VV , VV-abtA74-79, which
expresses a truncated form of the HIV - 1 (IIIB) envelope gene.
Table SA shows, only 18.81 cells treated with the HIV- peptide
were killed by these CTL. Therefore, these results suggest that viral
peptide charging of H- class I molecules 
by overnight pretreatment
does not modulate target cell sensitivity to lysis by NK cells.
Synthetic Viral Peptides Present throughout the Assay do not
Modulate Target Cell Susceptibility to Lysis by NK Cells
While my studies were underway, two reports from the same
laboratory (Chadwick and Miller, 1992; Chadwick et at, 1992),
suggested that when peptides (10 g/ml) were present during the
entire 6-h 51 Cr release assay following a 30, min preincubatio before
adding effector cells , Con blast target cells were more sensitive to
lysis by NK cells than those in the absence of peptide. U sing Con 
blasts or other cell lines as targets, I was unable to find that these
targets were more sensitive to lysis by NK cells when peptides were
present throughout the assay at a final concentration of 
10 g/ml
(Table 6). For example, as shown in Table 6, neither BALB/c splenic
Con A blasts, 18.81 (H-2d) or P815 (H-2d) target cells differed in
their sensitivity to lysis by NK cells in the presence of the influenza
H A 515 -526 (Kd-restricted) peptide. As expected, these targets were
sensitive to lysis by the CTL clone, B7-B7, when that peptide was
present (Table 5A). Similar results were observed with the VSV
peptide and other immunodominant peptides (Tables 5 and 6).
the reports referred to above, the authors used IL-
2-activated spleen
cells, also known as LAK cells. When LAK cells were obtained from
C57BL/6 mice and used as effectors against the LCMV NP (Db-
restricted) peptide, no difference was detected in the sensitivity of
the P52 targets to lysis by these effector cells (Table 4). LAK cells
generated from SCID (H-2d) mice are entirely NK cells, due to the
absence of T or B cells in these mice (Bosma et aI., 1983). Therefore,
SCID LAK cells were used as effectors in , assays where the influenza
HA5l5-526 peptide (Kd-restricted) was present throughout the assay.
Not surprisingly, no alterations in the susceptibility of either 18.81 or
P815 (both H-2d) targets to lysis by SCID LAK cells was observed in
the presence of the peptide (Table 6). Over two dozen experiments
with various peptide/target cell combinations with either NK or LAK
cells as effectors were performed, wfth' all giving similar negative
results. The targets included: normal" cells (Le., Con A blasts),
thymomas, mastocytomas, pre- cells, fibroblasts, and thymomas or
fibroblasts transfected with various H- class I molecules. Therefore,
as a result of these numerous experiments, I find that even when the
peptides are present throughout the assay, target cells are not more
sensitive to lysis by NK cells. Furthermore, other laboratories have
been attempting to modulate target cell sensitivity to NK cell-
mediated lysis synthetic viral peptides and have beenusmg
unsuccessful as well (R. Kiessling, H. -G. Ljunggren , and M. Trucco,
personal communications).
should point ' out that in my very earliest preliminary
experiments" I used the Db-restricted LCMV NP peptide and, based
on information from Dr. Michael Oldstone laboratory, the peptide
was included in the assays at 200 - 250 jlg/ml. At this extremely
high concentration, L-Db or DIR cells with' the NP peptide appeared
to be actually more resistant to lysis by NK cells, when compared to
the same targets without peptide, although the peptide-treated
targets were sensitive to lysis by LCMV -specific CTL (Figure 15).
Because the studies reported above (Chadwick and Miller, 1992;
Chadwick et aI., 1992) used considerably less peptide in their assays,
and to avoid any potential nonspecific effects, my subsequent
experiments used lower concentrations.
.
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Figure 15. Effect of LCMV NP peptide on the sensitivity of L-
Db and
DIR cells to NK cell-mediated lysis. 5lCr-labelled L-
Db (top) and DIR
(bottom) cells were plated in 96 well plates and either LCMV 
peptide (Db-restricted) for a final concentration of 
200 IJg/ml (filled
symbols), or medium (open symbols) were added to 
the appropriate
wells After 45 min at C, spleen cells from 
C57BL/6 mice, 3 days
(NK, t\) or 9 days (LCMV -CTL, 0) after LCMV infection were added at
various E:T ratios for a 6-h 51 Cr release assay.
., .
C. Saturation of Both H-2 Class I Allotypes on P52 (H-2b)
Cells with Peptides does not Increase Target Cell
Sensitivity to Lysis by NK Cells
It is possible that in the previous experiments we failed 
demonstrate a peptide-induced alteration of target cell susceptibility
cell-mediated lysis because only used single
immunodominant peptide which was presented on a single H- class
I allotype. Because saturation of both H-2 class I allotypes may have
given a different result, P52 target cells were pretreated overnight
with both the Kb-restricted VSV peptide and the Db-restricted LCMV
NP peptide. The cells were then labelled with 51 Cr, washed free of
peptide, and used as target cells in a 6-h killing assay against splenic
NK cells from C57BL/6 mice. In parallel , the peptides were added to
targets in the assay. As shown in Figure 16, when target cells were
treated overnight with both peptides and washed (Fig. 16a), or when
both pep tides were present throughout the assay (Fig. 16b), no
change in the sensitivity of P52 target cells to lysis by NK cells was
observed. Primary VSV - and LCMV -specific CTL were also generated
in C57BL/6 (H-2b) mice. As is also evident in Figure 16, these
effectors were only able to lyse the targets when the the targets
were prepulsed overnight with the appropriate peptide (Figure 16a)
or if the peptides were present in the assay (Figure 16b). As shown
in Figure 17 , similar results were obtained when the Kb-restricted
HSV-l gB peptide was used with the Db-restricted LCMV NP peptide.
:J ,
: - - :. ,  '- -' .-
xr:,
;' 
LCMV -specific CTL could only kill those targets pretreated overnight
with the LCMV peptide. These data further support the above
results suggesting that viral peptide charging of H- class I molecules
does not affect target cell susceptibility to NK cell-mediated lysis.
None VSV LCMV VSV + LCMV
Peptide Pretreatment
None VSV LCMV VSV + LCMV
Peptide(s) Assay
Figure 16. The combination of the VSV N and LCMV NP peptides
added to P52 cells does not alter target cell susceptibility to NK cell-
mediated lysis. 51 Cr-Iabelled P52 (H-2b) targets were either
preincubated overnight with the VSV N (Kb-restricted) and/or LCMV
NP (Db-restricted) peptides followed by washing (a), or the peptides
were present throughout the assay at 10 Ilg/ml (b). Activated
splenic NK cells (black bars), VSV -specific (striped bars) or LCMV-
specific CTL (grey bars) were then added for a 6-h 5 Cr release assay.
E:T ratio = 100: 1.
. :..:
CD 20
HSV + LCMVLCMVNone HSV
Peptide Pretreatment
Figure 17. The combination of the HSV-
l gB and LCMV NP peptides
added to P52 cells does not alter target cell susceptibility to NK 
cell-
mediated lysis. P52 (H-2b) targets ' were 
51 Cr-Iabelled and
preincnbated overnight with the HSV-l gB 
(Kb-restricted) and/or
LCMV NP (Db-restricted) peptides followed by 
washing. Activated
splenic NK cells (black bars), or LCMV -specific CTL 
(day 10 post-
infection, striped bars) were then added for a 5-
h 5lCr release assay.
E:T ratio = 100:1.
CHAPTR VI
PATHOGENESIS OF MCMV INCTION IN 
MICROGLOBULIN-
DEFICIENT MICE
A. Replicatio of the Prototypic NK-Sensitive Virus, 
MCMV, in Intact
or NK Cell-Depleted ~2-Microglob
Deficient or C57BL/6 Mice
MHC class I antigen expression has been implicated in 
the
susceptibility of bone marrow grafts (Yu aI.,
1992)
hematopoietic tumor cells (Hoglund et 
aI., 1991b) to control by NK
cells in vivo. Bone marrow or tumor cells 
expressing allogeneic H-
class I molecules are rejected by recipient NK cells, 
whereas those
cells from syngeneic animals grow well 
in vivo. This is consistent
with the "effector inhibition" model (Ljunggren and Kfirre, 
1990). 131-
micro globuli deficien t lIh m 
1-) J mice have a defect in H -
class I
antigen expressio (Koller et 
aI., 1990; Zij1stra et aI., 1990), and bone
marrow cells from these mice are rejected in H-
class I normal,
heterozygous littermates (Bix et 
aI., 1991), presumably due to 
the
deficit in class I expressio
In contrast, allogeneic H- class 1+ bone
marrow cells are able to grow in ~2m (-/-) recipients (Liao et 
aI.,
1991). These reports would seem to 
suggest that 13 2 m (-
/ - ) 
mice
would not have functional NK cells. However
, NK cells from 132m (-
/-)
mice are able to kill the mouse prototypi
NK-sensitive target cell,
Y AC-l (Hoglund et aI., 1991a; Liao et 
aI., 1991), and therefore would
be useful as an 
in vivo model in order to ask the questio
of whether
class I molecule expression was required for the 
regulatio of a
virus infection by NK cells. I infected intact or NK-depleted (injected
with anti-asialo GMI antiserum) ~2-microglobuli ficient (~2m (-
)) 
, or C57BL/6 mice (both H-2b) with the prototypic NK-sensitive
virus, MCMV. MCMV is sensitive to NK . cells in vivo (Bancroft et at,
1981; Bukowski' et aI. 1983, 1984, 1985) and is NK-sensitive
independent of T or B cell functions (Welsh et aI., 1991). The
C57BL/6 mice served as an H- class I antigen (~2m)-positi
MCMV -sensitive control. Three days post-infection, spleens were
harvested, and virus was quantitated. The results presented are the
average of 3 or 4 mice :t S.D. As shown in Table 7, splenic MCMV
virus titers from C57BL/6 mice were approximately 0.5 - 1 10glO PFU
higher in the NK-depleted group than NK-intact mice, as expected
(Bukowski et aI., 1983, 1984, 1985; Welsh et at, 1990; Shanley,
1990). Interestingly, a similar difference in MCMV titers was also
observed in the spleens of NK-depleted ~2m (-/-) mice as compared
to intact ~2m (- ) mice. Decreases, in splenic NK cell activity of anti-
asialo GMl-treated mice were observed, as measured by the lysis of
Y AC- l target cells (Table 7). I do not know why the anti-asialo GMI
treatment was more effective in the depletion of NK cell activity in
C57BL/6 than in ~2m (-/-) mice. In our experience, the reduction in
in vitro NK cell activity following anti-asialo GMI antiserum
treatment of mice infected with the more cytopathic viruses, such as
MCMV , is not as profound as with the noncytopathic virus , LCMV, or
following injection with poly I:C. This will be addressed in more
detail in the Discussion (Chapter VIII). Nonetheless, it is important
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to point out that the mice received the minimum effective dose of
anti-asialo GMI antiserum, in order to avoid any nonspecifi
effects
as can often occur when higher concentrations of anti-NK 
cell
reagents are used in vivo, and that increases in splenic virus titers
were observed in 
both groups of anti-asialo GMl-treated mice.
B. Expression of H-2 Class I Antigens on Thymocytes
Following MCMV Infection
During the course of a virus infection in normal mice, 
increases
in the expressio of H- class I molecules in various tissues is
observed (Bukowski and Welsh, 1986a). In order to ensure 
that H-
class I antigen expression in ~2m (- ) mice was absent even after
MCMV infection, so that the issue of whether or not H-
class I
molecules do play any role in ' the regulatio of MCMV by NK 
cells
could be addressed, thymocytes were isolated from 
both uninfected
and MCMV -infected ~2m (- ) and CS7BL/6 (control) mice 
and
stained for the expressio of H-2Db Figure 18 shows 
that whereas
increases in thymocyte expression of H-2Db following
MCMV
infection of CS7BL/6 mice can be detected by the 
antibodies, 28-11-
SS and 28- 14-8S, which recognize 131m-associ ted and normal or 
free
H - 2 D b heavy chain, respectively (Townsend et at, 1989), no
alterations in cell surface H-2Db could be found in 
MCMV -infected
~2m (-/-) mice. Taking the above data together, the results suggest
that, unlike other systems (e. , hematopoietic tumor cell rejection) in
which a role for NK cells has been .implicated, the regulation of a
virus infection by NK cells, at least in the case of MCMV, is
inde endent of MHC class I antigen expression.
C. In vitro and in vivo Evidence that , IFN-Mediated Protection from
NK Cell-Mediated Lysis Requires H-2 Class I Antigen Expression
As mentioned in Chapter IFN is produc,ed early during a
virus infection (Welsh, 1978) and has been shown to upregulate the
expression of MHC class I antigens on various cells (Lindahl et aI.,
1976; Bukowski and Welsh, 1985, 1986a). This has been correlated
with the ability of IFN to protect targets from lysis by NK cells
(Trinchieri and Santoli 1978; Welsh et at 1981). Because
thymocytes from uninfected, ' H- class I-normal mice are sensitive to
lysis by NK cells, whereas those from virus-infected animals are
resistant, thymocytes can sed monitor IFN -mediated
protection In VIVO. Therefore, I compared the sensitivity of
thymocytes from C57BL/6 and the H- class I-deficient, ~2m (-
/-)
mice to NK cell-mediated lysis before and after infection with MCMV.
This would provide a more direct assessment of whether MHC class I
molecule expression is necessary for IFN -mediated protection from
NK cell-mediated lysis. I also analyzed the NK-sensitivity of normal
and ~2m (-
/-) 
cell lines before and , after IFN~ treatment and
compared this to the expression of H- class I antigens. In the
evaluation of the cell lines in vitro as shown in Table 8, only the
~2m-normal cells were able to be protected from NK cell-mediated
lysis following IFN~ pretreatment; ~2m 
(.:-) 
cells were killed equally
well with or without overnight exposure to IFN ~. This was also
reflected in vivo. As Table 9 shows, thymocytes from uninfected
C57BL/6 or ~2m (-/-) mice were very sensitive to lysis by LCMV-
activated splenic NK cells from C3H/HeSnJ mice. Three days
following MCMV infection, however, the C57BL/6 thymocytes were
completely resistant to NK cell-mediated lysis. In contrast, this,
profound level of IFN protection observed with C57BL/6 mice was
not demonstrated when thymocytes obtained from MCMV - infected
~2m (-/-) mice were used as targets. The moderate reduction in the
sensitivity of thymocytes from MCMV -infected ~2m (-
/-) 
mice to NK
cell-mediated lysis, observed in Table 9, may have been due to
differences thymocyte, subpopulations (as reflected
preliminary experiment assessing CD4 and CD8 expression following
MCMV infection) when compared to C57BL/6 mice (Figure 19;
thymocytes were from Table 9, expo 3). It should be noted that a
cortisone-sensitive thymocyte subpopulation (presumably CD4+CD8+
double positive) appear$ to be the most sensitive to lysis by NK cells
(Hansson et aI., 1979), and this subpopulation is ,greatly reduced in
the MCMV -infected ~2m (-/-) mice. Nonetheless, the most important
conclusion from these experiments is that the' degree of IFN-
mediated protection was inversely correlated with H- class I
antigen expression in both thymocytes (Figure 18) and cell lines
2m f-)
L--
~~~
4 1 4 1
log10 fluorescence
C57BL/6
Figure 18. Expression of H-2Db on thymocytes from uninfected or
MCMV -infected CS7BL/6 and ~2m (-/-) mice. Single cell suspensions
of thymocytes were prepared from uninfected or MCMV -infected (3
days post-infection) CS7BL/6 or ~2m (-/-) mice and were stained
with the conformational-dependent, 28- 11-SS (b, e, h k) 
conformational- independent, 28- 14-8S (c, f, i I), anti- 2Db
monoclonal antibodies, followed by FITC-conjugated goat anti-
mouse Ig antiserum. Analysis was by FACStar. a- , staining of 
2Db on thymocytes from uninfected (a-c) or MCMV-infected (d-
CS7BL/6 mice. g- , staining of H-2Db on thymocytes from uninfected
(g-
i) or MCMV -infected U-l) ~2m (-/-) mice. Staining with second
antibody only (a, d, g, j).
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Figure 19. CD4 and CD8 expression on thymocytes from uninfected
and MCMV -infected ~2m (-/-) and C57BL/6 mice. Single cell
suspensions of thymocytes were prepared from individual
uninfected or MCMV -infected (3 days post-infection) C57BL/6 and
~2m (-/-) mice and stained with PE-Iabelled anti-CD4 and FITC-
conjugated anti-CD8 mAb. The presented profiles are representative
of 3 or 4 mice in each group. The percentage of the CD4+CD8+ double
positive and CD4+ and CD8+ single positive populations are indicatedin the appropriate quadrants. The CD4-C D 8 - double negative
populations in uninfected and infected groups ranged from 7 - 12%
(C57BL/6) and 11 - 14% (~2m (-
/- )). 
Two color analysis was by
FACStar.
(Table 8). These results are in line with a prevIous report in vitro
(Ljunggren et aI., 1990) and are the first in vivo evidence suggesting
that IFN -mediated protection re ire the expression of MHC class I
molecules, perhaps by delivering a negative signal to NK cells.
The above , data strongly suggested that H- class I-dependent,
IFN-mediated protection was not occurring in the ~2m (-/-) mice. I
sought further evidence for this from another angle. If splenic NK
cells were activated in the MCMV-infected ~2m (-/-) mice, and the
non-NK cells in the spleen were not IFN-protected, there should be
fewer spleen cells in NK-intact compared to NK-depleted (anti-asialo
G M I-treated) mice. When I analyzed the spleen cell number data
from all 4 experiments presented in Table 7, I found that in MCMV-
infected, anti-asialo GMl-treated ~2m (-/-) mice, there were 1.4 :! 0.
x 10 cells (n=13), whereas spleen cells from MCMV-infected, NK-
intact ~2m (-/-) mice averaged 9.4 :! 5.6 x 106 (n=12; p-cO. l). 
MCMV - infected, normal C57BL/6 mice, the opposite result was
observed (NK-intact: 1.3 :! 0.5 x 10 ; anti-asialo GMl-treated: 7.0:!
0 x 106 cells; n=13; p-cO.Ol). These results are direct evidence for a
lack of IFN -mediated protection in MCMV -infected ~2m (-/-) mice.
CHAPTER VII
IDENTICATION OF TH MOIETY RECOGNID BY mAb CZ-
A. Characteristics of the CZ- l Antigen
This laboratory has recently described the properties of a rat
anti-mouse mAb designated CZ- l (Vargas-Cortes et aI., 1992). The
CZ-l mAb defines an epitope expressed on 15-25% of mouse bone
marrow cells, 3-5% of thymocytes, and about 65% of splenocytes.
The antigen is sensitive to treatment of cells with proteases and
neuraminidase, but not to phosphatidylinositol (PI) phospholipase C,
suggesting that associated with non-PI- linked
sialogl ycoprotein. The molecule is expressed on B cells and virtually
all NK cells and CD8+ T cells. However, it is not expressed on most
peripheral CD4 + T cells unless they are first activated by T cell
receptor stimulation. It is an early bone marrow marker for
lymphocyte hematopoietic precursor cells, and it defines NK cells and
their precursors at all detectable stages of their generation (Vargas-
Cortes et aI., 1991). Unfortunately, due to the low affinity of the CZ-
mAb, previous efforts by others in the laboratory to identify the
properties of the CZ- antigen by conventional biochemical analyses
such as immunoprecipitation, Western blots and cross- linking
methods were unsuccessful. FACS analyses, however, suggested that
the CZ- antigen was a sialic acid-dependent epitope' of a non-PI-
linked membrane glycoprotein (Vargas-Cortes et aI., 1992). The"
leukocyte staining pattern of mAb CZ-l was not identical to any
100
other mAb that I have seen, but there ' are certain similarities in its
staining distribution to the OX-22 anti-rat mAb (Table 10), which
recognizes an isoform of CD45 (Spickett et aI., 1983).
The leukocyte common antigen CD45 represents a ubiquitous
group of membrane glycoproteins, of' 180-220 kD arising as a
consequence of alternative splicing of at least 3 exons (exons 4, 5,
and 6 or, A, B , and C; Figure 20) into 8 different cell surface isoforms
(Johnson et at, 1989; Trowbridge, 1991). These proteins are heavily
glycosylated, allowing for substantially increased heterogeneity due
pos t- tran slational modifications. CD45 molecules are
transmembrane protein tyrosine phosphatases thought
important' for coupling ' cell antigen receptor signals to the
phosphoinositol second messenger system. Both CZ-l and OX-
identify hematopoietic precursor cells and stain a low percentage of
thymocytes and a high percentage of splenocytes; some of these
staining properties have also been seen with antibodies to various
other isoforms of mouse ,(:D45 (Bottomly et at, 1989; Hathcock et 
at,
1992). These characteristics led me to question whether mAb CZ-
recognized a form of mouse CD45.
101
;J.
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TABLE 10
Comparative Analysis of Cells Staining
with CZ-l and OX-
- - - - - -- - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - -- - - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - - -  - - - - - - - - ---
CELL POPULATION
B cells
CD4+ T cells (naive)
CD8+ T cells ( 
NK cells
Bone marrow cells
Thymocytes
% OF CELLS STAINING WITH:
CZ-l OX-100 1006 50-100 100
100 l00
10-25 -
- - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - -   - -    --
aSummary of data taken from Spickett et aI., 1983; Vargas-Cortes et
at, ' 1992.
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Figure 20. Genomic organization of the first 5' proximal 8 exons of
the mouse CD45 gene. From Saga et at, 1990.
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Competitive Antibody-Binding Studies
Although the CZ- l antigen is absent from many lymphocyte cell
lines, we found both it and CD45 to be expressed on the pre-
cell
line, 18.81. The 18.81 cell line expresses several isoforms of 
CD45,
but expresses in highest abundance the isoform containing the exons
A, B, and C and in moderate abundance the isoform containing exons
and C (Saga et aI., 1990). Competitive binding studies were
therefore performed on this line using double color FACS analyses
and antibodies to several exons of CD45. Cells were exposed
simultaneously to mAb CZ-l and to mAb panreacti with all 
mouse
CD45 molecules or to exons A, B, or C. As a control experiment, the
rat anti-mouse IgM Hid' was used in place of mAb CZ-
Figure 21
shows that, whereas none of the CD45-specific mAb inhibited the
staining of cells with mAb Hid, the B-exon-specific mAb 
(CD45RB)
caused a substantial inhibition in the binding of 
mAb to the cells
(33% vs. 4% staining). Antibody to exon C (CD45RC) also caused a
moderate inhibition in staining with mAb CZ-l (33% vs. 15%), but it
should be noted that exon C is only expressed on this cell line in
isoforms that also express ex on B (Saga et at, 1990). Figure 21 
also
shows a general correlation between how brightly mAb CZ-
l and the
other CD45 mAb (CD45RA and CD45) stained 18.81 cells in
combinations in which there was no competition. Thus, the 
cells that
expressed high levels of the CZ- antigen also expressed high 
levels
of CD45. It should be noted that B cells predominantly express 
104
form of CD45 which contains all three exons (Johnson et aI., 1989;
Saga et aI., 1990; Trowbridge, 1991), but only antibody to the B 
exon
caused an almost complete inhibition of mAb CZ-l binding.
C. Expression of the CZ-l Antigen on CD45-Transfected Cells
'I 2 cells transfected with various isoforms of mouse CD45
(Johnson et aI., 1989), were assessed for their ability to react 
with
mAb CZ- Figure 22 shows ' that the nontransfected parent cell line
did not react at all with mAb CZ-l or the CD45 framework -specific
mAb. Cells transfected with a CD45 ' gene without the alternatively
spliced exons (T200/0) reacted with the CD45 framework-specific
mAb but not at all with mAb CZ- Cells transfected with CD45-
containing exon C (T200/C) reacted with C exon-specific mAb but not
at all with mAb CZ-1. In contrast, cells transfected with CD45 + 
exons
A, B , and C (T200/ABC) or CD45 + exons B and C (T200/BC) reacted
with the appropriate anti-CD45 mAb and also reacted at lower but
significant levels with mAb CZ- Although the level of 
staining with
mAb CZ-l was low, this was a reproducible positive result, highly
consistent with the antibody blocking data shown in Figure 21.
these experiments, each 'l 2 transfectant , cell line was reacted with all
of the various anti-CD45 mAb in order to confirm expressio
of the
appropriate exons, but Figure 22 for simplicity only shows data for
the most meaningful mAb for each transfectant cell line.
11'
,1J
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One might argue that because the staining of the '1 2
transfectants with mAb CZ-l was low, it might not 
necessarily be
CD45RB-specific staining. To ensure that the mAb' CZ-
l was indeed
reacting with a CD45RB-associated epitope on the '12 
transfectants, I
performed a competitive FACS analysis as was 
presented in Figure
21. As Table 11 shows, mAb CZ- ' stained 11 %
and 71 % of
T200/ABC and 18.81 control cells, respectively, in the 
absence of any
other mAb. When an antibody specific for 
CD45RB was added at the
same time as mAb CZ- , a significant inhibition in the 
staining with
mAb CZ-l was found (2% staining with T200/ABC; 11% with 18.
cells). The addition of a CD4 framework-specific antibody withTherefore,
'; 
mAb CZ-l to these cells did not inhibit mAb CZ-
l binding.
these results suggest that mAb CZ- recognizes a novel 
CD45RB-
associated, epitope.
D. Sialic Acid-Dependence of the CZ- l Epitope
This laboratory had previously reported that treatment of
spleen cells with neuraminidase, which cleaves sialic 
acid residues
from the surface of cells, would abrogate the 
ability of the CZ- mAb
to bind (Vargas-Cortes et aI., 1992). This indicated that the
expressio of the CZ-l epitope was sialic acid-
dependent. In order to
determine whether sialic acid was actually part of the CZ-
l epitope-
binding site, binding competition studies were 
done on 18.81 cells
between mAb CZ- l and either sialic acid or the 
larger neuramin-
,:-
';f'
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lactose. Figure 23 shows that 50 mM sialic acid caused a modest
inhibition in the binding of mAb CZ- l but not of mAb to H-2 class I
molecules (Ml) or mAb Hid. The larger neuramin-lactose molecule
at 50 mM caused a very significant selective inhibition of binding by
mAb CZ- l but not by' the two control antibodies. Thes results thus
indicate that sialic acid is likely a part qf the CZ-l epitope. This could
account for both its expression on a subpopulation of CD45 molecules
as well as for its low affinity, as IgM antibodies to carbohydrates are
often of low affinity.
107
., 
3" 
___n
----
_m_ --n --n
,. 
o , 3 4 '
 , . ' . . 
r '
- .' : 
c1 4 - 80..1 : _
;;,
94 36 
: '
. 51 10 : . . 88 0:1 
: n /n _n
It n
/_nn n
#- _
"",nn
o 19 : c1 12 3 3 : 12 c: 17 . 5 99 
CD4SR CD45R CD45RC CD5 NEGATIVECONTROLS
Figure 21. Competitive FACS analysis of mAb CZ- l and CD45RA, RB
RC, and CD45 framework antibodies on 18.81 cells. The pre- cell
line, 18. , was treated with mAb CZ- l or, as a control, another rat
anti-mouse IgM mAb that stains B cells, Hid. At the same time,
cells were also exposed to the anti-CD45 mAb. The cells were then
stained with a PE-goat anti-rat IgM (Jo chain-specific) antiserum and
a FITC-conjugated goat anti-rat IgG (1 chain-specific) antiserum. The
log 10 fluorescence of each color is indicated on the appropriate axis of
the presented two-color profiles. Numbers in the quadrants
represent the % of cells per quadrant. Negative controls: Top: FITC-
conjugated goat anti-rat IgG only; Bottom: PE-goat anti-rat IgM only.
!.-
:f\,
CD45RC
If 
i'\
, '\! \.- 
CD45RA
! \
\.. CZ,
) ,/  \
i i
.. -- 
CD45
, .-
(:, A \
'Ii. 
1)/ 
108
T200/0
, rr
j '\.- 
CD45RB
i .
. I
' .
\ CZ,:f 
l, 
,/ , \".
1\ 
18 8 1
':' ' , ! \ ,
CD4
:, ; \
Vl\ CZ-
:' " .. 
I.'" 
2 3
T200/ABC
noolc
nOO/B C
Log Fluorescence
Figure 22. ' FACS analysis of 'P 2 cells transfected with various
isoforms of CD45. The indicated 'P2 transfectants, parental line and
the CZ- l+ control pre-B cell line, 18. , were stained with' mAb CZ-
or with mAb specific for the indicated CD45 exons, followed by a
FITC-labelled goat anti-rat- Ig antiserum. The parental cells were
stained with mAb CZ-l or with the CD45 framework antibody. The
solid line in each profile shows the staining obtained with the FITC-
conjugated second antibody alone. In three of the profiles ('P 2 ,
T200/C, T200/0) the staining with mAb CZ- directly overlapped th
negative control.
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Figure 23. Inhibition of mAb CZ- l binding to 18.81 cells by sialic
acid and neuramin-lactose. 18.81 cells were incubated with (dotted
lines) or without (solid lines) SO mM sialic acid (A) or neuramin-
lactose (B) in the presence of mAb CZ- , anti-class I mAb, or Hid.
Cells were then washed and stained with FITC-labelled goat anti-rat
Ig. Analysis was by FACS.
111
CHAPTER VllI
DISCUSSION
The major focus of this thesis was to investigate the regulation
of a virus infection by NK cells and its relationship to NK cell
triggering. We first attempted to find conditions under which target
cells became more sensitive to NK cell-mediated lysis and, following
observations made during that study, to determine if the levels of H-
class I molecules or if viral peptide charging of H- class I
molecules played a role in the lysis of targets by NK cells.
Furthermore, because of the animal models used, the more broad
question concerning a role for MHC class I antigens themselves in the
regulation of a virus infection by NK cells in vivo could also be asked.
The identity of the signal transduction molecule recognized by
the novel mAb CZ- , which was generated in this laboratory and
reacts with all cytotoxic lymphocytes, including NK cells, was also
investigated. Its identification, as well as the characteristics of those
cells which express it, will help in understanding many of the
effector cell-mediated phenomena which occur during the course of a
virus infection.
VV -infecte s are sensitive to N,K cell-mediated lysis during
a "window of vulnerabilit We initially set out to determine 
target cells could be more sensitive to lysis by NK cells during a
discrete period of time post-infection. This question was based on
- . . . - . . - -
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prevIouS observations showing that in overnight assays, virus-
infected cells appeared to be more sensitive to NK cell-mediated lysis
as compared to uninfected cells (Trinchferi and Santoli, 1978),
whereas in short-term assays, virus-inf cted cells were often more
resistant to lysis by NK cells (Welsh and Hallenbeck, 1980).
Trinchieri and Santoli had demonstrated that in the overnight assays,
virus-induced ' IFN activated the NK cells" augmenting the target cell
lysis (Trinchieri and Santoli, 1978; Santoli et aI., 1978b). Because in
many previous studies by these investigators and others the target
cells were infected for 1 to 3 days, (depending upon the virus), it was
conceivable that during a certain period of time post-infectio , target
cells could be more sensitive to lysis by NK cells and that the earlier
investigations had assayed NK activity at times other than those of
enhanced target cell susceptibility to NK cell-mediated lysis. In a
time course study using short term (4 h) assays, we found that VV-
infected L929 cells become more sensitive to lysis by NK cells during
discrete window of time, which occurred approximately 24 h post-
infection and then subsequently .declined (Figure 5). Therefore, this
supported the hypothesis that the above studies might have indeed
missed the time when virus-infected cells were more susceptible
than uninfected cells to NK cell-mediated lysis, and is completely in
line with a previous study demonstrating that target cells, when
infected for longer periods, can become resistant to , lysis by NK cells
(Welsh and Hallenbeck, 1980).
r:,
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significant body of evidence has been presented in support
of an inverse correlation, between target cells expression of MHC class
antigens and susceptibility to NK cell-mediated lysis (Ljunggren
and Karre, 1990). Following VV infection and in line with previously
published reports (Maudsley and Pound, 1991), it was found that the
cell surface expression of H-2Kk and H-2Dk on L929 cells was
decreased 2- and 5-fold, respectively" by 24 h post-infectio (Figure
7), which corresponded to the "window of vulnerability
infection of ' cells results in the inhibition ' of host cell protein
synthesis (Moss, 1968), and this is probably why we observed the
quantitative decrease in H- class I expression. This quantitative 2-
to 5-fold change in target cell H- class I antigens following 
infection may have been sufficient enhance target cell
susceptibility to lysis by NK cells found during the "window of
vulnerability
" .
This is completely in line with the inverse 
correlation
between MHC' class I antigen expression and sensitivity' to NK cell-
mediated lysis.
It was also found that there was a decrease in the binding of
effectors to target cells as the VV infection of the target cells
progressed (Table 2). This suggests that for a given bound NK cell, its
ability to lyse a target was significantly enhanced, perhaps due to
increased stimulation of the NK cell. When the triggering of the NK
cells upon interaction with VV -infected targets, was investigated
usmg a (45Ca2+) influx assay, an enhanced triggering during the
window of vulnerability" was observed (Figure 6).
-.-
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Treatment of L929 cells with conventional protei
synthesis
inhibitors, such as cycloheximide, whic also have the capacity to
decrease H- class I expressio (Reichner et aI., 1988), not
surprisingly enhance ' target cell sens tivity to lysis by NK 
cells
(Kunkel and Welsh, 1981). In contrast, treatments with agents 
that
increase ' MHC class I antigen expression, such as ' IFN (Lindahl et 
aI.,
1976), , will make target cells ' more resistant to lysis by 
NK cells
(Trinchieri and Santoli, 1978; Moore et aI., 1980; Welsh and
Hallenbeck; 1980; Welsh et aI., 1981; Piontek et at, 1985).
Using the
(45Ca2+) influx assay, a correlation between the reduction in H- class
I antigen expression and triggering of the 
effector cells when targets
were treated with these reagents was also seen (Table 3).
With
regard to the experiment with cycloheximid
, we belieye that this is
the first observation that cycloheximide treatment of 
target cells
results in an Increase of NK cell triggering. Overall
, therefore, the
51 Cr release, H- class I ntigen expressio and triggering 
results
during the "window of vulnerability" are consistent with the 
inverse
correlation between MHC class I antigen expression and 
sensitivity of
targets to NK cell-mediated lysis. The "window of vulnerability
" may
be the point of attack by NK cells in vivo, as VV 
has been reported to
be an NK-sensitive virus (Bukowski et at, 1983, 1987).
Qlitative changes in H- class I molecules following V V
infection sted alterations in
r sentation.
Surprisingly, a nearly complete loss in the susceptibility of 
VV-
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infected targets to lysis ' by allospecific CTL 
was observed at a time
when the cells remained very sensitive to 
VV -specific CTL or NK
cells. However, we had found what appeared to be only a moderate
2- to 5-fold decrease in H-
class I expressio following VV infection
(Figure 7). Therefore, we had to be sure that this decrease in the
level of H- class I molecules per se
' was not accounting for the
abrogation of target cell sensitivity to lysis by 
allospecific CTL. Using
L929 variants or cycloheximide-treated , cells which 
expressed levels
of H- class I antigens at or 
significantly below those observed
following VV infection, it was found that 
these, targets were still
quite susceptible to allospecific CTL-mediated lysis 
(Figures 12, 13).
These results, therefore, suggested that 
qualitati , rather than the
quantitati changes in H- class I antigens, were important for 
this
resistance to allospecific CTL-mediated lysis.
All 0 specific CTL recognize endogenous 
peptides in the context
of MHC class I molecules (Parham et aI., 1987; Heath et 
aI., 1989),
and the level of available endogenous peptide 
antigen is a critical
factor in determining whether 
targets are recognized and killed 
CTL (Milligan et aI., 1990). If the generation of 
endogenous peptides
requires protein synthesis, then VV infection, which 
inhibits cellular
protein synthesi (Moss, 1968), would decrease the 
concentration of
these peptides available to 
newly synthesized MHC class I molecules.
As a result, the susceptibility of L929 cells to killing 
by allospecific
CTL would be predicted to ecrease upon 
infection with VV, and this
was ohserved (Figure 8). The approach taken to 
further investigate
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this hypothesis , involved the use of L929 cells, persistently-
infected
with LCMV (L(LCMV) cellsl which, because they express endogenous
LCMV peptides, are sensitive to lysis, by LCMV-specific CTL. 
Upon
superinfecti with VV, L(LCMV) c lls became ,resistant to lysis by
allospecific ,and LCMV -specific CTL (Figure 14). Therefore, the loss in
susceptibility of L(LCMV) cells to LCMV -specific CTL 
suggests that
VV -encoded peptides successfully compete
with LCMV (Le.,
endogenous) peptides for newly synthesized H-
class I molecules.
of H-2 ' las
sensitivit to NK cell-mediated I sis.
othesis. The
results obtained with the allospecific CTL led us 
to questio whether
viral peptide charging was also responsible for the 
enhanced
susceptibility of VV -infected cells to NK 
cell-mediated lysis. I should
point out one caveat here: applying the interpretatio
of the
allospecifc CTL experiments to NK ce\1s 
requirs the assumptio that
NK cells recognize the peptide/MHC, class I molecule 
complex in a
manner similar to CTL. Evidence published by 
others is consistent
with the possibility that the peptides presented by the 
MHC class I
molecules might be critical ' in target cell susceptibility to NK 
cell-
mediated lysis. The work of Dawson, Storkus and their 
colleagues
(Storkus et aI., 1989a, 1989b, 1991), which showed that a 
particular
residu blocking access to the peptide binding groove in HLA-
played a role in conferrng NK-resistance 
to ce\1s expressing this MHC
class I molecule, is quite in accord with the hypothesis 
that peptides
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are important in target cell sensitivity to
' killing by NK cells. This
suggested that NK cells, could interact with the peptide/MHC class I
complex. Additionally, a report using an HSV -1 infection model with
human NK cells, presented evidence similar to that which we found
with VV (Kaufman et at, 1992). In that study, CIR cells transfected
with various HLA class I molecules were considerably less sensitive
to NK cell-mediated lysis when , compared to nontransfected controls.
Upon ' HSV- l infection, however, the transfectants became much more
sensitive to lysis. Nontransfected CIR cells did not differ in their
susceptibility to NK cell-mediated lysis after HSV- infection.
Without a significant alteration in HLA class I antigen expresSIOn
following HSV - infection, these authors concluded that a qualitati ve
change in class I antigens (Le., viral peptide charging) might be
conferring sensitivity to NK cell-mediated lysis in the CIR HLA
transfectants (Kaufman et aI., 1992).
We took a direct approach to ask whether viral peptide
charging of H- class I molecules affects the sensitivity of targets to
NK cell-mediated lysis. In vitro, synthetic immunodominant viral
peptides will associate with MHC class I molecules in the presence of
' exogenous source of ~2-micToglobulin (Le. ,. FBS; Townsend and
Bodmer, 1989; Yewdell and Bennink, 1992) and targets so treated
will be sensitized for killing by virus (or peptide)-specifi CTL.
Therefore, the target cells were either pretreated with peptide
overnight followed by washing, or the entire 51 Cr release assay was
performed with peptide present. ' With neither of these approaches
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was a significant modulation of target cell susceptibility to lysis by
NK cells detected. It should be pointed out that, at least in the
overnight pretreatment protocol, greater than 80 - 90% of the class I
molecules should be charged with the added peptides (M. Trucco,
personal communication) and during a virus infection of mouse cells,
only about 0. 1 - 5% (dependent on the virus) of the H- class I
molecules are ' charged with the immunodominant peptides (J.
Yew dell and J. Bennink personal communication). We also
considered the possibility that adding ' a ngle immunodominant viral
peptide specific for a' single H- ' class I allotype was insufficient, in
the event that viral peptide charging of all of the H- class I
molecules on the targets was necessary to observe a difference in the
sensitivity of peptide-treated targets to NK cell-mediated lysis.
Therefore, pep tides specific for each of the Kb and Db class I
molecules were added to an H-2b (P52 lymphoma) target, using both
peptide treatment protocols described above. Even under these
conditions, no change in the cytolysis of targets by NK cells was
observed. It has been previously reported that the addition of
certain synthetic viral (or other class I -binding) peptides to target
cells in vitro will result in an upregulation of those H- class I
antigens for which the peptides are specific (Townsend ' et at, 1989;
Lie et aI., 1991), whereas with other peptides, this change does not
occur (Lie et at, 1991). It could therefore be argued that peptide-
induced alterations in the quantitative expression of target cell class
I antigens might affect the sensitivity of target cells to lysis by NK
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cells. For example, the NK-sensitive RMA- cells, which express
approximately 20% of the normal level of H- class I molecules do,
following treatment with Kb- and/or Db specific peptides, upregulate
their levels of cell surface class I antigens (Townsend et aI., 1989).
However, this does not resu1t in a modulation of the susceptibility of
these target cells to NK 'cell-mediated lysis (Franksson et al., 1991).
A major concern when peptide is, present throughout the assay
is the potential for effects upon the NK cells themselves. This cannot
be ruled out in these types of experiments. In fact, extremely high
concentrations of peptide ( 200 Jl g/ml) in analyses were
inhibitory (Figure 15). Therefore, in most of my experiments, a
group of target cells were included that were pretreated with
peptide overnight, followed by washing, in order to avoid this
possible variable. It should be noted that while these studies were
underway, it was reported that the addition to Con A blasts of
various synthetic viral immunodominant peptides defined for mouse
CTL, allowed the targets to become more sensitive to lysis by 
(actually LAK) cells (Chadwick and Miller, 1992; Chadwick et aI.
1992). Additionally, a study ill a human system published a few
months after these reports also presented evidence that a number of
synthetic immunodominant ,viral peptides sensitized targets to be
more susceptible to lysis by NK cells (Storkus et aI., 1992). These
authors used an overnight incubation of the targets with peptide
followed by a wash step, as , we did. I do not know why we could not
observe an enhanced sensitivity of the targets to NK (or LAK)' cell-
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mediated lysis under the, conditions we used or those recently
reported.
including
Even though a wide variety of target cells was used
fibroblasts, mastocytomas, pre- cells, thymomas,
fibroblasts or thymomas ' transfected with various H- class I
molecules, as well as Con A blasts, we ' were unable to find that any
member of the panel of 12 synthetic viral peptides could increase
target cell susceptibility to NK cell-mediated lysis. Furthermore, we
used peptides specific for essentially all mou e H- class I allotypes
of the H-2b (Kb , Db), H-2d (Kd , Dd , Ld) and H-2k (only Kk , not Dk)
haplotypes. The variety of the target cell and peptide combinations,
as well as the several experimental conditions used, would lead me
to believe that if a difference in target cell sensitivity to NK cell-
mediated lysis could be conferred by .peptides, it should have been
detectable in my assays. Furthermore, several other groups besides
ours have been unable to find a difference in the sensitivity of
mouse or human target cells to NK cell-mediated lysis following
treatment with MHC class I-binding peptides (R. Kiessling, H. -
Ljunggren, and M. Trucco, personal communications), and the group
reporting on the human data apparently cannot reproduce its results
(personal communication from the authors).
Considering the in vitro results with VV in our system and with
HSV -1 in the human system (Kaufman et aI., 1992), which suggest
that viral peptide charging of MHC class I molecules might modulate
the sensitivity of target cells to NK cell-mediated lysis, this indirect
evidence would, on the surface at least, be difficult to reconcile with
--..
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the peptide experiments. However, these data could also be
explained by mechanisms independent of the viral peptide charging
of MHC class I antigens. With respect to the results with VV, and as
pointed out above, the enhanced sensitivity of VV -infected cells to
NK cell-mediated lysis during the "window of vulnerability" may
have been due to a qualitative and/or quantitative change in cell
surface H- class I molecules. As mentioned often throughout this
thesis, an inverse correlation between target cell MHC class I antigen
expression and susceptibility to lysis by NK cells has been observed
in numerous systems (Ljunggren and Karre, 1990). Therefore, the
increased sensitivity of VV -infected cells to NK cell-mediated lysis
could simply be due to the VV- induced reduction in H- class I
antigen expression, resulting in enhanced NK cell triggering and lysis
of VV -infected targets.
results demonstrating
Consistent with this are the reports and our
that agents which upregulate (IFN~) and
downregulate (cycloheximide) MHC class I antigen expression,
decrease and increase, respectively, target cell susceptibility to lysis
by NK cells , and NK cell triggering. , The results from Leibson s group
with HSV -1 (Kaufman et aI., 1992), can also be interpreted by a
mechanism that is independent of the charging of HLA class I
molecules with viral peptides. In their report, these authors used
CIR cells--a very NK-sensitive target. Because of this high NK-
sensitivity, the killing of uninfected CIR targets by NK cells would be
at a maximum. Infection ' of CIR cells with HSV-l would not be able
to exceed this maximal level of NK-sensitivity. On the other hand,
'" -'---
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C 1 R cells, which are transfected with HLA class I mplecules, are
relatively resistant (or considerably less sensitive) to NK cell-
mediated lysis, as has been previouSly demonstrated (Storkus et aI.,
1989a, b). The obvious correlation is with MHC class I expression.
has also been previously shown that tumor necrosis factor-a (TNF
which is also produced by NK cells, will lyse cells infected with VSV
human CMV, Theiler s " murine encephalomyelitis virus (TMEV), 
HSV - , at a higher level than that observed with uninfected cells
(Paya et ' aI., 1988). Furthermore, cells treated with protein synthesis
inhibitors, such as actinomycin D or cycloheximide, are more
sensitive to NK cell-mediated lysis (Kunkel and Welsh, 1981). Like
other cytopathic viruses; HSV - 1 has the capacity to inhibit host cell
protein synthesis. It is possible that what appears to be a qualitative
change in class I antigens being responsible for the increased 
lysis of
HSV- infected CIR transfectants by NK cells is actually an enhanced
sensitivity of the infected cells to the cytotoxic moieties produced by
NK cells. This may have also played, a role in the observation with
VV -infected cells and will be discussed further in a later section.
I cannot formally rule out the possibility that viral peptide
charging of MHC class I antigens can, at least in some cases, modulate
target cell susceptibility to NK cell-mediated lysis. Rather than 1 or 2
different peptides being able to make , a difference, it might reqUIre a
particular heterogeneous set of peptides which, would only be
presented by MHC class I molecules during a virus infection. These
peptides might, then be sufficient to alter or prevent the proposed
"". . ,''!';' .; 
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negative signal delivered by the target cell class I molecules to the
effector cells (Karlhofer et at, 1992; Ciccone et at, 1992). The
addition of the natural peptides extracted from the NK-resistant RMA
cell line to the NK-sensitive RMA derivative, RMA-S, has been
reported to make the latter NK-resistant (Correa et aI., 1992).
Unfortunately, these authors did not indicate if the level of H- class
I expression was affected by this ' treatment, as peptides' added to
these two cell lines will result in an increase in class I antigens on
the cell surface (Townsend et at, 1989). In vitro results, however
are sometimes difficult to apply to tha which occurs in vivo. Indeed,
the one report suggesting that peptides can modulate target cell
sensitivity to lysis by human NK cells did propose that "exogenous
peptide effects on target cell sensitivity to principallyare
relevant vitro and not vivo presumably due the
requirements for high , concentrations of exogenous ~2m during
peptide exchange at the cell surface (Storkus et aI., 1992). Therefore,
at this stage, it would be difficult to make a generalized statement on
whether or not viral peptide charging of MHC class I molecules plays
a role in the control of a virus infection ' by NK cells.
Are H- c!ass I molecules , themse! s im ortan the
ation of a virus infection by NK cells in vivo? In order to ask
the question of whether H- class I molecules were 
required for the
regulation of a virus infection in vivo, NK-depleted or intact ~2m( -
/-)
mice were infected with the prototypic NK-sensitive virus, MCMV,
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and then compared to the ~2m-normal MCMV -susceptible, CS7BL/6
mice (both groups of mice are H-2b). As mentioned above, ~2m (-
/-)
mice are defective in the expression of H- class I molecules (Koller
et aI., 1990; Zijlstra et at, 1990). Therefore, these mice allowed us to
directly assess the role of MHC class I antigens in the regulation of a
virus infection by NK cells in vivo. In the CS7BL/6 control mice, it
was observed that splenic MCMV titers were much higher (.. S - 
10glO PFU) in the NK:.depleted group than in the NK-intact group
(Table 7), as has been previously reported (Bukowski et aI., 1983,
1984, 1985; Welsh et aI., 1990; Shanley et at, 1990). Interestingly,
in ~2m (-/-) mice, we also found a similar increase in splenic MCMV
titers in anti-asialo GMl-treated as compared to untreated mice.
difficult to explain observation was the fact that the anti-asialo GMI
treatment depleted only about SO% of the splenic NK cell activity in
the ~2m (-/-) mice, even though it was able to abrogate most of the
NK cell activity in the CS7BL/6 mice. I cannot explain why the
treatment of the ~2m (-/-) mice with the anti-asialo GMI antiserum
did not result in a more effective depletion of NK cell activity.
Clearly, we found increases in splenic MCMV viral titers in anti-asialo
G M 1 -treated as compared to untreated mice, in both CS7BL/6 and
~2m
/-)
concerned about using highermice. were
concentrations of anti-asialo GMI antiserum because, although
treatment of mice with this antiserum is rather selective for NK cells,
higher doses can react with other cells, and this would cause
problems in interpretation. The concentration of anti-asialo GMt
:y.:~~~ -;: ,: 
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antiserum that is used in our laboratory has been titrated on the
basis of its ability to totally deplete LCMV -induced splenic NK cell
activity. Cytopathic viruses, such as MCMV, which alter cellular
function much more so than the less pathogenic LCMV, might be able
to overcome the total NK depletion, perhaps by more quickly
activating NK cells, as it takes about 12 - 24 h for the antiserum to
ablate NK cell activity completely (Habu et aI., 1981). It should be
noted that associated with the activation of NK cells is an increase in
the expression of glycosphingolipids, such as asialo GMI (Welsh,
1986). This problem has recently been observed on occasion by
other members in the laboratory with MCMV, using both normal and
SCID C57BL/6 mice, and we at present cannot explain the lower
efficiency of this antiserum in mice infected with this virus. It is
possible that if only 90% of the splenic NK cells were depleted by the
anti-asialo GMI treatment, for example, the highly activated NK cells
generated by signals stimulated by enhanced MCMV replication
could account for the observed activity when compared to mice not
depleted of NK cells and producing lower levels of activating factors.
Also, with few CD8+ cells in the spleens of 2m (-/-) mice (almost
none), it would also make sense that the concentration of 
cells/total number of spleen cells would be higher than in normal
mice. This would make a difference in the NK cell to target cell ratio
and hence, be reflected in Y AC- lysis. Nonetheless, the most
important conclusion from the experiments presented in Table 7 
that the enhanced replication of MCMV in the spleens of anti-asialo
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G M I-treated ~2m (-/-) and C57BL/6 mice suggests that H- class I
molecules do not play a role in the regulation of MCMV by NK cells.
Other systems in which NK cells have been shown to play a role
have demonstrated that MHC class I molecules are particularly
important. For example, the growth of transplanted hematopoietic
tumor cells in mice is impaired unless the tumor recipient mice are
completely MHC-matched with the donor tumor (Hoglund et aI.,
1991 b). Elimination of MHC-disparate tumors in this model 
mediated by NK cells. The rejection of bone marow cells in mice has
also been shown to be somewhat dependent upon the MHC class I
allotypes expressed (Yu et aI., 1992). However, as described above,
when the H- class I-deficient ~2m (-/-) mice were injected with
MCMV and anti-asialo GMI antiserum, there were elevated viral
titers as compared to mice not receiving the antiserum (Table 7).
This is exactly what one observes with normal mice. If we also take
into, account the data presented in Figure 18, ' which shows that
thymocytes from ~2m (-/-) mice do not express , detectable levels 
H - 2D b , on their surface, even after MCMV infection, in contrast to the
other models mentioned above, our evidence suggests that the
regulation of MCMV by NK cells in vivo is independent of H-2 class I
antigen expression.
Thymocytes obtained from uninfected normal mice express
very low levels of MHC class I antigens, whereas, following a virus
infection there is a profound increase in class I expression
(Bukowski and Welsh, 1986a; Figure 18). In contrast, there is a lack
~~~ ~~~,,.~~~~;,: .\,- ,
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of detectable cell surface H-2Db on thymocytes from uninfected or
MCMV-infected ~2m (-
/-) 
mice (Figure 18). The upregulatio of MHC
class I antigens on thymocytes during a virus infection is 
correlated
with the production of IFN and with resistance to lysis by NK cells
(Hansson et aI., 1980; Bukowski and Welsh, 1986a). The experiments
presented using both normal and ~2m l-) thymocytes (Table 9) and
~2 m (-/-) and normal cell lines (Table 8), as well as a previously
published report (Ljunggren et aI. 1990), also support this
correlation. In fact, the experiments with the ~2m (- ) mice are the
first in vivo evidence supporting a requirement for MHC class I
antigen expression in IFN -mediated protectio from NK cell-
mediated lysis, and are consistent with the "effector inhibition
model (Ljunggren and Karre, 1990). It has been previously shown
that the ability of IFN to protect target cells from lysis by NK cells 
vitro can be abrogated by viruses which can inhibit host cell 
RNA or
protein synthesis (Trinchieri and Santoli et aI., 1978; Bukowski and
Welsh, 1985). Therefore, Trinchieri and Santoli proposed that 
vivo, NK cells could selectively kill virus-infected cells, due to 
the
fact that IFN cannot protect those targets from lysis by NK cells.
U ninfected cells would be protected from both infection as well as NK
cell-mediated lysis due to the effects of IFN (Santoli et aI., 1978b).
In vitro studies supported this concept with MCMV, which rendered
mouse fibroblasts resistant to IFN-mediated protectio (Bukowski
and Welsh, 1985). In ~2m (-/-) cells, IFN treatment does not cause
these cells to become resistant to lysis by NK cells, due to the lack of
..nt'IfI'; 'i::r.
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H - class I upregulation (Ljunggren et at, 1990; Table 8). Therefore,
in vivo, what could be occurring in these mice? IFN has at least four
major roles in a virus infection: 1. activate NK cells; 2. induce an
antiviral state in the uninfected cells; 3. protect uninfected cells from
lysis by NK cells, presumably by upregulating the expression of MHC
class I antigens; 4. sensitize targets for attack by CTL 
upregulating class I molecules. In ~2m (- ) mice, only 1 and 2 could
be operative. However, the same apparent NK-sensitivity of MCMV
occurs in these mice as in normal mice, as measured by splenic virus
ti ters.
The above results do not necessarily mean that the lack of IFN
protection is not playing some role during MCMV infection. In the 
i n
vivo experiments, it was always found that MCMV-infected, NK-
depleted normal (C57BL/6) mice were much more sick (e. g., ruffled
hair , hunched over back) than NK-intact animals. This should not be
too surprising, as MCMV is an NK-sensitive virus and replicates to
much higher titers in an NK-depleted host. However, NK-intact,
MCMV-infected ~2m (-
/-) 
mice were as sick or more so than similar
mice which were also treated with anti-asialo GMI antiserum.
Furthermore, the number of spleen cells from NK-intact ~2m (-
/-)
mice were lower than anti-asialo GMl-treated mice following MCMV
infection. This was the complete opposite of that which occurred in
~2m-normal C57BL/6 mice. Without the ability of IFN to protect
uninfected cells in the ~2m (-
/-) 
mice from attack by MCMV -induced,
activated NK cells by upregulating MHC class I antigens (Figure 18),
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this result makes sense. Therefore, although H- class I molecules do
not appear to play a role in whether or not 
MCMV is NK-sensitive,
the presence of these antigens may make a considerable difference
in the resultant morbidity, following infection. This would appear to
be consistent with the hypothesis presented by Trinchieri and Santoli
(Santoli et aI., 1978b) and seems to warrant further investigation.
PossiQJe MtIC cJass Unepen4ent mec anisms governing the
ation of virus infections by NK cells. I have been discussing the
relevance of my observations as they pertain to MHC class I
expression. How might NK cells be able to kill MCMV (or other
virus)- infected cells independent of H- class expression?
Essentially all viruses which have been shown
, under at least some 
vitro or in vivo conditions to be NK-sensitive, are 
cytopathic to the
cells they infect. Therefore, rather than the virus infection
modulating a target cell surface structure(s) which is inducing a
negative signal (Le., MHC class I molecules), these cytopathic viruses
might cause targets to be more sensitive than uninfected cells to 
lysis
by the cytotoxic moieties produced by NK cells. This would be a
direct result of the cytopathic effect of the virus infection itself.
For
example, I mentioned that VSV- , CMV- TMEV- and HSV- infected
cells are more sensitive to NK cell-produced TNF than uninfected
cells in vitro (Paya et aI., 1988).
0, as recombinant VV
This could also, have relevance 
expressing TNF a is cleared in
immunocompromised mice, whereas similar mice receiving the wild
' ,- 
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type VV control virus succumb to the infection (Sambhi et aI., 1991).
The mechanism of this is unclear, but it has also been shown that a
recombinant VV expressing IL-2 is eliminated in athymic nude mice
(Flexner et aI., 1987; Ramshaw et aI., 1987). This effect is
concomitant with the activation of NK cells (Karupiah et aI., 1990a)
and is dependent upon the productio of IFNy (Karupiah et 
aI.,
1990b), which can synergize with TNF to mediate a number of
effects upon cells in addition to antiviral activity (Wong and Goeddel
1986). The antiviral properties of IFNy itself cannot be ignored, as
NK cells are the major ' producers ' of IFNy early during a virus
infection (McFarland and Bigley, 1990). The enhanced sensitivity of
tumor cells to lysis by C' (Schlager and Ohanian, 1980) or NK cells
(Kunkel and Welsh 1981; Figure 13) following treatment with
metabolic inhibitors, might imply an increased susceptibility of
target cells to lysis ' by NK cell-produced perforin, which 
homologous to C' component C9 (Tschopp et aI., 1986; Young et 
aI.,
1986b; Zalman et aI., 1986), following infection with a cytopathic
VlfUS. Therefore, there are also MHC class I- independent factors
which, following a virus infection
, '
could make target cells more
sensitive to lysis by NK cells, in addition to affecting the growth of
the virus. Any, or all, of these elements could be operative during a
virus infection.
.. ..
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Effects of a virus infection on cytotoxic effector cells and
possible role for the CZ- l antigen During the early phase of a 
virus
infection , LGL NK cells accumulate at sites of virus replicatio (Welsh,
1986). For example, an Lp. infection with LCMV results in 
increase in activated peritoneal NK cells (Welsh, 1978), whereas an
intracerebral injection of mice with VV results in an increase of 
cells
with NK-like activity in the cerebral spinal fluid (Doherty and
Korngold, 1983). The chemotaxis of NK cells appears to correlate
with the production of various cytokines produced during a 
viral
infection--particularly, IFN and IL- For example, although IFN 
plays an important role , in NK activation and proliferatio , it can also
act as a chemotactic agent for NK or LAK cells (Welsh and 
Vargas-
Cortes, 1992). However, a number of other properties of IFN s
can
affect certain cell surface molecules which are involved in NK 
cell
effector functions (Welsh, 1986). The Fc"( ' receptor (CDI6) on NK and
other cells is upregulated, which would be of 
significant importance
for ADCC (Kiessling et at, 1980). Virus-induced IFNa/~ does increase
the expression of various sialoglycoproteins (Y ogeeswaran et aI.,
1982), which may provide a means for activated NK cells to remam
at sites of virus infection, as many sialoglycoprotei can bind 
lectins,
and activated NK cells are somewhat more adherent to nylon wool
than nonactivated (endogenous) NK cells. The effects of IFN s on 
the
expression of the putative murine NK cell receptors; NKR-
Pl and Ly-
49, have not yet been reported. Although IL-2 can also activate NK
cells and enhance their cytolytic effector capacity, unlike IFN~, high
132
doses of IL-2 can stimulate in vitro NK cell proliferati , which
generates the so-called LAK cells (Grimm et at, 1982). IL-2 can also
serve as a chemotactic agent for virus-induced NK cells (Welsh and
Vargas-Cortes, 1992). Whether or not IL- serves as a growth factor
for NK cells in vivo is unclear, as IL-2 production parallels the CTL
response and nude or SCID mice, which produce little if any IL- , can
generate activated NK cells (Welsh, and Vargas-Cortes, 1992).
However injection of mice with IL- does induce NK cell
proliferation in vivo (Biron et aI., 1990), perhaps through the
stimulation of IFNy production, which also 'can cause NK cell
proliferatio when administered in vivo (Biron et aI., 1984).
However, considering the redundancy of the immune system, one
cannot rule out a role for IL-
There may be some interdependence of IFNa/~ and IL-
during a virus infection. The cell, surface expression of the signal
transduction molecule, CD45, which is found on NK cells (as well as
other leukocytes), can be upregulated by virus-induced IFNa/~
(Welsh, 1986). The increase in CD45 expression appears to be a
direct result of cell activation, and CD45 is important in T cell
responses to anti-CD3 and IL- (Gilliland et aI., 1990; Trowbridge,
1991) . Additionally, certain anti-CD45 mAb can inhibit NK cell-
mediated lysis (Seaman et aI., 1981; Newman et aI., 1983). It has
been shown in this thesis that mAb CZ-l recognizes a sialic acid-
dependent epitope associated with a subpopulatio CD45RB
molecules (Figures 21-23). Previous work in our laboratory has
,., 
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shown that the CZ-l antigen is expressed on all NK cells and CD8+ T
cells, but not on CD4+ T cells or splenic macrophages (Vargas-Cortes
et aI., 1992). A paper in press from our laboratory (Copyright Notice,
Brutkiewicz et aI., 1993; also, Vargas-Cortes et aI., 1991), has further
demonstrated that only CZ- l + spleen cell$ or thymocytes can respond
to IL- Splenic CD8+ T cells, but not most CD4+ T cells, 
proliferated
in response to IL-2. This also helps explain why LAK cells, which are
generated incubating spleen cells peripheral
blood
lymphocytes in high concentrations of IL-
, are devoid of CD4+ T
cells. Furthermore, sorting of spleen cells into CD45RB+CZ-
l + and
CD45 RB +CZ- l- populations resulted in only the former 
populatio
proliferating in response to IL-2. NK cells , which are all CZ- , can be
stimulated to higher levels of cytotoxicity following incubation 
with
either IL-2 or IFN~. The ability of mAb CZ- l to block the 
NK cell
activation induced by either of these cytokines (Vargas-Cortes et 
aI.,
1991) suggests the existence of a common pathway for the
stimulation of enhanced NK cell-mediated cytotoxicity by 
these
agents.
It is likely that the CZ-l epitope is an activation/differentiatio
antigen which selectively expressed certain
lymphoid
subpopulations during vanous stages of ontogeny and, upon
receiving the appropriate stimulus, can be upregulated in CZ-
l- cells.
For example, although resting CD4+ T cells are, CZ- , following
activation by a virus infection in vivo, or by anti-CD3 and IL-
vitro, there is a marked increase in CZ- l+ cells in the splenic CD4+
'ro': 1!T.
:. 
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population (Vargas-Cortes et aI., 1992).
Other mAb specific for
different epitopes of CD45RB
Thl and Th2 (Bottomly et aI.,
(Lee et aI., 1990) CD4+ T cells.
have been used to distinguish between
1989) and virgin from primed/memory
The CZ- mAb has been found to stain
Th 1 and Th2 cell lines in a manner similar to these mAb 
(P. Rogers
and D. Parker, personal communication).
CD45 is a highly glycosylated molecule, and post-translational
modifications might be predicted to have significant effects 
upon
cells expressing vanous isoforms of CD45.
There is evidence to
suggest that the carbohydrate moieties
expressed by CD45 molecules
Thymic
play an important role in T cell ontogeny and CD45 function.
subpopulatio differ in their, expressio of different carbohydrate
epitopes on mouse CD45 molecules (Lefrancois, 1987). As mentioned
above, our laboratory has previously shown that the CZ-
l ' antigen is
also found in the thymus (Vargas-Cortes et 
aI., 1992) and its
expression is inducible in CZ- l- thymocytes (M. Vargas-
Cortes and R.
Welsh unpublished bserv ations). Recent
evidence has
demonstrated that blocking the glycosylatio of CD45 by treatment
of K562 or Daudi cells with tunicamycin, a specific inhibitor of N-
linked glycosylatio , will inhibit the cell surface expressio
CD45RB (Pulido and Sanchez-Madrid, 1990; 1992), as well as the
tyrosine phosphatase activity of CD45, further illustrating the
importance of glycosylation in the expression 
and function of CD45
and CD45RB, in particular. The identification of the significance of
the CZ- antigen (as well as other carbohydrate 
moieties on CD45
, ,. ' ,
f:'
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molecules) in these and other functions would therefore be of
interest.
During the course of a virus infection, expressio
of the CZ-
antigen could be very important in the late early stage, by 
playing a
role in the accumulation of LGL at the site of infection perhaps 
due,
at least in part, to the requirement of CZ- expression for IL-
responsiveness.
players
Furthermore, CZ- l + CD4+ T cells may be major
mediating the Th2 helper function for
antibody
productio , as well as other activities; it appears that 
CD8+ CTL
precursors do not need CD4+ Th cells for their generatio
into mature
CTL, provided that there is sufficient IL-2 present (Rahemtulla 
et aI.,
1991).
The results described in this thesis have gIVen us a 
clearer
understanding of viral pathogenesis and of signal transduction in 
vitro and 
vivo NK cell activity. number of important
observations were made in this regard and are listed 
below:
VV -infected target cells are more sensitive to NK 
cell-
mediated lysis during a "window of vulnerability
This "window of vulnerability" is correlated with
enhanced triggering of NK cells, but not with increased
binding of NK cells to VV -infected targets.
"""... +''''''
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Quantitative decreases in target cell H-2 class I
molecule expression occur following infection with VV.
VV - infected target cells are resistant to lysis by
allospecific CTL at a time when they are highly
sensitive to lysis by VV -specific CTL, suggesting
alterations in endogenous peptide presentation.
Viral peptide charging of H-2 class I molecules does
not modulate target cell sensitivity to NK cell-mediated
lysis.
6. In vivo, NK cells can regulate the prototypic NK-
sensitive virus , MCMV, independent of H- class I antigen
expressIOn.
class I molecules are required for lPN-mediated
protection from NK cells in vitro 
and in vivo.
The identification of the CZ-l epitope as part of, or associated
with CD45RB , raises new questions regarding signal transduction
events which occur at the effector cell level, as well as during
lymphocyte development. Therefore, this dissertation should
provide a foundation for further studies of the immune response to
virus infections.
. . - . - ,,,..
137
RECE
Allen, H. , J. Fraser, D. Flyer, S. Calvin, and R. A. Flavell. 1986. ~2-
micro globulin is not required for cell surface expression of 
the
murine class I histocompatibility antigen H-2Db or of a truncated H-
2Db. Proc. Natl. Acad. Sci. U. S. A. 83:7447-7451.
Alsheikhly, A., C. Orvell, B. Harvast, T. Andersson, P. Perlmann, and E.
Norrby. 1983. Sendai virus induced cell mediated cytotoxicity 
vitro. The role of viral glycoprotei in cell mediated cytotoxicity.
Scand. J. Immunol. 17:129-138.
Anderson, P., M. Caligiuri, C. O'Brien, T. Manley, J. Ritz
, and S. F.
Schlossman. 1990. Fc'Y receptor type III (CDI6) is included in the 
NK receptor complex expressed by human natural killer cells. Proc.
Natl. Acad. Sci. U. S. A. 87:2274-2278.
Anderson, P., M. Caligiuri, J. Ritz, and S. F. Schlossman. 1989.
negative natural killer cells express TCR as part of a
molecular complex. Nature 341:159-162.
CD3-
novel
Anderson, S. K., S. Gallinger, J. Roder, J. Frey, H. A. Young, and J. R.
Ortaldo. 1993. A cyciophilin-related protein involved in the function
of natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 90:542-
546.
, )
Arora, D. J. S., M. Houde, D. M. Justewicz, and R. Mandeville. 
1984. 
vitro enhancement of human natural killer cell mediated cytotoxicity
by purified influenza virus glycoproteins. J. Virol. , 52:839-845.
Atkinson, E. A., J. M. Gerrard, G. E. Hildes, and A. H. Greenberg. 
1989.
Production of inositol-phospholipid-derived second' messengers in 
rat natural killer cell line exposed to susceptible tumor targets. Nat.
Immun. Cell Growth Regul. 8:223-230.
138
Attaya, M., S. Jameson, C. K. Martinez, E. Hermel, C. Aldrich, 
J. Forman
K. Fischer Lindahl, M. J. Bevan, and J. J. Monaco. 1992. Ham 
- 2
corrects the class I antigen-processing defect in RMA-S cells. Nature
355:647-649.
Bancroft, G. J., G. R. Shellam, and J. E. Chalmer. 1981. Genetic
influences on the augmentation of natural killer (NK) cells during
murine cytomegalovirus infection. Correlation with patterns of
resistance. J. ImmunoI. 126:988-994.
Bandyopadhyay, S., B. Perussia, G. Trinchieri, D. S. Miller, and S. Star.
1986. Requirement for HLA-DR+ accessory cells in natural killing of
cytomegalovirus-infected fibroblasts. J. Exp. Med. 164:180- 195.
Berridge, M. J., and R. F. Irvine.
signalling. Nature 341:197-205.
1989. Inositol phosphates and cell
Bierer, B. E., B. P. Sleckman, S. E. Ratnofsky, and S. J. Burakoff. 
1989.
The biological roles of CD2, CD4, and CD8 in T-cell activation. Annu.
Rev. ImmunoI. 7:579-599.
Biron, C. A., G. Sonnenfeld, and R. M. Welsh. 1984. Interferon
induces natural killer cell blastogenesis in vivo. J. Leuk. BioI. 35 
:31-
37.
Biron, C. A., H. A. Young, and M. T. Kasaian. 1990. Interleukin 2-
induced proliferatio of mouse natural killer cells in' vivo. 
J. Exp.
Med. 171:173- 188.
Bishop, G. A., J. C. Glorioso, and S. A. Schwartz. 1983. Role of
interferon in human natural killer activity against target 
cells
infected with HSV -1. J. ImmunoI. 131: 1849- 1853.
. ."""''''.
''''"?M
' . , ., -
139
Bishop, G. A., S. D. Marli , S. A. Schwartz, 
and J. C. Glorioso. 1984.
Human natural killer cell recognition of herpes simplex virus type 1
glycoprotei specificity analysis with the use of monoclonal
antibodies and antigenic variants. J. Immunol. 133:2206-2214.
Bix, M., N. -So Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet.
1991. Rejection of class I MHC-deficient haema opoieti cells by
irradiated MHC-matched mice. Nature 349:329-331.
Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L.
Strominger, and D. C. Wiley. 1987. , Structure of the human class I
histocompatibility antigen, HLA-A2. Nature ' 329:506- 512.
Blanden, R. V., ' P. C. Doherty, M. B. C. Dunlop, I. D. Gardner
, R. M.
Zinkernagel, and C. S. David. 1975. Genes required for cytotoxicity
against virus-infected target cells in K and D regions of H-2 complex.
Nature 254:269-270.
Blazar, B., M. Patarroyo, E. Klein, and G. Klein. 1980. Increased
sensitivity of human lymphoid lines to natural killer cells after
induction of the Epstein-Barr viral cycle by superinfectio or sodium
butyrate. J. Exp. Med. 151:614-627.
Borysiewicz, L. K., B. Rodgers, S. Morrs, S. Graham, and J. G. P. 
Sissons.
1985. Lysis of human cytomegalovirus-infected fibroblasts by
natural killer cells: demonstration of an interferon-independent
component requiring expression of early viral proteins and
characterization of the effector cells. J. Immunol. 134:2695-2701.
Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined
immunodeficiency mutation in the mouse. Nature ' 301 :527-530.
Bottomly, K., M. Luqman, L., Greenbaum, S. Carding, J. West, T.
Pasqualini, and D. B. Murphy. , 1989. monoclonal antibody to
1:'
F i'
140
murine CD45R, distinguishes CD4 T cell populations 
that produce
different cytokines. Eur. J. Immunol. 19:617-623.
Braciale, T. J., V. L. Braciale, M. Winkler, I. Stroynowski
, L. Hood, J.
Sambrook, and M. -J. Gething. 1987. On the role of 
the
transmembrane anchor sequence of' influenza hemagglutini
target cell recognition by class I MHC-restricted, hemagglutini
specific cytolytic T lymphocytes. J. Exp. Med. 166:678-
692.
Brown, M. G., J. Driscoll, and J. J. Monaco. 1991. Structural and
serological similarity,' of MHC- linked LMP and proteosome
(multicatalytic proteinase) complexes. Nature 353:355-357.
Bruce, J., F. W. Symington, T. J. McKern, and J. 
Sprent. 1981. A
monoclonal antibody discriminating between subsets of T 
and B cells.
J. Immunol. 127:2496-2501.
Bukowski , J. F., and R. M. Welsh. 1985. Inability of interferon to
protect virus-infected cells against lysis by natural killer 
(NK) cells
correlates with NK cell-mediated antiviral effects in 
vivo. 
Immunol. 135:3537-3541.
Bukowski, J. F. , and R. M. Welsh. 1986a. Enhanced 
susceptibility to
cytotoxic T lymphocytes of target cells isolated 
from virus-infected
or interferon-treated mice. J. Viiol. 59:735-739.
Bukowski, J. F., and R. M. Welsh. 1986b. The role of natural 
killer
cells and interferon in resistance to acute infection of 
mice with
herpes simplex virus type 1. J. ImmunoL 137:3481-3485.
Bukowski, J. F., B. A. Woda, and R. M. Welsh. 
1984. ,Pathogenesis of
murine cytomegalovirus infectioll in 
natural killer cell-depleted mice.
J. Virol. 52:119-128.
141
Bukowski, J. F. , B. A. Woda, S. Habu, K. Okumura, and R. M. 
Welsh.
1983. Natural killer cell depletion enhances virus' synthesis 
and
virus-induced hepatitis in vivo. J. Immunol. 131:1531-
1538.
Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. 
Welsh.
Adoptive transfer studies demonstrating the antiviral effects
cells in vivo. J. Exp. Med. 161:40-52.
1985.
of 
Bukowski, J. F., K. W. McIntyre, H. Yang, and R. M. 
Welsh. 1987.
Natural killer cells are not required for interferon-mediated
prophylaxi against vaccinia or murine cytomegalovi
rus infections. J.
gen. Virol. 68:2219-2222.
Burgert, H. -G., J. L. Maryanski, and S. Kvist. 1987. "
E3/19K" protein
of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by
blocking cell-surface expression of histocompatibility class I 
antigens.
Proc. Natl. Acad. Sci. U. S. A. 84:1356-1360.
Carlow , D. A., U. Payne, N. Hozumi, J. C. Roder, and A. A. 
Czitrom.
1990. Class I (H-2Kb) gene transfection reduces susceptibility of
Y AC-l lympho targets to natural killer cells. Eur. J. Immunol.
20:841-846. 
Caren, 0., I. Virtanen, and E. Saksela. 1981. The 
cytotoxic activity
of human natural killer cells requires an intact secretory 
apparatus.
Cell Immunol. 58:97-106.
and E. Saksela. 1983.
conjugation with sensitiveCarpen, 0., 
I. Virtanen, V. -P. Lehto,
Polarization of NK cell cytoskeleton upon
target cells. J. Immunol. 131:2695-
2698.
Casali, P., and M. B. A. Oldstone. 1982. Mechanisms of 
killing of
measles-infected cells by human lymphocytes: interferon-associated
....""-"..,,
J'J!,
' .- ' """--''''
142
and unassociated cell-mediated cytotoxicity.
344.
Cell Immunol. 70:330-
Casali, P., J. G. P. Sissons, M. J. Buchmeier, and M. B. A. Oldstone.
1981. In vitro generation of human cytotoxic lymphocytes by virus.
Viral glycoproteins induce nonspecific cell-mediated cytotoxicity
without release of interferon. J. Exp. Med. 154:840-855.
Chadwick, B. S. , and R. G. Miller. 1992. Hybrid resistance in vitro.
Possible role of both class I MHC and self peptides in determining the
level of target cell sensitivity. J., Immunol. 148:2307-2313.
Chadwick, B. S., S. R. Sambhara, Y. Sasakura, and R. G. Miller. 1992.
Effect of class I MHC binding peptides on recognition by natural killer
cells. J. Immunol. 149:3150-3156.
Chambers, W. H., N. J. Vujanovic, A. B. DeLeo, M. W. Olszowy, R. B.
Herberman, and J. C. Hiserodt. 1989. Monoclonal antibody to a
triggering structure expressed on rat natural killer cells and
adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373-
1389.
Chow, S. C., and M. Jondal. 1990. A central role for phosphoinositid
hydrolysis in activating the lytic mechanism of human 
natural killer
cells. Immunology 70:106- 110.
Chow, S. C., J. Ng, C. Nordstedt, B. B. Fredholm, and M. Jondal. 1988.
Phosphoinositide breakdown and evidence for protein kinase C
involvement during human NK killing. Cell. Immunol. 114:96- 103.
Ciccone, E., D. Pende, O. Viale, A. Than, C. Di Donato, A. M. Orengo, R.
Biassoni; S. Verdiani, A. Amoroso, A. Moretta, and L. Moretta. 1992.
Involvement of HLA class I alleles in natural killer (NK) cell-specific
functions: expression of HLA-Cw3 confers selective protectio from
,,-, .. ,
I '
143
lysis by alloreactive NK clones displaying a defined specificity
(specificity 2). J. Exp. Med. 176:963-971.
Cohen, J. J., R. C. Duke, V. A. Fadok, and K. S. Sellins.
and programmed cell death in immunity. Annu.
10 :267 - 293.
1992. Apoptosis
Rev. Immunol.
Correa, I., N. -So Liao, and D. Raulet., 1992. Role of class I MHC 
and
self peptides in NK recognition. J. Cell. Biochem. 160:60 (abs.
Cox, J. H., J. R. Bennink" and J. W. Yewdell. 1991.
adenovirus E19 glycoprotei in the endoplasmic
essential to its ability to block antigen ' presentatio
174:1629-1637. 
Retention of
reticulum is
J. Exp. Med.
Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and 
J. R.
Bennink. 1990. Antigen presentation requires transport of MHC
class I molecules from the endoplasmic 
reticulum. Science 247:715-
718.
Dawson, J. R. , W. J. Storkus, E. B. Patterson, and P. CresswelL 
1989.
Adenovirus inversely modulates target cell class I MHC 
antigen
expression and sensitivity to natural killing. In: Ades, E. W., and C.
Lopez (eds.). Natural Killer Cells and Host Defense. Basel , Karger
, pp.
156- 159
del Val, M., H. Hengel, H. Hacker, U. Harlaub, T. Ruppert, 
P. Lucin, and
U. H. Koszinowski. 1992. Cytomegalovirus prevents antigen
presentatio by blocking the transport of peptide-loaded major
histocompatibility complex class I molecules into the medial-
Golgi
compartment. J. Exp. Med. 176:729-738.
" ,," - " . ;.. '. ' " ..: .
144
Dessner, D. S., and M. R. Loken. 1981.
antibody which specifically detects all murine
Immunol. 11 :282-285.
DNL1.9: a monoclonal
lineage cells. Eur. 
Deverson, E. V., I. R. Gow, W. J. Coadwell, J. J. Monaco, G. W. Butcher
and J. C. Howard. 1990. MHC class II region encoding proteins
related to the multidrug resistance family of transmembrane
transporters. Nature 348:738-741. 
Djeu, J. Y., J. A. Heinbaugh, H. T. Holden, and R. B. Herberman. 1979.
Augmentation of mouse natural killer cell activity by interferon and
interferon inducers. J. ImmunoI. 122:175-181.
Doherty,
induced
effectors
P. C., and R. Korngold. 1983., Characteristics of poxvirus-
meningitis: virus-specific and non-specific cytotoxic
in the inflammatory exudate. Scand. J. Immunol. 18: 1-7 .
Dorshkind , K., S. B. Pollack, M. J. Bosma, and R. A. Phillips. 1985.
Natural killer (NK) cells are present in mice with severe combined
immunodeficiency (scid). J. ImmunoI. 134:3798-
3801.I '
Falk, K., O. Rotzschke, S. StevanoviC , G. Jung, and 
1991. Allele-specific motifs revealed by sequencing
eluted from MHC molecules. Nature 351:290-296.
G. Rammensee.
of self-peptides
Fitzgerald, P. A., P. von Wussov , and C. Lopez. 1982. Role of
interferon in human natural killing of HSV -1 infected fibroblasts. J.
Immunol. 129:819-823.
Fitzgerald-Bocarsly, P., M. Feldman, M. Mendelsohn, S. Curl, and C.
Lopez. 1988. Human mononuclear cells whicb produce interferon-
alpha during NK (HSV -FS) assays are HLA-DR positive cells distinc
from cytolytic natural killer effectors. ' J. Leuk. BioI. 43:323- 334. 
145
Flexner, C., A. Htigin , and B. Moss.
infection in immunodeficient
expressio Nature 330:259-262.
1987. Prevention of vaccinia virus
mice by vector-directed IL-
Franksson, L., C. Ohlen, P. Hoglund,
' H. G. Ljunggren, and K. Karre.
1991. Protection from NK recognition by MHC molecules: 
effect of
empty class I molecules and H- binding viral 
peptides. Nat.
Immun. Cell Growth Regul. 10:122 (abs.
Frey, J. L., T. Bino, R. R. S. Kantor, D. M. Segal
, S. L. Giardina, J. Roder, S.
Anderson, and J. R. Ortaldo. 1991. Mechanism of 
target cell
recognitio by natural killer , cells: characterization of 
novel
triggering molecule restricted to CD3- large 
granular lymphocytes. J.
Exp. Med. 174:1527-1536.
Friedman, D. J., and R. P. Ricciardi.
gene represses accumulation of MHC
transcription. Virology 165 :303-305'
1988. Adenovirus type 12 EIA
class I mRNA at the level of
Gerrard, J. M" E. Hildes, E. A. Atkinson, and A. H. 
Greenberg. 1987.
Activation of inositol cycle in \arge granular lymphocyte 
leukemia
RNK following contact with an NK-sensitive tumor. 
In: Samuelsson,
B., R. Paoletti
, '
and P. W. Ramwell (eds.), Advances in Prostaglandin,
Thromboxane, and Leukotriene Research, Vol. 
17. New York, Raven
Press, pp. 573-576.
Gidlund, M., A. Orn, H. Wigzell, A. 
Senik, and I. Gresser. 1978.
Enhanced NK cell activity in mice injected with interferon and
interferon inducers. Nature 273 :759-761.
Gilliland, L. K., G. L. Shieven, L. S. Grosmaire, N. K. 
Damie, and J. A.
Ledbetter. 1990. CD45 ligation in cells regulates 
signal
transduction through both the interleukin-
receptor and the CD3/Ti
cell receptor. Tissue Antigens' 35:128- 135.
146
Giorda, R., and M. Trucco. 1991. Mouse NKR-P1. A family of genes
selectively coexpressed in adherent lymphokine-activated killer
cells. J. Immunol. 147:1701-1708.
Giorda, R., W. A. Ruderi, C. Vavassori, W. H. Chambers, J. C. Hiserodt,
and M. Trucco. 1990. NKR- , a signal transduction molecule on
natural killer cells. Science 249:1298- 1300.
Glas, R., K. Sturmhofel, G. J. Hammerling, K. Karre, and H. -
Ljunggren. 1992. Restoration of a tumorigenic phenotype by ~2-
micro globulin transfection to EL- mutant cells. J. Exp. Med.
175 :843-846.
Glynne, R., S. H. Powis, S. Beck, A. Kelly, L. -A. Kerr, and J. Trowsdale.
1991. A proteosome-related gene between the two ABC transporter
loci in the class II region of the human MHC. ' Nature 353:357-360.
Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael.
1987. Cytotoxic T lymphocytes recognize a fragment of influenza
virus matrix protein in association with HLA-A2. , Nature 326:881-
882.
Graves, S. S., J. Bramhall , and B. Bonavida. 1986. Studies on the
lethal hit stage of natural killer, cell-mediated cytotoxicity. I. Both
phorbol ester and ionophore are required for release of natural killer
cytotoxic factors (NKCF), suggesting a role for protein kinase C
activity. J. Immunol. 137:1977-1984.
Greenberg, A. H., and J. ' H. L. Playfair. 1974. Spontaneously arising
cytotoxicity to the P-815- Y mastocytoma in NZB mice. Clin. expo
Immunol. 16:99-110. 
147
0:-
Grimm, E. A., A. Mazumder, H. Z. Zhang, and S. A. Rosenberg. 1982.
Lymphokine-activated killer cell phenomenon.
Lysis of natural
killer-resistant fresh solid tumor cells by , interleukin 2-activated
autologous human peripheral blood lymphocytes. J. Exp. Med.
155:1823- 1841.
....'..
Gronberg, A., M. T. Ferm, J. Ng, C. W. Reynolds, and J. R. Ortaldo.
1988. Interferon-y treatment of K562 cells inhibits natural killer cell
triggering and decreases the susceptibility to lysis by cytoplasmic
granules from large granular lymphocytes. J. Immunol. 140:4397-
4402.
Guffee, J., W. Fan, and J. Stein-Streilein. 1989. The role of natural
killer cells in early defense to influenza virus infection by the
intranasal route. In: Lopez, C. and E. W. Ades (eds.), Natural Killer
Cells and Host Defense. Karger, Basel
, pp. 124-130.
Habu, S., H. Fukui, K. Shimamura, M. Kasai , Y. Nagai, K. Okumura, and
N. Tamaoki. 1981. In vivo effects of anti-asialo GM1. Reduction of
NK activity and enhancement of transplanted tumor growth. J.
Immunol. 127:34-38.
Habu, S., K. -I. Akamatsu, N. Tamaoki, and K. Okumura. 1984. In
vivo significance of NK cell on resistance against virus (HSV -
infections in mice. J. Immunol. ' 133:2743-2747.
Hager, C. C., K. C. Petroni, M. A. Boyce, L. D. Forester, and T. N.
Oeltmann. 1990. A possible role for protein kinase C activity but not
cyclic nucleotide-dependent protein kinases in human natural killer
cell lytic activity. Lymphokine Res. 9:1- 14.
Haller, 0., and H. Wigzell. 1977. Suppression of natural killer cell
activity with radioactive strontium: effector cells are marrow
dependent. J. Immunol. 118:1503-1506. 
148
Hansson, M., K. Kare, R. Kiessling, . Roder, B. Andersson, and P.
Hayry. 1979. Natural NK-cell targets in the mouse thymus:
characteristics of the sensitive cell population. J. Immunol. 123:765-
771.
Hansson, M., R. Kiessling, B. Andersson, and R. M. Welsh. 1980. Effect
of interferon and interferon inducers on the NK sensitivity of normal
mouse thymocytes. J. Immunol. 125:2225-2231.
Hatcher F. M., and R. E. Kuhn. 1982. Destruction of Trypanosoma
cruzi by natural killer cells. Sc;ience 218:295-296.
Hathcock, K. S., G. Laszlo, H. B. Dickler, S. O. Sharow, P. Johnson, I. S.
Trowbridge, and R. J. Hodes. 1992. Expression of variable exon A-
, and' C-specific CD45 determinants on peripheral and thymic T cell
populations. J. Immunol. 148:19-28.
Hauser , W. E. , Jr. , S. D. Sharma, and J. S. Remington. 1982. Natural
killer cells induced by acute and chronic Toxoplasma infection. Cell.
Immunol. 69:330-346.
Harfast, B., C. Orvell, A. Alsheikhly, T. Andersson, P. Perlmann, and E.
N orrby. 1980. The role of viral glycoproteins in mumps virus-
dependent lymphocyte-mediated cytotoxicity in vitro. Scand. J.
Immunol. 11:391-400.
Heath, W. R., M. E. Hurd, F. R. Carbone, and L. A. Sherman. 1989.
Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T
lymphocytes. Nature 341:749-752.
Henkar, P. A. , P. J. Millard, C. W. Reynolds, and M. P. Henkar. 1984.
Cytolytic activity of purified cytoplasmic granules from cytotoxic rat
large granular lymphocyte tumors. J. Exp. Med. 160:75-93.
149
Henney, C. S., K. Kuribayashi, D.
Interleukin-2 augments natural killer
338.
E. Kern, and S. Gillis. 1981.
cell activity. Nature 291 :335-
Herberman, R. B. 1982. Natural killer cells and their possible
relevance to transplantation biology. Transplantation 34: 1-7. 
Herberman, R. B., J. Hiserodt, N. Vujanovic, C. Balch, E. Lotzova, R.
Bolhuis, S. Golub, L. L. Lanier, J. H. Phillips, C. Riccardi, J. Ritz, A.
Santoni, R. E. Schmidt, and A. Uchida. , 1987. Lymphokine-activated
killer cell activity. Characteristics of effector cells and their
progenitors in blood and spleen. Immunol. Today 8:178- 181.
Herberman, R. B., M. E. Nunn, and D. H. Lavrin. 1975a. Natural
cytotoxic reactivity of mouse lymphoid cells against syngeneic and
allogeneic tumors. I. Distribution of reactivity and specificity. Int. J.
Cancer 16:216-229.
Herberman, R. B., M. E. Nunn, and H. T. Holden. 1978. Low density of
Thyl antigen on mouse effector cells mediating natural cytotoxicity
against tumor cells. J. Immunol. 121:304-309.
Herberman, R. B., M. E. Nunn, D. H. Lavrin , and R. Asofsky. 1973.
Effect of antibody to e antigen on cell-mediated immunity induced in
syngeneic mice by murine sarcoma virus. J. Natl. Cancer Inst.
51:1509- 1512.
Herberman, R. B., M. E. Nunn, H. T. Holden, and D. H. Lavrin. 1975b.
Natural cytotoxic reactivity of mouse lymphoid cells against
syngeneic and allogeneic tumors. II. Characterization of effector
cells. ' Int. J. Cancer 16:230 239.
150
Herberman , R. B., M. E. Nunn, H. T. Holden, S. Staal, and J. Y. Djeu.
1977b. Augmentation of natural cytotoxic reactivity of mouse
lymphoid cells against syngeneic and allogeneic target 
cells. Int. J.
Cancer 19:555-564.
Herberman, R. B., S. Bartram, J. S. Haskill" M. Nunn, H. T. Holden
, and
W. H. West. 1977a. Fc receptors on mouse effector cells mediating
natural cytotoxicity against tumor cells. 
J. Immunol. 119:322-326.
Hiserodt, J. C., L. J. Britvan, and S. R. Targan. 1982. Characterization
of the cytolytic reaction mechanism of the human natural killer 
(NK)
lymphocyte: resolution into binding, programming, and killer 
cell-
independent steps. J. Immunol. 129:1782-1787.
Hofer E., M. Diichler, S. A. Fuad, J. P. Houchins, T. Yabe, and F. H. Bach.
1992. Candidate natural killer cell receptors. Immunol. Today
13 :429- 430.
Houchins, J. P., T. Yabe, C. McSherry, and 
F. Bach. 1991. DNA
sequence analysis of NKG2, a family of related cDNA 
clones encoding
type II integral membrane proteins on human natural killer 
cells. 
Exp. Med. 173:1017-1020.
Hoglund, P., C. Ohlen, E. Carbone, L. Franksson, H. -G. Ljunggren
, A.
Latour, B. Koller, and K. Kiirre. 1991a. Recognition of ~2-
micro globulin-negati (~2m -) T-cell blasts by natural killer 
cells
from normal but not from ~2m - mice: 
nonresponsiveness controlled
by ~2m- bone marow in chimeric mice. Proc. Natl. Acad. 
Sci. U. S. A.
88:10332- 10336.
Hoglund, P., R. Glas, C. Ohlen, H. -G. Ljunggren, and K. 
Kare. 1991b.
Alteration of the natural killer repertoire in H- transgenic mice:
specificity of rapid lymphoma cell clearance determined by the H-
phenotype of the target. J. Exp. Med. 174:327-334.
151
Ito, M., F. Tanabe, A. Sato, Y. Takami, and S. Shigeta. 1988. A potent
inhibitor of protein kinase inhibits natural killer activity. Int. J.
Immunopharmacol. 10:211-216.
Janeway, C. A., Jr. 1992. The T cell receptor as a multicomponent
signalling machine: CD4/CD8 coreceptors and CD45 in T cell
activation. Annu. Rev. Immunol. 10:645-674.
Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C.
Wiley. 1991. Identification of self peptides bound to purified HLA-
B27. Nature 353:326-329.
Johnson, P., L. Greenbaum, K. Bottomly, and I. S. Trowbridge. 1989.
Identification of alternatively spliced exons of murine CD45 (T200)
required for reactivity with B220 and other T200-restricted
antibodies. J. Exp. Med. 169:1179- 1184.
Jondal, M., J. Ng, M. Pataroyo, and P. -A. Broliden.
ester regulation of Ca2+ flux during natural, lectin
dependent killing. Immunology 59:347-352.
1986. Phorbol
and antibody-
Karlhofer, F. M., R. K. Ribaudo, and W. M. Yokoyama.
class I alloantigen specificity of Ly-49+ IL-2-activated
cells. Nature 358:66-7Q.
1992. MHC
natural killer
Karupiah , G., B. E. H. Coupar, M. E. Andrew, D. B. Boyle, S. M. Phillips,
A.. Mtillbacher, R. V. Blanden I. A. Ramshaw. 1990a. Elevated
natural killer cell responses in mice infected with recombinant
vaccinia virus encoding murine IL-2. J; Immunol. 144:290-298.
upiah, G., R. V. Blanden, and I. A. Ramshaw. 1990b. Interferon Y
is involved in the recovery of athymic nude mice from recombinant
vaccinia virus/interleukin 2 infection. J. Exp. Med. 172:1495-1503.
Kasai, M.,
glycolipid
Immunol.
M. Iwamori, Y. Nagai, K. Okumura, and T. Tada.
on the surface of mouse natural killer cells.
10:175- 180.
152
1980. A
Eur. J.
Kaufman , D. S., R. A. Schoon, and P. J. Leibson. 1992. Role for major
histocompatibility complex ,class 1 in regulating natural killer cell-
mediated killing of virus-infected cells. Proc. Natl. Acad. Sci. U. S. A.
89:8337 -8341. 
Kawase, I., D.. L. Urdal , C. G. Brooks, and C. S. Henney. 1982. Selective
depletion of NK cell activity in vivo and its effects on the growth of
NK sensitive and resistant tumor cell variants. Int. J. Cancer 29:567-
574.
Karre, K., M. Hansson, and R. Kiessling. 1991. Multiple interactions , at
the natural killer workshop. Immunol. Today 12:343-345.
Kiessling, R. W., and R. M. Welsh. 1980. Killing of normal cells by
activated mouse natural killer cells: evidence for two patterns of
genetic regulation of lysis. Int. J. Cancer 25 :611-615.
Kiessling, R., E. Eriksson, L. A. Hallenbeck, and R. M. Welsh.
comparative analysis of the cell surface properties of
versus endogenous mouse natural killer cells. J. Immunol.
1557.
1980. A
activated
125: 1551-
Kiessling, R., E. Klein, and H. Wigzell. 1975a. "Natural" killer cells in
the mouse. I. Cytotoxic cells with specificity for' mouse 
Moloney
leukemia cells. Specificity ' and distribution according to genotype.
Eur. J. Immunol. 5:112-117. 
Kiessling, R. , E. Klein, H. Pross, and H. Wigzell. 1975b. "Natural" killer
cells in the mouse. II. Cytotoxic cells with specificity for mouse
!i'
153
Moloney leukemia cells.
Immunol. 5:117- 121.
Characterization of the killer cell. Eur. J.
Kincade, P. W. G. Lee, T. Watanabe, L. Sun, and M. P. Scheid. 1981.
Antigens displayed on murine B lymphocyte precursors. J. Immunol.
127 :2262-2268.
Koller, B. H. , P. Marack, J. W. Kappler, and O. Smithies. 1990. Normal
development of mice deficien in ~2M, MHC class' I proteins, and CD8+
cells. Science 248 :1227- 1230.
Kroczek, R. A., K. C. Gunter, R. N. Germain, and E. M. Shevach. 1986.
Thy- functions as a signal transduction molecule in T lymphocytes
and transfected B lymphocytes. Nature 322:181- 184.
Kunkel, L. A., and R. M. Welsh. 1981. Metabolic inhibitors render
resistant target cells sensitive to natural killer cell-mediated 
lysis.
Int. J. Cancer 27:73-79.
Kupfer, A., G. Dennert, and S. J. Singer. 1983. Polarization of the
Golgi apparatus and the microtubule-organizing center within cloned
natural killer cells bound to ' their targets. Proc. Natl. Acad. Sci. U. S.
A. 80:7224-7228.
Lanier, L. L., C. Chang, M. Azuma, J. J. Ruitenberg, J. J. Hemperly, and
J. H. Phillips. 1991a. Molecular and functional analysis of human
natural killer cell-associated neural cell adhesion molecule (N-
CAM/CD56). J. Immunol. 146:4421-4426.
Lanier, L. L. , G. Yu, and J. H. Phillips. 1991b. Analysis of FcyRIII
(CDI6) membrane expression and association with CD3 and FceRI-
by site-directed mutation. J. Immunol. 146:1571- 1576.
154
Lanier, L. L., R. Testi, J. Bindl , and J. H. Phillips. 1989a. Identity of
Leu-19 (CD56) leukocyte differentiation antigen and neural cell
adhesion molecule. J. Exp. Med. 169:2233-2238.
Lanier, L., G. Yu, and J. H. Phillips.
with a receptor (CDI6) for IgG Fc
Nature 342:803-804.
1989b. Co-association of CD3
on human natural killer cells.
Larson, J. K. , W. H. Wunner, L. Otvos, Jr., and H. C. J. Ertl. 1991.
Identification of an immunodominant epitope within the
phosphoprotein of rabies virus that is recognized by both class I- and
class II-restricted T cells. J. Virbl. 65:5673-5679.
Lee, D. R., R. J. Rubocki, W. -R. Lie, and T. H. Hansen.
murine MHC class I genes, H-2Dq and H-2Lq are
homologous to each other, H-2Ld , and two genes reported
tumor-specific antigens. J. Exp. Med. 168:1719- 1739.
1988. The
strikingly
to encode
Lee, W. T., X. -M. Yin, and E. S. Vitetta. 1990. Functional and
ontogenetic analysis of murine CD45Rhi and CD45Rl CD4+ T cells. 
Immunol. 144:3288-3295.
Lefrancois, L.
antigens ' during
139 :2220-2229.
1987. Expression of carbohydrate differentiation
ontogeny of the murine thymus. J. Immunol.
Leibson, P. J., D. E. Midthun, K. P. Windebank, and R. T. Abraham.
1990. Transmembrane signaling during natural killer cell-mediated
cytotoxicity. Regulation by protein kinase C activation. J. Immunol.
145:1498- 1504.
Liao, N. -S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC
class I deficiency: susceptibility to natural (NK) cells and impaired
NK activity. Science 253:199-202.
155
Lie, W. -R., N. B. Myers, J. M. Connolly, J. Gorka, D. R. Lee, and T. H.
Hansen. ' 1991. The specific binding of peptide ligand to Ld class I
major histocompatibility complex molecules determines their
antigenic structure. J. Exp. Med. 173:449-459.
Lindahl, P., I. Gresser, P. Leary,
treatment of mice: enhanced
antigens on lymphoid cells. Proc.
1287.
and M. Tovey.
expression of
N atl. Acad. Sci.
1976. Interferon
histocompatibility
U. S. A. 73:1284-
Ljunggren , H. -G., and K. Kare. 1990. In search of the "missing self"
MHC molecules and NK cell recognition. Immunol. Today 11 :237-244.
Ljunggren, H. -G., K. Sturmhofel , E. Wolpert, G. J. Hammerling, and K.
Karre. 1990. Transfection of ~2-microglobuli restores IFN-
mediated protection from natural , killer cell lysis in Y AC-l lymphoma
variants. J. Immunol. 145:380-386.
Lopez, C., R. Ryshke, M. Bennett. 1980. Marrow-dependent cells
depleted by 89Sr mediate genetic resistance to herpes simplex VlfUS
type 1 infection in mice. Infect. Immun. 28:1028- 1032.
MacFarland, R. I., W. H. Burns, and D. O. White. 1977. Two cytotoxic
cells in peritoneal cavity of virus-infected mice:, antibody-dependent
macrophages and nonspecific killer cells. J. Immunol. 119:1569-
1574.
Maryanski, J. L., P. Pala, G. Corradin, B. R. Jordan , and J. -C. Cerottini.
1986. H-2-restricted cytolytic T cells specific for HLA can recognize
synthetic HLA peptide. Nature 324:578-579.
Maryanski , J. L., P. Pala, J. -C. Cerottini, and G. Corradino 1988.
Synthetic peptides as antigens and competitors in recognition by H-
156
2-restricted cytolytic T cells specIfic for HLA.
1405.
J. Exp. Med. 167:1391-
Masson, D., and J. Tschopp. 1987. A family of serine esterases in
lytic granules of cytolytic T lymphocytes. Cell 49:679-685.
Maudsley, D. J., and J. D. Pound. 1991. Modulation of MHC antigen
expression by viruses and oncogenes. Immunol. Today 12:429-431.
McFarland, H. I., and N. J. Bigley. 1990. AGM1+ spleen cells contain
gamma interferon (IFN-y) gene transcripts in the early, sex-
dependent production of IFN- after Picornavirus infection. 
J. Virol.
64:4407 -4413.
Mellencamp, M. W., P. C. M. O'Brien, and J. R. Stevenson. 1991.
Pseudorabies virus-induced suppression of major histocompatibility
complex class I antigen expression. J. Virol. 65:3365-3368.
Milligan, G. N., L. A. Morrison, J. Gorka, V. L. Braciale, and T. J.
Braciale. 1990. The recognition of a viral antigenic moiety by class I
MHC-restricted cytolytic T lymphocytes is limited by the availability
of the endogenously processed antigen. J. Immunol. 145:3188-
3193.
Minato, N., B. R. Bloom, C. Jones , J. Holland, and L. M. Reid. 1979.
Mechanism of rejection of virus in persistently infected tumor cells
by athymic nude mice. J. Exp. Med. 149:1117- 1133.
Moller, J. R., B. Rager-Zisman, P. -C. Quan , A. Schattner, D. Panush, J. K.
Rose, and B. R. Bloom. 1985. Natural killer cell recognition of target
cells expressing different antigens of vesicular stomatitis virus. Proc.
Natl. Acad. Sci. U. S. A. 82:2456-2459.
157
Monaco, J. J. , S. Cho, and M. Attaya. 1990. Transport protein genes in
the murine MHC: possible implications for antigen processing.
Science 250:1723- 1726.
Moore, M., W. J. White, and M. R. Potter.
cell susceptibility to human natural killer
Cancer 25:565-572.
1980. Modulation of target
cells by interferon. Int. J.
Moretta, A. , C. Bottino, D. Pende, G. Tripodi, G. Tambussi , O. Viale, A.
Orengo, M. Barbaresi, A. Merli, E. Ciccone, and L. Moretta. 1990.
Identification of four subsets of human CD3- CD 16+ natural killer (NK)
cells by the expression of clonally distributed functional surface
molecules: correlation between subset assignment of NK clones and
ability to mediate specific alloantigen recognition. J. Exp. Med.
172:1589- 1598.
Moss, B. 1968. Inhibition of HeLa cell protein synthesis by the
vaccinia VIrIon. J. Virol. 2:1028- 1037.
Munoz, A., L. Carrasco, and M. Fresno.
susceptibility of HSV - infected cells to
interferon. J. Immunol. 131:783-787.
1983. Enhancement of
natural killer cells by
Miillbacher, A. , I. A. Ramshaw, and B. E. H. Coupar. 1989. Vaccinia-
interleukin 2 recombinant virus or exogenous interleukin 2 does not
alter the magnitude or immune response gene defects of the
cytotoxic T-cell response to vaccinia virus in vivo. Scand. J. Immunol.
29:1-
Nakamura, T., K. Takahashi, T. Fukazawa, M. Koyanagi, A. Yokoyama,
H. Kato, H. Yagita, and K. Okumura. 1990. Relative contribution of
CD2 and LFA-l to murine T and natural killer cell functions. 
Immunol. 145:3628-3634.
158
Newman, W., L. D. Fast amd L. M. Rose. 1983. Blockade of NK cell
lysis is a property of monoclonal antibodies that bond to distinct
regions of T-200. J. Immunol. 131:1742-1747.
Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C
and its implications for cellular regulation. Nature 334:661-665.
Nitta, T., H. Yagita, K. Sato, and K. Okumura. 1989. Involvement of
CD56 (NKH- l/Leu-19 antigen) as an adhesion molecule in natural
killer-target cell interactions. J. Exp. Med. 170:1757- 1761.
Nunn, M. E., R. B. Herberman, and H. T. Holden. 1977. Natural cell-
mediated cytotoxicity in mice against non-lymphoid tumor cells and
some normal cells. Int. J. Cancer 20:381-387.
Nunn, M. , J. Djeu,
cytotoxic reactivity
leukemia. Proc. Am.
D. Lavrin, and R. Herberman. 1973. Natural
of rat lymphocytes against syngeneic Gross
Assoc. Cancer Res. 14:87 (abs.
Oldstone, M. B.' A. 1991.
Virol. 65:6381-6386.
Molecular anatomy of viral persistence.
Ortaldo, J. R. , S. O. Sharow , T. Timonen, and R. B. Herberman. 1981.
Determination of surface antigens on highly purified human NK cells
by flow cytometry with monoclonal antibodies. J. Immunol.
127 :2401-2409.
Ortaldo, J. R., W. Phillips, K. Wasserman, and R. B. Herberman. 1980.
Effects of metabolic inhibitors on spontaneous and interferon-
boosted human natural killer cell activity. J. Immunol. 125:1839-
1844.
Pala, P., H. C. Bodmer, R. M. Pemberton, J. -C. Cerottini, J. L.
Maryanski, and B. A. Askonas. 1988. Competition between
- - - - -. - - - - - -
159
unrelated
Immunol.
peptides recognized
141 :2289-2294.
2Kd -restricted T cells.
Parham, P., C. Clayberger
, ,
S. L. Zorn, D. S. Ludwig, G. K. Schoolnik, and
A. M. Krensky. 1987. Inhibition of alloreactive cytotoxic T
lymphocytes by peptides from the a2 domain of HLA-A2. Nature
325:625-628.
Paya, C. V., N. Kenmotsu, R. A. Schoon, and P. J. Leibson. 1988.
Tumor necrosis factor and lymphotoxin secr tion by human natural
killer cells leads to antiviral cytotoxicity. J. Immunol. 141:1989-
1995.
Perussia, B., and G. Trinchieri. 1981. Inactivation of
cell cytotoxic activity after interaction with target cells.
126:754-758.
natural killer
J. Immunol.
Piontek, G. E., K. Taniguchi, H. -G. Ljunggren , A. Gronberg, R. Kiessling,
G. Klein, and K. Karre. 1985. ' YAC- MHC class I variants reveal an
association between increased H- expression after interferon
treatment or in vivo passage. J. Immunol. 135:.4281-4288.
Podack, E. R., and P. J. Konigsberg. 1984. Cytolytic T cell granules.
Isolation, structural, biochemical, and functional characterization. J.
Exp. Med. 160:695-710. 
Pulido, R. and F. Sanchez-Madrid. 1990. Glycosylation of CD45:
carbohydrate composition and its role ' in acquisition of CD45RO and
CD45RB T cell maturation-related antigen specificities during
biosynthesis. Eur. J. Immunol. 20:2667-2671.
Pulido" R. and F. Sanchez-Madrid. 1992. Glycosylation of CD45:
carbohydrate processing through Golgi apparatus is required for cell
160
surface expression and protein stability.
468.
Eur. J. Immunol. 22:463-
Quan, P. - , T. Ishizaka, and B. R. Bloom. 1982. , Studies on the
mechanism of NK cell lysis. J. Immunol. 128:1786- 1791.
Quillet, A., F. Presse, ' C. Marchiol- Fournigault, A. Harel-Bellan, M.
Benbunan, H; Ploegh, and D. Fradelizi. 1988. Increased resistance to
non-MHC-restricted cytotoxicity related to HLA A, B expression.
Direct demonstration using ~2-microglobulin-transfected Daudi cells.
J. Immunol. 141:17-20.
Rahemtulla, A. W. P. Fung-Leung, M. W. Schilham, T. M. Kiindig, S. R.
Sambhara, A. Narendran, A. Arabian, A. Wakeham, C. J. Paige, R. M.
Zinkemagel, R. G. Miller, and T. W. Mak. 1991. Normal development
and function of CD8+ ' cells but markedly dec'reased helper cell
activity in mice lacking CD4. Nature 353:180- 184.
Ramshaw, I. A., M. E. Andrew, S. M. Phillips, D. B. Boyle, and B. E. H.
Coupar. 1987. Recovery of immunodeficient mice from vaccinia
virus/lL- recombinant infection. Nature 329:545-546.
Reichner, J. S., S. W. Whiteheart, and G. W. Hart.
traffiCking of cell surface sialoglycoconjugates.
263:16316- 16326.
1988. Intracellular
J. BioI. Chem.
Ritz, J., R. , E. Schmidt, J. Michon, T. Hercend, and S. F. Schlossman.
1988. Characterization of functional surface structures on human
, natural killer cells. Adv. Immunol. 42:181-211.
Roder, J., R. Kiessling, P. Biberfield, and B. Andersson. 1978. Target-
effector interaction in the natural killer (NK) cell system. II. The
isolation of NK cells and studies on the mechanism of killing. 
Immunol. 121:2509-2517.
161
Rotzschke, 0. , K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung,
and H. -G. Rammensee. 1990. Isolation and analysis of naturally
processed viral peptides as recognized by cytotoxic T cells. Nature
348:252-254. 
Routes, J. M. 1992. IFN increases class I MHC antigen expression on
adenovirus-infected human cells without inducing resistance to
natural killer cell killing. J. Immunol. 149:2372-2377.
Routes, J. M. 1993. Adenovirus EIA inhibits IFN-induced resistance
to cytolysis by, natural killer cells. J. Immunol. 4315-4322.
Ryan, J. C., E. C. Niemi, R. D. Goldfien, J. C. Hiserodt, and W. E. Seaman.
1991. NKR- , an activating molecul , on rat natural killer cells
stimulates phosphoinositide turnover and a rise in intracellular
calcium. J. Immunol. 147:3244-3250.
Ryan, J. C., J. Turck, E. C. Niemi , VI. M. Yokoyama, and W. E. Seaman.
1992. Molecular cloning of the NK1.1 antigen, a member of the NKR-
PI family of natural killer cell activation ' molecules. J. Immunol.
149;1631- 1635.
Saga, Y., K. Furukawa, P. Rogers, J. -So Tung, D. Parker, and E. A. Boyse.
1990. Further data on the selective expression of Ly- isoforms.
Immunogenetics 31 :296-306.
Sambhi, S. K., M. R. J. Kohonen-Corish, and I. A. Ramshaw. 1991.
Local production of tumor necrosis factor encoded by recombinant
vaccinia virus is effective in controlling viral replication in vivo.
Proc. Natl. Acad. Sci. U. S. A. 88:4025-4029. 
Santoli, D., G. Trincbieri, and F. S. Lief. 1978a. Cell-mediated
cytotoxicity against virus-infected target cells in humans. 
---  - - .
162
Characterization of the effector lymphocyte.
531.
J. Immunol. 121:526-
Santoli, D., G. Trinchieri, and H. Koprowski. 1978b. Cell-mediated
cytotoxicity against virus- infected target cells in humans. II.
Interferon induction and activation of natural killer cells. 
lmmunol. 121:532-538.
Scalzo, A. A. , N. A. Fitzgerald, C. R. Wallace, A. E. Gibbons, Y. C. Smar,
R. C. B urton, and G. R. Shellam. 1992. The effect of the em v -
resistance gene, which is' linked to the natural killer cell gene
complex,- is mediated by natural killer cells. J. Immunol. 149:581-
589.
Scheppler, J. A. , J. K. A. Nicholson , D. C. Swan , A. Ahmed-Ansar, and J.
S. McDougal. 1989. Down-modulation of MHC-I in a CD4+ T cell line,
CEM- after HIV-l infection. J. Immunol. 143:2858-2866.
Schlager, A. I., and S. H. Ohanian. 1980. Tumor cell lipid composition
and sensitivity to humoral immune killing. I. Modification of cellular
lipid and fatty acid content by metabolic inhibitors and hormones. J.
Immunol. 124:626-634.
Seaman, W. E., E. Eriksson, R. Dobrow, and J. B. Imboden. 1987.
Inositol trisphosphate is generated by a rat natural killer cell tumor
in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during
activation by target cells. Proc. Natl. Acad. Sci. U. S. A. 84:4239-
4243.
Seaman, W. E., N. Talal, L. A. Herzenberg, L. A. Herzenberg, and J. A.
Ledbetter. 1981. Surface antigens on mouse natural killer cells: use
of monoclonal antibodies to inhibit or to enrich cytotoxic activity. 
Immunol. 127 :982-986.
163
Sentman, C. L., J. Hackett, Jr., V. Kumar, and M. Bennett. 1989.
Identification of a subset of murine natural killer cells that mediates
rejection of Hh- ld but not Hh- lb bone marrow grafts. J. Exp. Med.
170:191- 202.
Shanley, J. D. 1990. In vivo administration of monoclonal antibody
to the NK1.1 antigen of natural killer cells: effect on acute murine
cytomegalovirus infection. J. Med. Virol. 30:58-60.
Spickett, G. P., M. R. Brandon , D. W. Mason, A. F. Williams , and G. R.
Woolett. 1983. MRC OX- , a monoclonal antibody that labels a new
subset of T lymphocytes and reacts with the high molecular weight
form of the leukocyte-common antigen. J. Exp. Med. 158:795-810.
Spies, T., and R. DeMars. 1991. Restored expression of major
histocompatibility class I molecules by gene transfer of a putative
peptide transporter. Nature 351 :323-324.
Spies, T., M. Bresnahan, S. Bahram, D. Arnold, G. Blank . Mellins, D.
Pious, and R. DeMars. 1990. A gene in the human major
histocompatibility complex class II region controlling the class I
antigen presentation pathway. Nature 348:744-747.
Springer, T. A. 1990.
Nature 346:425-434.
Adhesion receptors of the immune system.
Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1978. Monoclonal
xenogeneic antibodies to murine cell surface antigens: identification
of novel leukocyte differentiation antigens. Eur. J. Immunol. 8:539-
551.
Steele, T. A. , and Z. Brahmi. 1988. Phosphatidylinositol metabolism
accompanies early activation events in tumor target cell-stimulated
human natural killer cells. Cell. Immunol. 112:402-413.
164
Stein-Streilein, J., and J. Guffee. 1986. In vivo treatment of mice and
hamsters with antibodies to asialo GMI increases morbidity and
mortality to pulmonary influenza infection. J. Immunol. 136:1435-
1441.
Storkus, W. J., J. Alexander, J. A. Payne, J. R. Dawson, and P. Cresswell.
1989a. Reversal of natural killing susceptibility in target cells
expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. U. S.
A. 86:2361-2364. 
Storkus, W. J., J. Alexander, J. A. Payne, P. Cresswell, and J. R. Dawson.
1989b. The ex 1/ ex 2 domains of class I HLA molecules confer
resistance to natural killing. J. Immunol. 143:3853-3857.
Storkus, W. J., R. D. Salter, J. Alexander, F. E. Ward, R. E. Ruiz, P.
Cresswell, and J. R. Dawson. 1991. Class I-induced resistance to
natural killing: identification of nonpermissive residues in HLA-A2.
Proc. Natl. Acad. Sci. U. S. A. 88:5989-5992.
Storkus, W. J., R. D. Salter, P. Cresswell, and J. R. Dawson. 1992.
Peptide-induced modulation of target cell sensitivity to natural
killing. J. Immunol. 149:1185- 1190.
hls, A. K., and O. Caren. 1989. Generation of inositol phosphates
during triggering of cytotoxicity in human natural killer and
lymphokine-activated killer cells. Scand. J. Immunol. 29:211-216.
Su, H. C., K. A. Leite-Morris , L. Braun, and C. A. Biron. 1991. A role
for transforming growth factor-~ 1 in regulating natural killer cell
and T lymphocyte proliferative responses during acute infection with
lymphocytic choriomeningitis , virus. J. Immunol. 147:2717-2727.
165
Takasugi, M., M. R. Mickey, and P. I. Terasaki. 1973. Reactivity of
lymphocytes from normal persons on cultured tumor cells. Cancer
Res. 33:2898-2902.
Tanaka, Y., and S. S. Tevethia. 1988. Differential effect of adenovirus
2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I
antigens and H-2Kb- and H-2Db-restricted SV-40-specific CTL-
mediated lysis. Virology 165:357-366.
Tian, Q., M. Streuli, H. Saito, S. F. Schlossman, and P. Anderson. 1991.
polyadenylate binding protein localized to the granules of cytotoxic
lymphocytes induces DNA fragmentation in target cells. Cell 67:629-
639.
Timonen, T., A. Ranki, E. Saksela, and P. Hayry. 1979. Human natural
cell-mediated cytotoxicity against fetal fibroblasts. III.
Morphological and functional characterization of the effector cells.
Cell. Immunol. 48:121- 132.
Tomkinson, B. E. R. Maziarz, and J. L. Sullivan.
Characterization of the cell-mediated cellular cytotoxicity
acute infectious mononucleosis. J. Immunol. 143:660-670.
1989.
during
Townsend, A. R. M. , J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith
and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein
recognized by cytotoxic T lymphocytes can be defined with short
synthetic peptides. Cell 44:959-968.
Townsend , A., and H. Bodmer. 1989. Antigen recognition by class 
restricted T lymphocytes. Annu. Rev. Immunol. 7:601-624.
Townsend, A., C. Ohlen, J. Bastin, H. -G. Ljunggren, L. Foster, and K.
Karre. 1989. Association of class I major histocompatibility heavy
and light chains induced by viral peptides. Nature 340:443-448.
166
Trinchieri, G., and D. Santoli. 1978. Anti-viral activity induced by
culturing lymphocytes with tumor-derived or virus- transformed
cells. Enhancement of natural killer activity by interferon and
antagonistic inhibition of susceptibility of target cells to lysis. J. Exp.
Med. 147:1314- 1333.
Trinchieri, G., D. Granato, and B. Perussia. 1981. Interferon-induced
resistance of fibroblasts to cytolysis mediated by natural killer cells.
Specificity and mechanism. J. Immunoi. 126:335-340.
Trowbridge, I. S. 1991.
protein tyrosine phosphatases.
CD45. A prototype for transmembrane
J. BioI. Chem. 266:23517-23520.
"I'
Trowsdale, J. , I. Hanson, I. Mockridge, S. Beck, A. Townsend, and A.
Kelly. 1990. Sequences encoded in the class II region of the MHC
related to the 'ABC' superfamily of transporters. Nature 348:741-
744.
Tschopp, J., D. Masson, and K. K. Stanley. 1986. Structural/functional
similarity between proteins involved in complement- and cytotoxic
T -lymphocyte-mediated cytolysis. Nature 322:831-834.
Van Bleek, G. M., and
endogenously processed
class I H 2Kb molecule.
S. G. Nathenson. 1990. Isolation of an
immunodominant viral peptide from the
Nature 348:213-216.
van Boxel, J. A. , J. D. Stobo, W. E. Paul, and I. Green. 1972. Antibody-
dependent lymphoid cell-mediated cytotoxicity: no requirement for
thymus-derived lymphocytes. Science 175: 194- 196.
Vargas-Cortes, M., C. L. O'Donnell, M. C. Appel, J. W. Maciaszek, K. S.
Yurkunas, and R. M. Welsh. 1992. A lymphocyte differentiation and
167
activation antigen, CZ- that distinguishes between CD8+ and
unstimulated CD4+ T lymphocytes. Eur. J. Immunol. 22:1043- 1047.
Vargas-Cortes, M., C. O'Donnell, J. Maciaszek, T. A. ,Moore, M. Bennett,
V. Kumar, and R. M. Welsh. 1991. Monoclonal antibody CZl blocks
IL- function and identifies an activation and differentiation antigen
on NK cells, their precursors and progenitors. Nat. Immun. Cell
Growth Regul. 10:153 (abs.
Vivier, E. , N. Rochet, J. P. Kochan, D. H. , Presky, S. F. Schlossman, and P.
Anderson. 1991 a. Structural similarity between Fc receptors and T
cell receptors. Expression of the y-subunit of FceRI in human T cells,
natural killer cells and thymocytes. J., Immunol. 147:4263-4270.
Vivier, E., P. Morin, C. O'Brien, B. Druker, S. F. Schlpssman, and P.
Anderson. 1991b. Tyrosine phosphorylation of the FcyRiII (CDI6): 
complex in human natural killer cells. Induction by antibody-
dependent cytotoxicity but not by natural killing. J. Immunol.
146 :206- 21 0.
Waneck G. L;, D. H. Sherman, S. Calvin, H. Allen , and, ,R. A. Flavell.
1987. Tissue-specific expression of cell-surface Qa- antigen from a
transfected Q7b gene of C57BL/I0 mice. J. Exp. Med. 165:1358-1370.
Welsh, R. M. 1978. Cytotoxic cells induced during lymphocytic
choriomeningitis virus infection of mice. I. Characterization of
natural killer cell induction. J. Exp. Med. 148: 163 - 181.
Welsh, R. M. 1986. Regulation of virus infections by natural killer
cells. ' Nat. Immun. Cell Growth Regul. 5:169- 199.
Welsh , R. M. , and L. A. Hallenbeck. 1980. Effect of virus infections
on target cell susceptibility to natural killer cell-mediated lysis. 
Immunol. 124:2491-2497.
168
Welsh, R. M., and M. Vargas-Cortes. 1992. Natural killer cells in viral
infection. In: Lewis, E., and J. O'D. McGee (eds.), The Natural Immune
System: the natural killer cell. Oxford, Oxford University Press, pp.
108- 150.
Welsh, R. M., and R. M. Zinkernagel. 1977. Heterospecific cytotoxic
cell activity induced during the first three days of acute lymphocytic
choriomeningitis virus infection of mice. Nature 268:646-648.
Welsh, R. M., J. O. Brubaker, M. , Vargas-Cortes, and C. L. O'Donnell.
1991. Natural killer (NK) cell response to virus infections in mice
with severe combined immunodeficiency. The stimulation of NK cells
and the NK cell-dependent control of virus infections occur
independently of T and B cell function. J. Exp. Med. 173:1053- 1063.
Welsh, R. M., K. Kare, M. Hansson, L. A. Kunkel, and R. W. Kiessling.
1981. Interferon-mediated protection of normal and tumor target
cells against lysis by mouse natural killer cells. J. Immunol. 126:219-
225.
Welsh, R. M. , P. L. Dundon, E. E. Eynon, J. O. Brubaker, G. C. Koo, and C.
L. O'Donnell. 1990. Demonstration of the antiviral role of natural
killer cells in vivo with a natural killer cell-specific monoclonal
antibody. Nat. Immun. Cell Growth Regul. 9:112- 120.
Welsh, R. M. , R. J. Natuk, K. W. McIntyre, H. Yang, C. A. Biron, and J. F.
Bukowski. 1989. Factors influencing the control of virus infections
by natural killer cells. In: Reynolds, C. W., and R. H. Wiltrout (eds.
Functions of the Natural Immune System. New York, Plenum
, pp
111- 128.
Welsh, R. M., R. M. Zinkernagel, and L. A. Hallenbeck. 1979. Cytotoxic
cells induced during lymphocytic choriomeningitis virus infection of
169
mice.
481.
II. Specificities" of the natural killer cells. J. Immunol. 475-
Windebank, K. P. , R. T. Abraham, G. Powis, R. A. Olsen" T. J. Bara, and
P. J. Leibson. 1988. Signal transduction during human natural killer
cell activation: inositol phosphate generation and regulation by cyclic
AMP. J. Immunol. 141:3951-3957.
Wolfe, S. A., D. E. Tracey, and C. S. Henney. 1976.
natural killer" cells by BCG. Nature 262:584-586.
Induction of
Wong, C. Y. , J. J. Woodruff, and J. F. Woodruff. 1977. Generation of
cytotoxic T lymphocytes during Coxsackievirus B- infection. III.
Role of sex. J. Immunol. 119:591-597.
Wong, G. H. W. , and D. V. Goeddel. 1986. Tumour necrosis factors 
and ~ inhibit virus replication and synergize with interferons.
Nature 323:819-822.
Yang, H., and R. M. Welsh. 1986. Induction of alloreactive cytotoxic T
cells by acute virus infection of mice. J. Immunol. 136:1186- 1193.
Yewdell, J. W., and J. R. Bennink. 1992. Cell Biology of antigen
processing and presentation to major histocompatibility complex
class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1- 123.
Yogeeswaran, G., R. Fujinami, R. Kiessling, and R. M. Welsh.
Interferon-induced alterations in sialic acid and glycoconjugates
929 cells. Virology 121 :363-371.
1982.
of L-
Yokoyama, W. M., J. C. Ryan, J. J. Hunter, H. R. C. Smith, M. Stark, and
W. E. Seaman. 1991. cDNA cloning of mouse NKR-Pl and genetic
linkage with Ly-49. Identification of natural killer cell gene
complex on mouse chromosome 6. J. Immunol. 147:3229-3236.
170
Yokoyama, W. M., L. B. Jacobs, O. Kanagawa, E. M. Shevach, and D. I.
Cohen. 1989. A murine T lymphocyte antigen belongs to a
supergene family of type II integral membrane proteins. 
Immunol. 143:1379- 1386.
Yokoyama, W. M., P. J. Kehn, D. I. Cohen, and E. M. Shevach. 1990.
Chromosomal location of the Ly-49 (AI , YE1/48) multi gene family.
Genetic association with the NK1.1 antigen. J. Immunol. 145:2353-
2358.
Young, J. D. -E., H. Hengartner, E. R. Podack, and Z. A. Cohn. 1986a.
Purification and characterization of cytolytic pore-forming protein
from granules of cloned lymphocytes with natural killer activity. Cell
44:849- 859.
Young, J. D. -E., Z. A. Cohn, and E. R. Podack. 1986b. The ninth
component of complement and the pore-forming protein (Perforin 1)
from cytotoxic T cells: structural, immunological, and functional
similarities. Science 233: 184- 190.
Yu, Y. Y. L., V. Kumar, and M. Bennett. ' 1992. Murine natural killer
cells and marrow graft rejection. Annu. Rev. Immunol. 10:189-213.
Zalman, L. S. , M. A. Brothers, F. J. Chiu, and H. J. Muller-Eberhard.
1986. Mechanism of cytotoxicity of human large granular
lymphocytes: relationship of the cytotoxic lymphocyte protein to the
ninth component (C9) of human complement. Proc. Natl. Acad. Sci. U.
S. A. 83:5262-5266.
Zijlstra, M. , M. Bix, N. E. Simister, J. M. Loring, D. H. Raulet, and R.
Jaenisch. 1990. ~2-microglobulin deficient mice lack CD4-CD8+
cytolytic T cells. Nature 344:742-746.
171
Zinkemagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic
cells: studies on the biological role of polymorphi major
transplantation antigens determining T-cell restriction--specificity,
function and responsiveness. Adv. Immunol. 27:51- 177.
